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Metal-organic framework (MOF) nanoparticles are highly promising drug delivery carriers 
for chemotherapy due to their tailorable properties, biocompatibility and responsiveness to 
external stimuli. However, MOFs are typically characterised as infinite repeating crystals, 
and there is limited thermodynamic insight as to how the properties and performance of a 
MOF change as a function of its particle size. It is also not clear what properties are ideal for 
drug delivery, or what simulation methods should be used to best mimic drug uptake and 
delivery experiments.  
In this thesis, molecular simulations were used to elucidate the particle-size influence on 
guest-molecule adsorption and induced framework flexibility in a flexible MOF, DUT-
8(Ni), with various external surface functionalities. Standard and novel simulation 
techniques were also used to model the uptake and release of cisplatin (a chemotherapy drug) 
inside biocompatible MOFs UiO-66 and UiO-66(NH2) and compared to experimental results 
to test the advantages and limitations of each method. The simulation methods were finally 
used to test property – performance relationships in a series of biocompatible and pH 
sensitive MOFs as cisplatin delivery carriers, to pinpoint a selection criterion for MOFs used 
in further cancer-treatment research.  
Overall, the external surface is not important for simulations in which the results mainly 
depend on the non-bonded interactions because the influence of the external surface on 
interaction energies is short-ranged. However, the external surface significantly contributes 
to the internal energy of the framework, hence it is important when characterising a MOF’s 
structural responses to external stimuli. Experimental drug uptake and delivery is carried out 
in aqueous solution. Simulations with and without water show that the non-solvated models 
can be misleading, and it is therefore crucial to understand the limitations of solvent free 
models whenever they are applied in drug delivery research. Finally, simulations of cisplatin 
uptake and release in potential MOF carriers show that wide pores interconnected by large 
windows will enhance drug molecule uptake from solution, which relies on the accessible 
pore volume and the driving force / energy barriers associated with uptake. Retention can be 
enhanced by creating large diffusion energy barriers. This can be achieved by functionalising 
the framework’s channels to get strong, dispersed adsorption sites, or by reducing the pore-
window size, however the latter will also compromise drug-molecule uptake. 
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CHAPTER 1. INTRODUCTION 
 
1.1. Metal-organic frameworks 
 
Metal-organic frameworks (MOFs) consist of metal nodes attached by coordination bonds 
to multidentate organic ligands, forming typically microporous (pore diameter < 2 nm [1]) 
or mesoporous (pore diameter 2 – 50 nm [1]) crystalline materials. The metal nodes consist 
of either a single metal cation (for example, a subclass of MOF, “zeolitic imidazole 
frameworks” consist of single metal ions such as Zn(II) or Co(II) connected by imidazolate-
type organic ligands [2]) or a cationic inorganic cluster (for example, a prototypical MOF 
called UiO-66 consists of Zr6O4(OH)4 nodes coordinated by bidentate aromatic ligands [3]). 
These precursors self-assemble into crystals when exposed to the correct solvothermal 
conditions (i.e. the application of solvent and high temperatures to enhance interactions 
between the precursors spurring crystallisation).  
 
One of the first documentations of MOFs was in 1965 when Tomic formed “coordination 
polymers” (another term used to describe MOFs) via solvothermal synthesis. They found 
that the thermal stability of the as-made structures depended on the metal used, for instance 
metal ions less-able to change their ionic valency form more stable structures [4]. In their 
work, the as-made materials were not strictly porous because they contained solvent, 
however it induced the idea that MOFs could exhibit permanent porosity because of space 
between the metal nodes created by the organic ligands. There was limited research in the 
decades following this preliminary work, largely due to difficulties associated with the 
synthesis of MOFs. More specifically, the aim of synthesis is to create a material with 
predetermined properties (such as pore size, in the case of porous materials). This is 
particularly troublesome with MOFs because their insolubility means synthesis must be 
carried out in a single step. Therefore, the reactants must be subunits of the target material 
(the “molecular building block” approach in which literal fragments of the product are used 
as reactants), and the methodology must be capable of using those subunits to create a 
crystalline product [5]. Other issues with MOF synthesis that initially hindered their 
production included the lack of control associated with the orientation of building units, and 
accessing the pores was difficult due to strong guest-host interaction energies which caused 




It was over 30 years since the work of Tomic that MOF research rapidly accelerated 
following pioneering work from Yaghi and co-workers: In 1999, they used the molecular 
building block approach to synthesise one of the first MOFs to display permanent porosity, 
MOF-5. Their work showed (by determining N2 adsorption isotherms) that MOF-5 was 
highly porous after desolvation (something that had been previously difficult to achieve due 
to framework collapse during solvent removal), with a pore volume of ~ 0.6 cm3/cm3 
(compared to < 0.47 cm3/cm3 for zeolites), and that MOF-5 undergoes reversible 
adsorption/desorption, hence exhibits permanent porosity [8]. X-Ray diffraction showed that 
the structure of MOF-5 could be predicted from the building units (BDC and 
Zn(NO3)2.4H2O) and that it is stable up to 300 °C. X-ray diffraction of N2 and Ar adsorbed 
in MOF-5 showed that it had a larger surface area than expected (3,800 m2/g) due to 
surprising adsorption sites surrounding the aromatic functional group of the BDC ligands [8, 
9]. Amongst other uses, high surface area adsorbents are used to reduce the energy intensity 
of gas adsorption processes, hence the high surface area of MOF-5 compared to conventional 
adsorbents (such as zeolites ~ < 720 m2/g [10], and activated carbons ~ 500 – 1,500 m2/g, 
though the maximum reported < 3,000 m2/g [11, 12]) sparked a lot of interest in the 
development of MOFs.  
 
Shortly after the initial synthesis and characterisation of MOF-5, Eddaoudi et al 
systematically synthesised a collection of MOFs with the same underlying topology as 
MOF-5 but with different pore sizes and chemical functionalities. Each of these isoreticular 
MOFs (i.e. a collection of MOFs with the same underlying topology, in this case known as 
the IRMOF series) was synthesised using the same reaction conditions but different organic 
ligands. Therefore, based on the secondary building units added to the reaction mixture, they 
had prior knowledge of the structures before they were synthesised [13]. As well as desirable 
material properties such as the porosity and surface area, this pioneering research highlighted 
several important advantages of MOFs compared to other microporous materials. Firstly, the 
pore size and shape can be dictated by precursors, meaning MOFs can be tailored for specific 
applications. Secondly, reticular synthesis (i.e. the systematic design of MOFs based on 
precursors and the ability to predict structures pre-synthesis) allows structural properties to 
be tuned methodologically. Finally, MOFs with the same topology can have different 
functionalities (or a variety of functionalities in the same framework) by adding functional 




Since these pioneering works, MOFs have been extensively shown to exhibit large pore 
cavity sizes and porosities typically exceeding 50 % [14], enabling a high loading of guest 
molecules [15] or the incorporation of large guest molecules [16] into the framework. 
Furthermore, their typically well-defined pore windows have demonstrated the potential of 
MOFs in applications reliant upon molecular sieving (e.g. separation [17] and target-specific 
catalysis [18]), and their large internal surface areas (typical BET surface areas for MOFs 
are > 1,000 m2/g [14]) have shown huge potential for enhanced adsorption (e.g. in gas 
storage and catalysis applications [19]). Because of the clear advantages of MOFs compared 
to more conventional porous materials, there has been an exponential increase in the number 
of MOFs synthesised, characterised, and published in the Cambridge Structural Database 
(CSD) [20]. In 2019, there was ~ 96,000 MOFs recorded in the CSD and based on a 
hypothetical database built up from all possible combinations of molecular building units, 
there could be ~138,000 in future [21, 22]. As seen by the large number of published 
structures, MOF synthesis and characterisation techniques are now well developed, however 
there remain challenges, for example associated with precise control of functional group 
positions, pore size, shape and stability [23].  
 
The exponential growth of MOF entries in the CSD has been largely due to vast amounts of 
research on enhancing their properties for specific applications. For example, to enhance the 
internal surface area, ligands with high denticity and distributed functional groups tend to be 
used [24]. To date, DUT-60 has the largest recorded accessible surface area (7,800 m2/g) 
and pore volume (90.3 %) [25], and hypothetically MOFs with surface areas > 14,000 m2/g 
could be synthesised, but there remain challenges in achieving this goal such as the collapse 
of frameworks upon desolvation and interpenetration of frameworks during crystal 
formation (i.e. frameworks grow into each other’s pore space, a problem which can be solved 
in some cases by varying the concentrations of reactants)  [19]. In situations where larger 
guest molecules are used, researchers have also focussed on increasing the pore size to 
accommodate such guests. Intuitively, the main approach to increase the pore size would be 
to use longer ligands, however this results in synthesis challenges such as the 
interpenetration of frameworks [14]. Rod-shaped molecular building units (i.e. chains of 
metal – carboxylate) were found to prevent interpenetration due to their intrinsic packing in 
crystals (for example, the mesoporous framework MOF-74 is only accessible via 1-D [26]). 
 
As in the pioneering work of Edduadi et al [13], a lot of the structural development of MOFs 
was carried out using the concept of reticular synthesis in which the properties of a 
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prototypical structure such as HKUST-1 [27] and UiO-66 [3, 28] are modified. One of the 
key reasons for the use of reticular synthesis is to create a family of MOFs with a shared 
desired property. For example, similar to many MOFs MOF-5 has limited industrial use 
because weak Zn(II) – O bonds are susceptible to water, meaning it will degrade in moist 
conditions [29]. In comparison, UiO-66 consists of the same 1,4-BDC ligands, but instead 
has Zr6O4(OH)4 nodes which coordinate to twelve ligands (as opposed to six ligands that 
coordinate the Zn4O nodes in MOF-5). Zirconium forms strong bonds with the carboxylate 
groups of 1,4-BDC ligands, and its high valency (forming the large metal clusters) results in 
a high charge density of the nodes, enhancing coordination bonds in UiO-66, granting it 
stability in water, organic solvents, and across a broad range of temperatures making it a 
strong potential candidate for a variety of industrial processes. To retain the good stability 
whilst increasing the pore volume and window aperture, Cavka et al used the same metal 
nodes but increased the ligand size to synthesise the isoreticular structures UiO-67 
(biphenyl-dicarboxylate ligands) and UiO-68 (terphenyl dicarboxylate ligands) [3]. These 





Figure 1.1. Fine-tuning the properties of metal-organic frameworks by variation of the metal 
nodes and organic ligands [3, 13, 30]. Colour scheme: purple = Zn, blue = Zr, grey = C, red 
= O. Hydrogens have been omitted for clarity. (PLD = pore-limiting diameter, the smallest 





Overall, numerous important achievements have been made which highlight the potential of 
MOFs in real-life applications [31]. For instance, as mentioned many MOFs are susceptible 
to hydrolysis, therefore losing their porosity in the presence of water vapour. However, based 
on prototypical structures (such as ZIF-8 [2] and UiO-66 [3]) a variety of MOFs which are 
less susceptible to chemical degradation due to strong covalent bonding and hydrophobicity 
have been developed, as highlighted in the review by Ding et al [32]. As well as the record 
internal surface areas and porosities, other major achievements include (but are not limited 
to) the synthesis of MOFs that can host catalytic reactions inside the pores (e.g. in MOF-11, 
“open metal sites” / unsaturated nodes are created by removing water from the Cu-
paddlewheel post synthesis forming Lewis acid sites [33]), the addition of amine 
functionality inside the frameworks (e.g. using ligands with electronegative groups that can 
coordinate to amine functionalised molecules [34]), the precise control of particle size (e.g. 
by manipulating the rate of nucleation in the reaction mixture [35]), and the development of 
MOFs that respond to external stimuli such as pressure and temperature [36].  
 
MOFs have been successfully used in some industrial applications, such as trapping toxic 
gas and fruit ripening reduction [37]. Other upcoming industrial applications for MOFs 
include their use in separation processes (e.g. CO2 or SO2 capture from flue gas, because the 
uniformly sized micropores of MOFs segregate molecules based on their size and shape, and 
they can be synthesised with open metal sites, which are strong adsorption sites for electron 
rich species such as sulphurous compounds, water and so on [38, 39]), gas storage (e.g. large 
quantities of H2, a green renewable fuel, can be stored at low pressure because of the large 
internal surface areas and porosity of MOFs [40]), and heterogeneous catalysis (e.g. 
methanol synthesis from syngas, because the uniform, open pore network of MOFs will 
hinder the diffusivity of large guest molecules whilst allowing smaller guest molecules to 
pass unhindered, and their large internal surface areas allow for a high density of active sites 
[31, 41, 42]). 
 
Though MOFs are promising for such industrial applications, it is unlikely that they will 
replace the established adsorbents such as zeolites or activated carbons currently used. 
Firstly, many MOFs show poor stability in the presence of polar compounds (which interfere 
with the coordination bonds between the metal nodes and organic ligands [29, 43]), and they 
are associated with high production costs (nearly an order of magnitude higher than the 
production cost of most zeolites, due to the cost and lack of availability of the organic 
ligands) [44]. Secondly, industrial-scale applications require good space-time-yields of 
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synthesis for economic efficiency, which is difficult because MOFs are typically formed in 
dilute solutions with long reaction times (that said, promising contributions have recently 
been made towards the large-scale synthesis of MOFs such as those described in the review 
by Dunne et al [45])  [46]. Instead, it is far more likely that MOFs will be commercially used 
in smaller, more niche applications (i.e. in sectors with typically higher production costs and 
consumer prices, such as the pharmaceutical industry). 
 
Recently there has been a major focus on the use of MOFs in biomedical applications (as 
highlighted in the review by Yang et al [47]), largely due to the aforementioned economic 
reasons, and the fact that some MOFs are endogenous (with zinc or calcium metal nodes). 
One of the major applications is as bioimaging agents. For example, Sene et al loaded an 
MRI contrasting agent (maghemite) onto the external surface of MIL-100(Fe) and an 
anticancer drug (doxorubicin) into the pores. The contrasting agent enhanced relaxivity 
(relaxation rates of proton spins in nearby water molecules, used to improve the contrast of 
MRI scan images), while the loaded doxorubicin achieved targeted drug delivery [48]. 
Another biomedical application for MOFs is biosensing. For example, Hu et al loaded gold 
nanoparticles into MIL-101 and incorporated glucose oxidase and lactate oxidase onto the 
external surface for the detection of glucose and lactate. Upon detection, an inactive reporter 
molecule (leucomalachite green) oxidised into an active probe molecule (malachite green) 
enhancing the Raman signals (which provide information of the chemical structures) [49]. 
Bio-catalysis is another area where MOFs are highly promising, for example Navarro-
Sánchez loaded the enzyme protease into the mesopores of MIL-101(Al)-NH2 and exposed 
it to harsh environments that would otherwise denature the enzyme (extreme pH, 
temperatures up to 95 °C, and competitor enzymes), finding that the MOF stabilised protease 
enabling higher activities under the tested conditions [50]. Finally, MOFs are extremely 
promising drug delivery carriers. 
 
1.2. Drug delivery 
 
Currently, one of the main drug delivery challenges is associated with chemotherapy. As an 
overview, one in two people are diagnosed with cancer in their lifetime, and the main method 
for treating cancer is chemotherapy. During chemotherapy, drugs (“chemotherapeutics” 
which are usually cytotoxic) are intravenously administered into the patients. One of the 
most common World Health Organisation [51] approved chemotherapeutics is cisplatin (cis-
diamminedichloroplatinum (II), Pt(NH3)2Cl2), which is effective against various types of 
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cancer, for example soft tissue cancer and sarcomas. Cisplatin is a cytotoxic drug that attacks 
dividing cells by cross-linking with purine bases in DNA. Cell regulation mechanisms 
attempt to fix the damaged DNA, and when this fails the cells undergo controlled self-
destruction (apoptosis) [52]. Unfortunately however, cancer is difficult to treat for a 
multitude of reasons, including (but not limited to) its reoccurrence (a general belief is that 
tumours grow from a single stem cell which are slow growing and hence resistant to 
chemotherapeutics), the similarity of cancer DNA to normal DNA, that no two cancers are 
the same, and that there are no specific biomarkers thus making tumours difficult to target 
[53]. Because of the lack of distinguishing features, chemotherapeutics such as cisplatin are 
non-specific and will target any dividing cells (cancerous or not), leading to the harmful side 
effects of chemotherapy such as (but not limited to) nausea, immunosuppression, 
haemorrhages and kidney problems. Non-specific drug administration also reduces the 
dosage reaching the tumour, enabling it to develop drug resistance [52].  
 
Targeted drug delivery would be a viable method to overcome most of the aforementioned 
issues. One tactic is to tailor the drugs to target cancer cells. For example, healthy cells 
metabolise using oxidative phosphorylation in normal aerobic conditions, whereas cancer 
cells mainly use glycolysis. Attempts have been made to inhibit glycolysis, however this has 
so far been unsuccessful as cancer cells can shift their primary metabolism mechanism. More 
recent research has been aimed at using cationic drugs to target the cancer cell mitochondria, 
which have a more negative potential compared to normal mitochondria [54]. Instead, World 
Health Organisation approved cytotoxic drugs (which are known to be effective against 
cancer [51]) can be loaded into a non-toxic carrier. An ideal carrier would harbour the cargo 
through healthy parts of the body and only release it in the vicinity of a tumour, enhancing 
the payload whilst reducing harmful side effects. 
 
The hunt for an ideal nanocarrier is often met with a compromise. Organic carriers (e.g. 
liposomes [55], dendrimers [56], micelles [57], and peptides [58]) are biocompatible (non-
toxic), however they tend suffer from premature release and low drug loading capacity [47]. 
Instead, inorganic carriers (such as silica nanoparticles [59] and oxides [60]) were 
established to improve the quantity of drugs reaching the tumour, yet they themselves have 
harmful side effects (for instance they can be poisonous and/or induce an immune response) 
[61]. MOFs on the other hand are one of the most promising nanocarriers, because their large 
porosities and surface areas enable high drug loading capacities, weak coordination bonds 
and careful selection of building units (e.g. the use of Zn ions as opposed to toxic 
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alternatives) render some MOFs biocompatible, and the vast number of building units make 
it possible to fine tune the framework properties (for example to improve colloidal stability, 
prevent premature release, or to induce target recognition) [47]. 
 
Several experimental studies have highlighted the strong potential of MOF nanocarriers in 
chemotherapy [47]. For example, Zhoe et al loaded a MOF (PCN-333) with a non-toxic drug 
(paracetamol) and tyrosinase enzyme. This system acted as a nanoreactor, and when PCN-
333 was taken up by cancer cells the tyrosinase converted the paracetamol to produce toxic 
products [62]. Another advantage of MOF nanocarriers is that they can respond to certain 
external stimuli (such as pH). Structural variation in response to pH change is particularly 
interesting for cancer research as the extracellular pH surrounding a tumour tends to be acidic 
(increased rates of glycolysis by cancer cells increases their extracellular acidity: pH<6.8 
compared to pH=7.2 in healthy areas of the body [63]). For example. Zhang et al loaded 
doxorubicin into a mesoporous MOF (MIL-101) with functionalised external surface. 
Benzoic-imine bonds on the surface induced a pH responsiveness which released the drug 
cargo [64]. 
 
There still however remain several challenges associated with the use of MOFs as 
nanocarriers. Firstly, to enhance uptake into cancer cells (i.e. active targeting) or 
accumulation in the vicinity of a tumour (i.e. passive targeting which uses the enhanced 
permeability and retention effect) while reducing bioaccumulation in healthy parts of the 
patient and the possibility of an immune response, the external surfaces need to be 
functionalised and there needs to be a precise tailoring of the particle morphology (typically 
nanoparticles ~ 20 – 200 nm diameter are needed) [47, 65]. Secondly, there are severely 
limited in-vivo studies to validate the biocompatibility of MOFs which otherwise shown 
impressive drug delivery capabilities, and toxicology reports in literature are often 
contradictory [66]. For example the contrasting toxicology studies on ZIF-8 nanoparticles 
by Vasconcelos et al (who reported that ZIF-8 is non-cytotoxic [67]) and Tamames-Tabar et 
al (who reported that ZIF-8 is toxic as zinc competes with Fe and Ca ion in ion channels 
[68]). Typically, a safe choice would be MOFs consisting of endogenous or bioactive 
building blocks (e.g. Fe, Zr, or Zn nodes) [47]. Finally, though these and other experimental 
studies have been very promising and provided extremely insightful results, research has 
predominantly focussed on well-known MOFs (e.g. MIL-100, MIL-101, ZIF-8, UiO-66) 
with no clear indication as to why these MOFs were chosen and whether they are the best 
suited candidate for the job. In other words, for a drug carrier system, it is not yet clear what 
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structural properties researchers should be aiming for in a MOF to achieve the best uptake 
and delivery. This is where molecular simulations come in handy. 
 
1.3. Molecular simulations of drug delivery 
 
Molecular simulations in no way can replace experimental studies, instead they complement 
each other. In experiments, real-life macroscopic data is gathered (averaged across many 
particles and often the time duration of the experiment). Molecular simulations mimic 
experimental results by calculating microscopic properties of an atomistic system (which 
due to computational limitations, are typically less than several thousand atoms). For 
comparison to experimental results, the microscopic properties are averaged across 
sufficiently large ensemble collections or long simulation times, using simulation techniques 
called Monte Carlo (MC) and Molecular Dynamics (MD) respectively. Ultimately, by 
collecting the same data using atomistic scale models, it is possible to uncover in-depth 
thermodynamic details behind experimental results that would not otherwise be possible. To 
ensure a theoretical model is reliable, simulation results must be validated against 
experimental data. Discrepancies between experimental and theoretical results are usually 
caused by incorrect definitions of interatomic interactions or imperfections in the real-life 
(versus the idealised simulated) material. If the model-derived properties are compared to 
the experimental values and they agree, this suggests the interatomic interactions are 
correctly defined. A good model can then be used to test new theories, that is if an analytical 
theory matches the simulated results that apply the same theory, it can be validated [69]. As 
well as theory validation and the provision of in-depth thermodynamic insights, a working 
model can also be used to highlight the most influential parameters on certain properties. 
Furthermore, it can be tested on hypothetical materials or extreme conditions that would not 
be possible experimentally. Finally, simulations can often be transferred between similar 
systems to produce vast quantities of data quickly, which for instance is particularly useful 
when screening MOFs for drug delivery [70, 71].  
 
Drug uptake and release depend on host-guest interaction energies and the MOF pore 
network. However, as detailed in the review by Kotzabasaki et al, there is limited 
thermodynamic insight into drug uptake and release mechanisms. The available studies in 
literature tend to use standard MC and MD simulations to capture the aforementioned effects 
[71]. For example, several groups (Liu et al [72], Wang et al [73], Li et al [74]) used grand-
canonical MC (GCMC) simulations to get insightful information behind the uptake and 
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release of an anticancer drug 5-FU (Fluorouracil). They found that uptake and release are 
predominantly governed by the pore volume and isosteric heats of adsorption (a direct 
measure for the strength of the interaction between the solid and the fluid) respectively. To 
enhance loading whilst reducing release rates, several groups have focussed on adding 
defects to MOFs (missing ligands or nodes from the crystalline structure) or functionalising 
them (by incorporating for instance hydrophilic/hydrophobic groups such as NH2, OH, CH3 
to the organic ligands). For example, Filippousi et al compared MOFs (UiO-66 and UiO-67) 
with missing ligand defects for their interaction energies and uptake of cisplatin and 
paclitaxel using first principles (ab-initio) MD simulations (AIMD). They found that defects 
create favourable adsorption sites, and that the accessibility of these adsorption sites 
increases with the pore size [75]. GCMC and ab-initio simulations have also been used to 
highlight that improved interaction energies (hence release kinetics) are achievable by 
functionalising MOFs, for example adding polar groups to the organic ligands which 
establish hydrophilic drug-framework hydrogen bonding or hydrophobic groups to increase 
water stability. The addition of functional groups also reduces the pore volume reducing 
uptake [71, 76-78]. 
 
1.4. Research motivation 
 
Most computational studies focus on characterising MOFs based on the properties of the 
bulk material (i.e. the repeating crystalline unit). As mentioned, to avoid an immune response 
and enhance uptake into cancer cells, MOF nanoparticles (20 – 200 nm diameter) are 
required [47, 65]. At this length scale, the external surface area per unit volume increases 
(comparing 100 µm and 100 nm diameter spherical crystals, the external surface areas per 
unit volume are 6 x 104 m2/m3 and 6 x 107 m2/m3 respectively). Therefore, the external 
surface will be more influential on performance related properties such as the guest molecule 
uptake and guest-host interaction energies [79]. In Chapter 3, nanoparticles and 
microparticles of a complex MOF called DUT-8(Ni) [80] have been simulated to study the 
effects of the external surface on the framework properties. Due to the complexity of the 
framework (discussed further in the chapter) and the availability of experimental data to 
corroborate the simulations, a relatively simple N2 guest molecule has been employed to 
focus predominantly on how the external surface influences properties such as the MOF 
internal energy and its structural changes as a result of guest molecule adsorption. In doing 
so, it has been determined whether it is enough to model the bulk material or if it is important 




In Chapters 4 – 6, the uptake and release of one of the world leading cytotoxic 
chemotherapeutics (cisplatin) [51], is quantified in a variety of different MOFs: 
 
Chapter 4 focusses on the validity of different simulation techniques when quantifying 
cisplatin uptake and release. To do this, biocompatible MOF UiO-66 and an amine 
functionalised version UiO-66(NH2) have been used due to the available experimental data 
for comparison [81]. As mentioned, the majority of computational studies to date have 
utilised standard techniques such as MC, MD and ab-initio simulations [71]. As well as 
these, less common techniques such as steered-MD, umbrella sampling [82, 83], alchemical 
simulations [84], and GASP [85] have been used to look at the insight and limitations 
associated with different computational methods. Furthermore, the inclusion of water in 
MOF – drug delivery simulations is novel, and whilst the majority of simulation papers do 
not include water [71] it is integral in uptake and release experiments [47]. The impact of 
water on cisplatin uptake and release is also uncovered in Chapter 4, to test whether or not 
it is needed in drug – MOF simulations involving such polar guest molecules. 
 
Using the methods investigated in Chapter 4, Chapter 5 compares the feasibility of two 
different techniques commonly used to enhance the uptake and retention of drug molecules 
in MOFs – adding defects [75, 86] or increasing the ligand size whilst adding functional 
groups [71, 76-78]. For this purpose, the water stable, biocompatible series of MOFs with 
increasing pore size: UiO-66, UiO-67, and UiO-68 were used [3] with and without 
hydrophilic amine functional groups [87, 88]. Due to the high connectivity of UiO-66 nodes 
and the use of monodentate carboxylic acids (modulators) during synthesis [87], UiO-66 is 
prone to missing ligand defects [88]. Ab-initio simulations have been used to predict the 
likelihood of synthesising a given defect concentration when using modulators of varying 
acidity, and MD simulations were used to determine the cisplatin retention properties of 
defective UiO-66 against UiO-67 and UiO-68 with and without hydrophilic functional 
groups. 
 
Finally, Chapter 6 uses the previously drawn conclusions regarding modelling nanoparticles 
(Chapter 3), modelling techniques and their limitations for drug delivery (Chapter 4), and 
the most reliable method for improving release kinetics while maintaining a good 
hypothetical uptake (Chapter 5), to screen a selection of pH sensitive ZIFs as cisplatin drug 
delivery carriers [89]. The benefit of the selected ZIFs include their biocompatibility as well 
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as their stability in normal parts of the body (pH = 7.2) and lack of stability in the acidic 
extracellular space surrounding a tumour (pH < 6.8) [63]. 
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CHAPTER 2: THEORY 
 
Molecular simulations mimic real-life systems using atomistic models. Different levels of 
theory can be used to construct the model depending on the nature of the system and the 
properties of interest. “Classical simulations” are particularly useful when the properties of 
interest mainly rely on intermolecular interactions (e.g. adsorption and diffusion). In these 
simulations, atoms are treated as point nuclei that obey the laws of classical mechanics. 
Interatomic interactions in classical simulations are calculated from parameter sets called 
forcefields, and this calculation is relatively quick meaning that classical simulations can be 
used to model large systems within computational limitations. Forcefields tend to be derived 
from experiments or ab-initio simulations, therefore the reliable use of a forcefield depends 
on how it was parameterised and its transferability between systems. Ab-initio simulations 
also treat atoms as point nuclei, but the forces between atoms are determined from the 
electronic structure which is resolved for every static configuration of nuclei. Therefore, ab-
initio simulations determine energies and forces with far greater accuracy than classical 
simulations. However, the high computational cost (that scales exponentially with the 
number of atoms) limits the system size that can be feasibly modelled using ab-initio 
simulations. 
 
2.1. Crystallographic models 
 
Both classical and ab-initio molecular simulations require an input model that is 
representative of the of the real-life system. For MOFs, the input models are normally 
crystallographic structures which have been refined using experimental techniques such as 
X-ray diffraction [1] and collated in databases such as the Cambridge Structural Database 
(CSD) [2]. Within reasonable computational limitations, classical simulations can handle 
several thousand atoms, and ab-initio simulations can handle several hundred atoms [3]. 
However, even small MOF nanoparticles (normally < 100 nm [4]) contain millions of atoms. 
For example, take UiO-66 which consists of 456 atoms in a 2.1 nm3 unit cell. Now imagine 
a small spherical UiO-66 nanoparticle of 50 nm diameter. It has a volume of 65500 nm3 and 
contains 14 million atoms. To work around this problem, periodic boundary conditions 
(PBCs) are employed in this work, which make use of the fact that MOF crystals are built 




PBCs duplicate the original unit cell into an infinite lattice of identical cells. Atoms within 
the primitive unit cell then interact with other atoms in the unit cell as well as atoms in 
neighbouring unit cells. If the simulation moves an atom through the PBC (i.e. out of the 
original primitive unit cell into a neighbouring cell), an identical atom reappears at the 
opposite edge of the primitive unit cell. To prevent atoms inside the primitive cell interacting 
with their own periodic image, the “minimum image convention” is used. This means that 
the size of the primitive unit cell must be at least double the cut-off radius (i.e. the distance 
at which pairwise interactions are truncated, see Section 2.3.1). If the minimum image 
convention is not obeyed, unrealistic artefacts result from interactions between a particle and 
its periodic image [5]. Figure 2.1 illustrates these concepts more clearly. 
 
 
Figure 2.1. Periodic boundary conditions (represented by thick black lines) surrounding the 
unit cell of UiO-66 as an example. For the system to obey the minimum image convention, 
pairwise interactions must be truncated using a cutoff radius (thick red line) less than or 
equal to half the unit cell length. 
 
The input model will significantly influence how well the simulations represent real-life 
experiments. For example, if large microparticles were modelled using finite boundary 
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conditions (i.e. impenetrable walls that completely segregate the system), a substantial 
fraction of atoms would be on an effective external surface. This is an unrealistic 
representation of real-life microparticles which must be modelled using PBCs in three 
dimensions [5]. Conversely, MOF nanoparticles have large external surface area to volume 
ratios, and therefore the external surface will influence the framework properties [6]. Either 
finite boundary conditions or PBCs can be used to model the external surface if there is a 
sufficient vacuum gap implemented between the MOF surface and the unit cell boundary. 
To model segregated nanoparticles, “sufficient vacuum gap” entails that the external 
surfaces of MOF nanoparticles in adjacent unit cells do not interact (when PBCs are used) 
and that fluid next to the boundary exhibits bulk-like behaviour (i.e. it is far enough away 
from the MOF surface not to interact with it). Furthermore, due to the small diameter of 
simulated nanoparticles compared to real-life nanoparticles, care must be taken to ensure 
that there is a region in the crystal which does not experience interaction energies from any 
external surface (thus representing the “bulk” region of the nanoparticle as oppose to the 
“surface” region). 
 
Finally, as shown in Figure 2.2, MOF nanoparticles can be modelled as completely 
segregated frameworks surrounded by vacuum in three dimensions (“core-shell” model, as 
in the work of Zhang et al [6]), or as a two-dimensional infinite slab (as in the work by 
Semino et al [7]). In this work, the latter method has been used because it is computationally 
cheaper (fewer atoms are needed to model nanoparticles of a given diameter and there is a 
smaller vacuum gap hence fewer fluid molecules at pressures close to the saturation 
pressure). Furthermore, the slab models provide more insight into how individual surfaces 
(that vary depending on the direction of crystal cleavage and the surface functionality) 






Figure 2.2. Nanoparticle models, showing the “core-shell” and infinite slab models. 
 
 
2.2. Ab-initio simulations 
 
Subsection 2.2 was adapted from the confirmation report affiliated with the same Doctor of 
Philosophy qualification as this thesis [8].   
 
Ab-initio (first-principle) simulations use quantum methods to determine the electronic 
structure of a static configuration of atoms. The electronic structure details the energy and 
forces acting on individual atoms. For systems involving MOFs, this information can be 
used (for example) to derive host-guest interaction energies [9], or partial atomic charges of 
the framework (which can then be used in classical simulations [10]). Furthermore, ab-initio 
simulations can be used to determine the internal energies of structures, which can then be 
used to calculate binding energies (e.g. of ligands to nodes [11]) and relax the atomic 
coordinates to obtain the structure at its local energy minima (hence the most favourable 
conformation at a given guest loading) [12, 13]. For these applications (which are also used 
in this thesis), there is a need to find the lowest energy ground state of electrons. In 
simulations where the atoms can move (e.g. system relaxation towards its local minima on 





Ab-initio simulations determine the electronic ground state by solving Schrödinger’s 
equation: 
 
     ?̂?𝜑 = 𝐸𝜑     Equation 2.1 
 
Where Ĥ is the Hamiltonian operator (in this case for a system of N electrons and M nuclei), 
φ is the electronic wave function (i.e. a unique set of solutions / eigenstates for the 
Hamiltonian operator), and E is the ground state energy (i.e. a set of the eigenvalues, EN, that 
correspond to each eigenstate, φN) [14] . It is not possible to analytically solve Schrödinger’s 
equation because it is a multibody problem (M nuclei and N electrons interacting) that results 
in a complex Hamiltonian which consists of the electron kinetic energy, K̂E, neutron kinetic 
energy, K̂N, and the potential energy between electrons, ÛEE, neutrons, ÛNN, and electrons 
and neutrons, ÛNE: 
 
?̂? = ?̂?𝐸 + ?̂?𝑁 + ?̂?𝐸𝐸 + ?̂?𝑁𝑁 + ?̂?𝑁𝐸   Equation 2.2 
 
Simplifications exist and have been validated to solve Schrödinger’s equation. For example, 
the Born-Oppenheimer approximation assumes that the nuclei are fixed and hence K̂N can 
be neglected. This approximation is justified since the nuclei are > 1,800 times heavier than 
atoms. Since the nuclei are assumed static, the potential energy between nuclei is a fixed 
value, hence ÛNN is a solvable constant. These assumptions simplify the wavefunction to a 
3N variable (K̂E, ÛEE, ÛNE), which is still considerable given the number of electrons in 
typical MOF systems. Two common methods for solving Schrödinger’s equation after these 
assumptions are the Hartree-Fock method (HF) and Density Functional Theory (DFT) [14]. 
 
HF approximates the electronic wave function as a determinant of individual electron 
wavefunctions (φ = ∑ φi(r)
N
i=1 ) [14]. However, this method requires a complete set of 
single-electron wave functions, and it does not account of the electron correlation (i.e. 
interactions between electrons that couple their movement). Not taking into account the 
electron correlation leads to discrepancy with experiments, and although post-HF 
corrections can be implemented they are limited to systems with a few atoms [15]. 
 
DFT is similar to HF in the sense that the many-bodied system is reduced to a series of 
single-electron equations, but it does not suffer from the limitations of the HF method and 
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is hence more applicable to larger scale systems such as those used in this thesis [15]. It 
relies on the one-to-one mapping between the electronic ground state and electron density. 
Specifically, the electron density (η(r)) that minimises the energy functional (E = fn(η(r)) 
provides the solution to Schrödinger’s equation (thus reducing the 3N-dimensional problem 
to a 3-dimensional problem that depends on the spatial coordinates of electrons, r). 
Unfortunately, this energy functional is not known. Instead, the ground state energy can be 
found using Kohn-Sham (KS) equations [14]. 
 
For an N-electron system, DFT splits Schrödinger’s equation into N single electron KS 





𝛻2 + 𝑉(𝑟) + 𝑉𝐻(𝑟) + 𝑉𝑋𝐶(𝑟)] 𝜑𝑖(𝑟) = 𝜀𝑖𝜑𝑖(𝑟)  Equation 2.3 
 
Here, φi(r) is the single electron wavefunction and εi is the orbital energy. The first term in 
the KS equation (−
ħ2
2m
∇2) is the kinetic energy of the singular electron which is known (ħ 
is Planck’s constant, m is the electron mass). The second term (V(r)) is the electron – nuclei 
interaction energy which is also known. The Coulombic repulsion between the electron of 
interest and the total electron density (VH(r)) depends on the electron density (to which the 
electron of interest contributes). The corrective removal of this contribution is accounted for 
by the exchange correlation energy term (VXC(r)). VXC(r) is the functional derivative of the 
exchange – correlation energy (VXC(r) =
δEXC(r)
δη(r)
) and it is unknown in Equation 2.3. 
 
The exchange – correlation energy accounts for quantum electron-electron interactions and 
differences in the kinetic energy. There is no explicit function to determine VXC, instead it is 
approximated using either the localised density approximation (LDA) or the generalised 
gradient approximation (GGA) [14].  The LDA method approximates the position-
dependent exchange correlation energy as that of an electron gas (VXC
electrongas
) which has 





[𝜂(𝑟)]     Equation 2.4 
 
Realistically the electron density is non-uniform across any region of space, and therefore 
cannot accurately be described by the LDA model. A popular improvement is the GGA 
method which calculates the exchange – correlation energy using both the localised electron 
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density and its gradient. Various functionals (such as PBE [16]) have been developed to 
incorporate the local electron density gradient into VXC
GGA(r) [14]. So far, only the local Pauli 
repulsion forces between electrons and the electron cloud (represented by LDA or GGA) 
have been included in the exchange correlation term. Non-local van der Waals forces can be 
included as a summative addition to VXC(r) to improve the accuracy of the exchange 
correlation energy. In this work, (at a compromise between cost and accuracy), the PBE 
functional [16] was used to approximate the Pauli repulsion contribution to the exchange 
correlation energy, and DFT-D3 dispersion corrections [17, 18] were implemented.  
 
𝑉𝑋𝐶(𝑟) = 𝑉𝐿𝐷𝐴(𝑟) + 𝑉𝐺𝐺𝐴(𝑟) + 𝑉𝑉𝐷𝑊(𝑟)   Equation 2.5 
 
By defining each term in Equation 2.3, it becomes clear that there is a circular loop present 
(i.e. the Hartree potential depends on the electron density which needs to be solved using the 
Hartree potential). The Kohn-Sham equations therefore must be solved iteratively in a self-
consistent field: Firstly, a trial η(r) is defined. The Kohn Sham equations are solved using 
η(r) to calculate the single electron wavefunctions (φi(r)). The electron density is then 
recalculated (ηKS(r) = 2 ∑ φi
∗(r)φi(r)i ). If ηKS(r) ≠ η(r), the trial density is updated, and 
the steps reiterated. If ηKS(r) = η(r), the density is at its ground state and can be used to 
calculate the total energy. In other words, at the electronic ground state, the combined single 
electron density given by the N-Kohn Sham equations is equal to the electron density of a 
many-bodied system [14, 15].  
 
When solving the KS equations, the wavefunction is expanded using atomic basis sets 
(functions that define the spatial distribution of electrons surrounding a nucleus). The basis 
sets can be a linear combination of atomic orbitals or planewaves (PW). Slater type orbitals 
(STOs) accurately represent the short and long ranged electron distribution surrounding 
atomic nuclei, however they must be solved numerically. Gaussian type orbitals (GTOs) can 
be solved analytically, however they are less accurate as they cannot represent the cusp of 
the molecular orbital (near to the nucleus) as well as STOs. However, a linear combination 
of GTOs provides similar accuracy to STOs. As opposed to the nuclei centred basis sets, 
PWs use efficient fast Fourier transformations to efficiently expand the wavefunction, which 
is particularly useful in periodic systems. However, the small region of real-space occupied 
by core electron would require a large energy cut-off to capture all the necessary detail in 
reciprocal space which would be very computationally demanding. Therefore, PWs need to 
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be used with pseudopotentials (smoothing functions) to implicitly model core electrons [19], 
whereas valence electrons (important for chemical bonding) are treated explicitly.  
 
The ab-initio simulations in this work use an efficient Gaussian-Planewave (GPW) method 
(as implemented in CP2K) to get the benefits of both GTO and PW basis sets. In the GPW 
method, the valence electrons are represented using Gaussian basis sets for the wavefunction 
(and KS matrix), and planewaves for the electron density [20-25]. For all simulations, the 
planewave cut-off was carefully chosen by determining the smallest cut-off which does not 
influence the system energy. The pseudopotentials used were those developed by Goedecker, 
Teter and Hutter [21, 26, 27], and Gaussians were modelled using MOLOPT (molecular 
optimised) basis sets [28]. These parameter sets have been tried and tested in multiple MOF 
simulation papers (for example [29-31]).  
 
2.3. Classical simulations 
 
2.3.1. Interaction energies 
 
Calculation of interatomic interaction energies is essential for constructing molecular 
simulations, regardless of whether an ensemble or time-based approach is used to determine 
the thermodynamic observable of interest. Rather than solving Schrödinger’s equation for 
every atomic configuration, classical simulations calculate the energy and forces acting on 
atoms using parameter sets called “forcefields”. Forcefields are derived from experiments or 
ab-initio simulations and they therefore allow a comparatively quick and efficient 
calculation of the energy and forces acting on atoms, at the cost of accuracy. In classical 
simulations, the overall potential energy (UTotal) is the sum of non-bonded and bonded 
interaction energies. 
 
  𝑈𝑇𝑜𝑡𝑎𝑙 = 𝑈𝑁𝑜𝑛−𝐶𝑜𝑢𝑙𝑜𝑚𝑏𝑖𝑐 + 𝑈𝐶𝑜𝑢𝑙𝑜𝑚𝑏𝑖𝑐 + 𝑈𝑇𝑜𝑟𝑠𝑖𝑜𝑛 + 𝑈𝐵𝑒𝑛𝑑 + 𝑈𝑆𝑡𝑟𝑒𝑡𝑐ℎ   Equation 2.6 
               
                Non-bonded energies    Bonded energies 
 
In this work, ensemble-based GCMC simulations (see Section 2.3.3) are used to calculate 
the adsorption isotherms for N2 in DUT-8(Ni) (Chapter 3). In Chapters 4 and 6, they are also 
used to calculate the maximum loading of cisplatin and MOF – cisplatin interaction energy 
in various frameworks. In this thesis, to reduce computational cost the bonded contribution 
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to the energies were ignored in the GCMC simulations (i.e. the MOF and guest molecules 
are modelled as being rigid). This is justifiable for N2 as it consists of strong, rigid, triple 
covalent bonds. The only MOF which shows substantial structural changes is DUT-8(Ni) 
[32] and these structural changes are accounted for using the osmotic framework adsorbed 
solution theory, in which separate GCMC simulations are carried out in a set of rigid 
structures (see Section 2.4.2) [13]. Finally, though cisplatin is flexible [33], GCMC 
simulations are used only to provide an initial, screening value for the maximum uptake and 
interaction energies, as discussed in the relevant chapters. On the other hand, all time-based 
MD simulations account for the flexibility of water, cisplatin, and the frameworks since the 
properties being measured strongly depend on it (for example the guest molecule diffusivity, 
adsorption sites and interaction energies in densely packed systems). 
 
Non-bonded energy terms 
  
In all classical simulations, non-Coulombic interactions between two atoms (i and j) 
separated at a distance, ri,j, were calculated using the 12-6 Lennard Jones potential, which 
describes the pairwise interaction energy (UNon−Coulombic) as the difference between the 
short-ranged repulsive (Pauli repulsion, (σi,j ri,j⁄ )
12
) and long-ranged attractive 
(dispersion, (σi,j ri,j⁄ )
6
) interactions [44]: 
 










)    Equation 2.7 
 
The parameters εi,j and σi,j refer to the depth of potential well (i.e. the most favourable 
interaction energy between atoms i and j) and the collision diameter between the two atoms 
of interest (i.e. the nuclei separation when two atoms are touching). They are calculated for 
each combination of atoms using the Lorentz-Berthelot mixing rules (σi,j = (σi + σj)/2 
and εi,j = √εiεj [34]). Coulomb’s law was used to calculate the electrostatic contribution to 





      Equation 2.8 
 




As a rule of thumb, as ri,j → 2.5σi,j the non-Coulombic potential becomes negligible 
(UNon−Coulombic → 0) [5]. For efficient computation, a cut-off radius (rcutoff) is therefore 
implemented to truncate the non-Coulombic potential between pairs of atoms where ri,j >
rcutoff. Of course, the factor 2.5 is a generalised rule of thumb, and therefore the suitable 
cutoff radius is selected as the atomic separation whereby UNon−Coulombic ≈ 0. 
Recommended values of rcutoff are normally published with the forcefield. 
 
A simple cut-off radius cannot be accurately used when truncating Coulombic interactions 
because they converge over longer distances (i.e. multiple periodic images of the unit cell). 
Instead, Ewald summation uses a Fourier transformation to split the Coulombic potential 
energy into its slowly converging and rapidly converging contributions. Truncation errors 
are therefore avoided since the slow converging Coulombic potential converges rapidly in 
Fourier space [35]. Adaptations to the Ewald method are available such as the particle-mesh 
Ewald (PME) summation. In PME, instead of multiple calculations to determine the 
contribution of potential from the reciprocal space, the charges are assigned to a grid using 
interpolation, which allows for a much more efficient single calculation of the reciprocal 
term [36]. Finally, the Wolf summation method directly calculates pairwise Coulombic 
interactions. To do this, the pairwise Coulombic potentials are shifted so that the energy is 
negligible at a given cut-off radius [37]. 
 
In this work, the GCMC simulations were carried out using the Multipurpose Simulation 
Code (MuSiC, known for its computational efficiency [38, 39]). Since the MOF is static, 
MuSiC uses Ewald summation to accurately capture an electrostatic potential grid, prior to 
the GCMC simulation. During the GCMC simulation, to improve computational efficiency 
the Coulombic interactions between guest molecules and the fixed framework are calculated 
by interpolating the values saved in this grid. Coulombic interactions between guest 
molecules on the other hand are calculated using the Wolf Summation method. (This 
combination of pre-emptive grid building and on-the-fly calculations is very common [39]). 
The MD simulations were carried out using the GROningen Machine for Chemical 
Simulations (GROMACS, known for being one of the fastest and most comprehensive MD 







Bonded energy terms 
 
Bonded contributions to the potential energy arise from bond stretching (2-body interaction), 
bond bending (3-body interaction), and bond torsion (4-body interaction). Figure 2.3 
describes these terms and provides examples of the functions used to calculate the potential 
energy attributed to each (note that the exact function used to calculate each term depends 




Figure 2.3. Principles of bond stretching, bending and torsion with example functions used 




Φ ) and constants related to the equilibrium bond length, angle and torsion angle 
(bi,j, θi,j,k




It is useful to assume that parameters used to calculate the potential energy (ε, σ, force 
constants, bond equilibrium values) are transferrable between atoms in similar chemical 
environments. For this reason, standardised forcefields have been developed to universally 
describe parameters for the derivation of potential energy (e.g. the Dreiding forcefield [42] 
or Universal Force Field [43] used to model the MOFs in this work). Though generic, these 
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standardised forcefields are transferrable and have been shown to reproduce experimental 
data. As well as the non-Coulombic and bonded parameters, partial atomic charges (q) are 
also available in most forcefields. However, they are less transferrable, hence the partial 
atomic charges for MOFs used in this thesis were obtained from DFT simulations (see 
Section 2.2). 
 
All N2 parameters (ε, σ, q) were taken from the Transferable Potentials for Phase Equilibria 
(TraPPE) forcefield (in which parameters are based on vapour-liquid phase equilibrium data 
[44, 45]). As shown in Chapter 3, this combination of forcefields accurately reproduced 
experimental adsorption inside DUT-8(Ni). For cisplatin, the ab-initio derived forcefield by 
Yesylevskyy et al [33] was used. In their work, they use a standardised, well accepted 
method to derive the forcefield (i.e. DFT optimisation, followed by energy calculations of 
cisplatin configurations with constrained bond lengths and angles around the equilibrium 
structure). This method produced similar parameter sets as other groups who used ab-initio 
simulations and vibrational spectroscopy experiments [46, 47]. Yesylevskyy et al also 
performed MD simulations in TIP3P water (also used in this work) to compare the standard 
forcefield parameters to parameters derived using novel methods in solution, concluding that 
while the results differ they show the same qualitative trends [33]. In this work, the forcefield 
created using the (more widely accepted) standardised methods was used because many of 
the simulations are carried out in a solvent-free system. As shown in the relevant chapters, 
results (such as the interaction energy and potential energy barriers) were compared to ab-
initio simulations and experimental data where available.  
 
Now that the interaction energies have been explained the following subsections detail how 
they are used to obtain thermodynamic properties from classical simulations. 
 
2.3.2. Statistical thermodynamics 
 
Simulations provide microscopic properties (e.g. atomic velocities, atomic positions, 
pairwise interaction energies) that are not directly relatable to the macroscopic properties 
measured experimentally (e.g. adsorption enthalpy, uptake). Statistical thermodynamics 
provides a mathematical method of relating microscopic to macroscopic properties. Take for 
example adsorption experiments; at equilibrium guest molecules rapidly fluctuate between 
different configurations inside the MOF as well as between the MOF and reservoir. This 
generates many microstates (that have different energies and number of adsorbed guest 
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molecules), all of which correspond to different values of the thermodynamic property of 
interest. The recorded measurement (e.g. the adsorption energy or uptake) is then an average 
value across these microstates, which should have a net constant value provided enough 
sampling time. In simulations, the same average thermodynamic properties would be 
calculated using a time-independent ensemble average (ensemble meaning a collection of 
microstates generated using common constraints set to represent the macroscopic system). 
Assuming the system is ergodic (i.e. over a sufficiently large dataset all possible 
configurations have been visited) and representative of the macroscopic system, the 
experimental time-average and simulated time-independent ensemble average should be 
equal provided a sufficient sampling size and time are used (Equation 2.9) [5, 48]: 
 
[5]          𝑀𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 = 〈𝑀〉 = ∑ 𝑀𝑖𝑃𝑖𝑖           Equation 2.9 
 
Equation 2.9 essentially means that the thermodynamic property of interest (M) observed in 
time-dependent experiments averaged over a large number of particles (Mobserved) should 
be equal to the simulated time-averaged measurement (〈M〉) and the simulated ensemble 
average (Mi is the value in microstate i, and Pi is the probability of being in microstate i) [5].  
 
To ensure that the macroscopic system is being represented by the microstates generated 
during molecular simulations, a set of constraints are applied to the system. Three popular 
sets of constraints (which are also used in this thesis) include:  
 
1- Canonical ensemble (N, V, T): Represents a closed isothermal system as the number of 
particles N, volume V and temperature T are kept constant. 
2- Isothermal-isobaric ensemble (N, P, T): Represents an isolated system as the number of 
molecules N, pressure P and temperature T are constant. 
3- Grand-canonical ensemble (μ, V, T): Represents an open isothermal system as the 
chemical potential μ, volume V and temperature T are constant 
 
 
2.3.3. Grand-canonical Monte Carlo simulations 
 
Subsection 2.3.3 was adapted from the confirmation report affiliated with the same Doctor 




Adsorption experiments consist of a reservoir (e.g. of bulk gas at fixed temperature and 
pressure) exposed to the MOF. Guest molecules can enter and leave the MOF from the 
reservoir (i.e. the number of particles, N, can fluctuate). At equilibrium, guest molecules in 
the reservoir and the MOF share the same temperature and chemical potential. Therefore, 
the most appropriate set of ensemble constraints to model adsorption experiments is the 
grand-canonical ensemble (in which N can vary, but μ, V, and T are fixed), which is the 
focus of this section [5].  
 
Deriving an ensemble average 
 
In GCMC simulations, thermodynamic properties are calculated using an ensemble average 
of the microstates when the system is at equilibrium. The probability of a system with N 
particles occupying microstate i (Pi with an associated energy Ui) is:  
 








              Equation 2.10 
 
Where kB and T are the Boltzmann constant and the absolute temperature [48]. The grand 





kBT) across the 
entire ensemble: 
 





𝑘𝐵𝑇𝑖,𝑁     Equation 2.11 
 
The grand-canonical partition function can be used to describe thermodynamic state 










𝑘𝐵𝑇𝑖      Equation 2.12 
 
Equation 2.12 is currently written in a quantum sense. More specifically, the Boltzmann 
factor (as written in Equation 2.12) would need to be solved for each microstate using 
Schrödinger’s Equation for a many-bodied system. The thermodynamic average would then 
need to be calculated from many microstates. Instead, by rewriting Equation 2.12 in the 
classical limit it becomes an easier to solve function of the particle coordinates r and 
momenta p. For this purpose, the energy is expressed as a Hamiltonian (ℋ(r, p)) of the 
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potential (U(r)) and kinetic (𝒦(p)) energies [5]. The sum across all microstates can be 
rewritten as: 
 
  〈𝑀〉 = ∫ 𝑀(𝑟, 𝑝)𝑄(𝑟, 𝑝) 𝑑𝑟𝑑𝑝     Equation 2.13 
 






















𝑘𝐵𝑇   Equation 2.14 
 
The kinetic energy can be analytically solved as 𝒦(p) = V Λ3⁄  (where V is the system 
volume), and the de Broglie wavelength is Λ = ℏ√β 2πm⁄  (where ℏ is Planck’s constant 
and m is the particle mass). In a system containing N indistinguishable particles, the kinetic 

























𝑁     Equation 2.16 
 
As a function of the spatial coordinates of particles, the potential energy renders the 
integrand in Equation 2.16 unsolvable via analytical techniques. Due to the 
multidimensionality of N particles with 3-D coordinates, standard numerical methods also 
cannot be used. This is where Monte Carlo comes in handy.  
 
Monte Carlo is a stochastic method in which random configurations of particles in the system 
are generated to solve the integrand. In the simplest of Monte Carlo schemes, this would 
involve generating entirely random configurations (regardless of how high the energy is) 
and evaluating the integral for each case. As the sample size tends to infinity, the integrand 
should converge to the correct answer. However, since high energy regions are included in 
the statistical set, random sampling is inefficient, especially in dense systems such as the 




To improve the simulation efficiency, configurations should only be sampled in areas where 
the Boltzmann factor is non-negligible (importance sampling). To achieve importance 
sampling, prior knowledge of the probability distribution (i.e. the likelihood of 
configurations according to the Boltzmann factor) would be required. Unfortunately, the 
probability distribution is not known explicitly. Instead, importance sampling can be 




Monte Carlo methods evaluate thermodynamic properties as in Equation 2.17. To do this 
efficiently, the probability density (Q(r)) is required (but it is not known explicitly). If it 
were known, by randomly generating a large number (NMC) of configurations according to 






𝑁)𝑁𝑀𝐶𝑖=1    Equation 2.17 
 
Although Q(r) is not known explicitly, it is possible to sample the system according to the 
Boltzmann factor using the Metropolis method. Basically, the configurations are generated 
from a “random walk” in the energy space. More specifically, a small random displacement 
(see Trial Moves) is imparted on the system, transforming it from the old to the new 
configuration (o → n). Each step in the walk is accepted or rejected based on the change in 
energy caused by this displacement. The acceptance criteria in this Markov chain (i.e. 
sequence of microstates where the probability of each configuration depends only on the 
current configuration) gradually lowers the potential energy (whether it is lowered at a 
particular step in the chain depends on a probability defined in the acceptance criteria, as 
described below). Once equilibrated, the system is independent of the initial configuration, 
and further Metropolis iterations keep the system in equilibrium [49]. 
 
To reach its equilibrium distribution, the system sampling must be ergodic (i.e. all possible 
configurations are sampled as NMC → ∞) and the condition of detailed balance must be 
satisfied (i.e. the net flux between two states at equilibrium must be zero). From a 
mathematical perspective, Q(r) defines the likelihood of being in a particular configuration. 
The overall probability of moving the system from o → n is given by a translation matrix 
(πo→n = αo→npo→n) which accounts for the probability of attempting the move (αo→n) and 
the probability of accepting the move (po→n). Detailed balance implies: Q(n)πn→o =
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Q(o)πo→n, and in the Metropolis algorithm, the displacement is imparted on a random 
particle (hence αo→n = αn→o and Q(o)po→n = Q(n)pn→o). Provided enough iterations of 
the algorithm (and based on the acceptance criteria detailed below), the system will converge 
to its equilibrium distribution: Q(eq) = lim
NMC→∞
Q(o)p(NMC−1)→NMC [5, 49]: 
 
1) Calculate the potential energy of the current configuration (U(o)) 
2) Impart a small random displacement on a random particle 
3) Calculate the potential energy of the new configuration (U(n)) 




= e−β(U(n)−U(o)) < 1  (If: U(o) < U(n)) 
po→n = 1     (If: U(o) > U(n)) 
5) Generate a random number (rand) equally distributed between 0 – 1. If rand < po→n 
accept the trial move. If rand > po→n reject the trial move 




In the Metropolis method, random displacements are imparted on particles to establish a 
Markov chain. For the grand canonical Monte Carlo simulations used in this work, the trial 
moves are to insert, delete, rotate or translate a randomly selected guest molecule. For 
rotation or translation moves, a particle is selected at random and given new, random 
coordinates. The acceptance ratio for such displacements is: po→n = e
−β(U(n)−U(o))  as 
described above. 
 
Insertion and deletion trial moves add a particle with random coordinates or remove a 
randomly selected particle. If in state 𝑜 the number of particles is N, insertion and deletion 
moves are accepted with the probabilities [5]: 
 




 p(N → N − 1) = min [1,
Λ3N
V
e−β(μ+U(N−1)+U(N))]  (deletion) 
 





3βP) [5]. At high pressures in the tight confinement of micropores, gas will exhibit 
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non-ideal behaviour. For this reason, the Peng Robinson equation of state was used to 
calculate the fugacity in Chapter 3 [50]. 
 
2.3.4. Molecular dynamics simulations 
 
Unlike Monte Carlo simulations which calculate an ensemble average, molecular dynamics 
simulations mimic experiments by calculating the time evolution of a trajectory. Properties 
are expressed as a function of the momentum and positions of particles. In theory, once 
equilibrated thermodynamic properties obtained from MD and MC simulations should be 
equal provided a large enough simulation time and ensemble size are used to overcome 
statistical error (Equation 2.9). The most applicable type of simulation depends on the system 
and properties of interest. For example, MC simulations have no concept of time, hence for 
transport properties only MD is applicable. In MD simulations, if there are large energy 
barriers associated with the system of interest (e.g. cisplatin moving through narrow pore 
windows in a MOF), then the system can become trapped in a favourable energy 
configurations and the simulations will not be able to sample the entire phase space [51]. 
Finally, when modelling dense systems (such as cisplatin + water in micropores as described 
in Chapters 4-6), MC simulations can result in many rejected moves which is not an efficient 
use of computational resource.  
 
MD simulations are initiated by defining the positions of atoms and their velocities. To 
resolve the time-based trajectory, pairwise potential energies are calculated at each time step 
using Equation 2.6. The force acting on each particle (fi) is then the derivative of the potential 








     Equation 2.18 
 
Based on Newton’s equation of motion (which states that the force is a product of mass, mi 
and acceleration (∂2ri)/(∂t
2)), the particle acceleration can be calculated, hence the particle 
velocity, hence the particle coordinates. However, the equation of motion cannot be solved 
analytically because the force is a continuous function of the position, therefore the motion 
of many particles is coupled. Instead, it is solved using finite difference numerical 
integration, and so to avoid instability of the numerical method a small timestep is required 
[52]. For example, numerical integration is commonly implemented using Verlet [53], 
velocity Verlet [54] or leap-frog [55] algorithms. The small timestep (typically ~ 1-2 
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femtosecond) is a bottleneck for the simulation time (picosecond – nanosecond scale), which 
must be sufficiently large that the net value of the property being measured does not change 
with time and hence it is independent the initial configuration. For this reason, MD 
simulations are normally equilibrated prior to a production simulation over which the 
property of interest is recorded. 
 
As in MC, MD simulations make use of an ensemble to represent the macroscopic system, 
normally the canonical ensemble (NVT) or the isothermal-isobaric ensemble (NPT). The 







therefore their velocity. Different thermostats can be applied to control the temperature. For 
example, the efficient Berendsen thermostat algorithm rescales the particle velocities, yet 
the suppression of the kinetic energy means that the isothermal ensembles are not correctly 
implemented, so in this work the Berendsen thermostat was only used during equilibration 
[56]. A modified version of this thermostat (“velocity-rescaling”) adds an additional 
stochastic term to enable the correct kinetic energy distribution while retaining a good 
control of the temperature [57]. Alternatively, as in the case of Andersen [58] and Nosé-
Hoover [59, 60] thermostats, the system is coupled to an imaginary heat bath and a random 
particle is allocated a new velocity or energy from a Maxwell-Boltzmann distribution 
respectively (this corresponds to the transfer of momentum or energy caused by a collision 
between the random particle and a particle in the constant temperature heat bath). The 
allowance of temperature (hence kinetic energy) oscillations means that the latter algorithms 
can correctly monitor the temperature in the canonical ensemble. Therefore, in this work the 
Nosé-Hoover thermostat was used during production simulations. The pressure of a system 
can be regulated using a barostat. The Berendsen barostat couples the system to a pressure 
bath and rescales the box volume and particle coordinates to maintain a constant pressure. 
However, it dampens fluctuations in the pressure preventing fluctuations in the kinetic and 
potential energies that are representative of the NPT ensemble [56]. Alternatively, the 
Parrinello-Rahman barostat (used in production simulations in this thesis) couples the system 
to a variable volume “piston”. The position of the piston defines the energy terms added to 








Diffusion energy barrier 
 
The self-diffusivity of a molecule (D) can be calculated from equilibrated MD simulations 







 )                             Equation 2.19 
 
Where t is the simulation time, r is the position of the molecule of interest, d is the number 
of dimensions of the system (in these simulations, d = 3). The numerator is called the mean-
square displacement which can be plotted as a function of time to calculate the self-
diffusivity.  
As mentioned, MD simulations may not adequately sample the phase space if large energy 
barriers associated with the system prevent a molecule from moving out of a potential well. 
To overcome this, additional energy can be added to the system by increasing the 
temperature, thus increasing the probability of the molecule escaping the energy well. 





RT                             Equation 2.20 
 
Where D0 is a constant relating to the frequency of attempts to move and the step size, Ea is 
the diffusion activation energy, R is the universal gas constant and T is the absolute 
temperature. A semi-log plot of the diffusion coefficient and inverse temperature can 
therefore be used to calculate the diffusion energy barrier [63]. 
 
Steered-MD and umbrella sampling 
 
At low temperatures, high energy barriers can result in an inaccessibility of some regions of 
the system within reasonable MD times. While increasing the temperature enables the 
calculation of a diffusion energy barrier, it is not clear what part of the system corresponds 
to this energy barrier. Instead, steered-MD (SMD) and umbrella sampling simulations offer 
a means of computing the various energy barriers at different positions in the system. 
 
In SMD, an external force or velocity is imposed on a group of atoms (SMD atoms, e.g. the 
group that is being pulled through the system, in Chapters 4-6 cisplatin) to direct them along 
a predetermined reaction coordinate. This is implemented for instance by applying a constant 
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velocity to an auxiliary (dummy) atom which moves it along the coordinate path of interest. 
Typically, a harmonic spring binds the SMD atoms to the auxiliary atom, forcing the SMD 
atoms along the coordinate path while imposing no constraints in other directions (assuming 






2                            Equation 2.21 
 
Where USMD  is the harmonic potential around the auxiliary atom, kspring is the spring 
stiffness, r is the position of the SMD atoms (i.e. centre of mass), and r0 is the position of 
the auxiliary atom which moves at a constant velocity along the reaction coordinate [64]. In 
this thesis, kspring and the velocity of the auxiliary atom were tested to ensure that the 
simulation path is reproducible, i.e. the variation in force along the reaction coordinate is not 
a function of kspring (which is sufficiently large) and the velocity (which is sufficiently 
slow). 
 
Results from SMD simulations (without further analysis or simulations) are useful when 
looking at dynamic mechanisms or estimates for the individual contributions to the change 
in potential energy as the SMD atoms move along the reaction coordinate [65]. However, 
work applied to the system renders it no longer in equilibrium, and very slow velocities 
(hence inaccessibly large simulation times) would be required in SMD simulations to bring 
the system to equilibrium. Instead, techniques such as Jarzynski’s equality exist to relate the 
work done during non-equilibrium SMD to the free energy difference between a start and an 
end configuration [66]. Alternatively, to get accurate changes in free energy as a function of 
the reaction coordinate, snapshots can be extracted from the SMD simulations and used as 
initial configuration windows for umbrella sampling.  
 
Umbrella sampling can be used to investigate guest molecule diffusion in microporous 
materials [67]. Compared to metadynamics, a similar method that is also widely used, 
umbrella sampling (which is used in this thesis) has the advantage that the free energy profile 
is less dependent on input parameters (e.g. in the case of metadynamics the height and width 
of Gaussians need to be defined) and there are less likely to be errors in in the profile as a 
result of poor sampling convergence [68]. 
 
The free energy of a system (Helmholtz, A(N, V, T) or Gibb’s G(N, P, T) depending on the 
ensemble, for now denoted F) is related to the partition function: F = −kBTlN(Ξ). The 
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change in free energy as a system with N particles transitions from state i to state j is then: 
∆F = Fj − Fi = −kBTlN (
Ξj
Ξi
). In umbrella sampling, the Boltzmann factor is replaced using 
a weighting function (w(r)) which describes the probability of visiting a point in the 
configuration space. Therefore, the change of free energy can be rewritten as a ratio of 
averages of the probability distributions proportional to w(r) (see Frenkel and Smit, Chapter 














                                   Equation 2.22 
 
In practice, to carry out umbrella sampling configuration windows along the reaction 
coordinate are extracted from the SMD simulations (each window represented as i). An 




2) keeping the SMD atoms within its constraints (though it is allowed to 
move without constraint within the window). This bias potential allows high energy regions 
of the system to be adequately sampled. The total window potential (UUS,i) is then a sum of 
the bias (Ubias(r)i = −kBTlN(w(r)i)) and unbiased potential energies (Uunbias,i): 
 
UUS,i = Uunbias,i + Ubias(r)i                     Equation 2.23 
 
Individual MD simulations constrained to each sampling window are carried out to calculate 
the system forces as a function of the reaction coordinate. By running the MD simulations 
for long enough, the probability distribution function in each window is converged. As 
calculated from the series of MD simulations, the probability distribution contains bias terms 
for each window which influences the free energy. The free energy in each window and the 
overall unbiased probability function depend on each other. Therefore, an iterative process 
is needed to calculate the unbiased free energy differences along the reaction coordinate (the 
potential mean force, PMF). The most widely used method for doing this is the weighted 
histogram analysis method (WHAM) [69]. WHAM normalizes the probabilities in each 
window using the weighting function derived from the bias potential, then sums the 
normalised probabilities across all windows to obtain a total unbiased distribution function 
[70]. For the analysis to work, there needs to be significant overlap of the weight function 
between the sampling windows, otherwise (as shown in Frenkel and Smit [5]) there is a 






GCMC simulations are not appropriate for determining drug loading in micropores filled 
with water. The high density will result in atom overlap and hence many rejected moves. 
Instead, the free energy difference between cisplatin in solution and cisplatin in a solvated 
framework was calculated using the Bennett Acceptance Ratio (BAR) [71]. BAR estimates 













                                   Equation 2.24 
 
(As before, w is a weighting function and the derivation can be found in Frenkel and Smit, 
Chapter 7 [5]). The weighting function is calculated based on minimising the variance of 
averages on the right-hand side of Equation 2.24 using Lagrange multipliers [5]. Further 
details of how this technique was applied to model cisplatin uptake from solution are 
explained in Chapter 4. 
 
2.4. Material characterisation 
 
2.4.1. Pore network 
 
When comparing MOFs for use in an application such as drug delivery, it is useful to 
compare their performance against structural properties such as the accessible surface area, 
pore volume, pore cavity size and pore window diameter (illustrated in Figure 2.4). In this 




(a) (b)  
Figure 2.4. Illustration of (a) the accessible surface area (solid black line) and accessible pore 
volume (grey) for a probe (orange) inside the pore of a MOF (blue) [72], and (b) the pore-
size. 
 
The accessible surface area is the area that a probe (diameter σP) occupies as it rolls around 
the framework atoms (diameters represented as σA). Computationally this is achieved using 
a Monte Carlo algorithm that randomly picks positions on a sphere surrounding each 
framework atom in turn, with a diameter of σT= σA+ σP. The probe at each point on the 
sphere is then tested for overlap with other framework atoms, and from this the fraction of 
points without overlap (ω) can be calculated. The accessible area surrounding a framework 
atom i is then ai = ωπσT,i
2  and the total accessible surface area is A = ∑ ai
NMOF
i . Normally 
the probe diameter is equal to the collision diameter of N2 (σP = 3.261 Å) as this is useful 
when comparing resulting surface areas to experimental BET (Brunauer–Emmett–Teller 
[73]) values [72]. The collision diameter of framework atoms were taken from the Universal 
Forcefield [43]. 
 
The pore-size distribution (PSD) defines the pore cavity sizes present in a MOF. Poreblazer 
calculates the PSD using MC simulations in which a random test point is defined in the 
system and a probe is added at this point and tested for overlap with the framework atoms. 
If no overlaps are found, a larger probe is added at the same trial position (and so on) until 
the largest probe that can occupy that point in the system is identified [72].  
 
Finally, the accessible pore volume defines the availability of space that is translocated 
throughout the periodic system. Poreblazer calculates this by splitting the simulation box 
into cubes, placing a probe in each cube and testing for overlap between the probe and the 
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framework atoms. If there is no overlap, the cube is added to a list of cubes that can be 
occupied. Two cubes are connected if they are adjacent in PBCs. Poreblazer tests the 
accessibility by finding the largest cluster of cubes in the system and testing the connectivity 
as a continuous path of occupiable cubes across PBCs. This is carried out for probes of 
increasing size to find the largest probe that can be translocated through the system, and such 
an algorithm also allows the pore window diameter to be calculated [72]. 
 
2.4.2. Framework flexibility and OFAST 
 
Some MOFs exhibit framework flexibility, a significant and reversible structural change in 
response to external stimuli such as the exposure to guest molecules. In this work, framework 
flexibility specifically refers to the opening and closing of pores to enhance or reduce the 
pore volume (a.k.a. gate-opening and gate-closing). The phenomenon occurs because the 
structure (and in this case the guest molecules) is transitioning between two states of 
equilibrium that correspond to two variations of the external conditions. This framework 
flexibility is of particular interest in biomedical applications where a specific biological 
conditions could trigger a response of the MOF nanocarrier [74].  
 
Framework flexibility can be modelled using MD simulations, for example Salles et al used 
MD to model the framework response of MIL-53(Cr) to CO2 adsorption. Their results were 
able to capture the breathing effect previously seen in in-situ X-Ray powder diffraction 
experiments [75]. Hybrid MD/MC is another approach to investigate flexibility as a function 
of guest molecule loading, for example Ghoufi et al used hybrid MD/MC to model CO2 
adsorption in MIL-53(Cr) obtaining adsorption isotherms that closely match experimental 
data [76]. However, due to the complexity of framework flexibility (i.e. such as its reliance 
on detailed properties such as the metal node spin state) the use of transferrable forcefields 
is not appropriate and forcefields must be carefully fitted to experiments or ab-initio 
simulations. On the other-hand, ab-initio MD can be used [77] but the re-evaluation of 
Schrödinger’s equation at every timestep would be extremely computationally demanding. 
 
In comparison, the Osmotic Framework Adsorbed Solution Theory (OFAST) is simple to 
use and computationally cheap. It was successfully used (and developed) by Coudert et al to 
predict the “gate-opening” pressure (i.e. the pressure of guest molecule at which framework 
flexibility occurs) for Cu(4,4′-bipy)(dhbc)2 and MIL-53(Al) [13]. The theory uses Equation 
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2.25 to calculate the osmotic potential (Ωk
os(T, P)) of the open and closed pore phases (phases 
are denoted as k).  
 
𝛺𝑘
𝑜𝑠(𝑇, 𝑃) = 𝐹𝑘
ℎ𝑜𝑠𝑡(𝑇) + 𝑃𝑉𝑘 − ∫ (∑ 𝑁𝑖(𝑇, 𝑃)𝑉𝑚,𝑖(𝑇, 𝑃)𝑖 )𝑑𝑃
𝑃
0
   Equation 2.25 
 
Three factors contribute to the osmotic potential (hence gate-opening/closing): the free 
energy of the empty framework (Fk
host(T)), the gas-gas interaction energy (represented as a 
multiple of the pressure P  and volume Vk), and the MOF-gas interaction energy (represented 
as the integral of the adsorption isotherm, where Ni is the moles of gas adsorbed and Vm,i is 
the molar volume). For each pressure, the structure with the lowest osmotic potential will be 
the structure that is most likely to occur. At gate-opening/closing, the open and closed pore 




2.4.3. Morphology prediction 
 
The morphology of MOFs (i.e. the crystallographic faces that appear in the final particles) 
govern its performance properties such as the mass transfer of guest molecules into the pore 
cavities, especially in the case of MOFs with 1-D channels (more examples can be found in 
[78]). Another important property influenced by particle morphology is the framework 
flexibility (see Section 2.4.2). To understand why the morphology influences properties such 
as guest molecule uptake and framework flexibility, there is a need to know the crystal 
morphology so that the correct surfaces can be captured in the simulations. Unfortunately, it 
is not easy to accurately predict the morphology since it is heavily dependent upon the 
reaction conditions (i.e. solvents, impurities, additives). It is however also dependent upon 
factors that are already known (i.e. atomic positions, unit cell dimensions, bond strengths), 
and therefore it is possible to get a reasonable prediction of the crystal morphology [79]. 
 
The equilibrium morphology of a MOF is that which minimises the external surface energy 
per unit volume. This equilibrium shape can be determined using a Wulff plot which is a 
series of vectors perpendicular to each Miller plane drawn from a midpoint. Surface free 
energies of the associated Miller plane dictate the length of each vector. Once constructed 
perpendicular lines are drawn from each vector (i.e. parallel to each Miller plane) to establish 
the equilibrium shape [80]. Surface energies (Esurface) can be calculated by performing DFT 









N − NEbulk)        Equation 2.26 
 
Where, N is the number of atoms, Eslab
N  is the total energy of the slab, and Ebulk is the energy 
of a bulk unit cell [81]. This calculation is very computationally demanding, however. 
Firstly, considerations previously mentioned (i.e. having long enough slabs that Esurface ∝ 
slab length and ensuring Esurface ≠ f(vacuum length)) needs to be considered by performing 
multiple DFT optimisations on a variety of large structures. Secondly “large structures” 
means in excess of several hundred atoms, which in DFT terms is extremely expensive. 
 
Smaller crystals are more likely to exhibit their equilibrium shape (typically near-spherical), 
because the shape of larger crystals are dominated by the rate at which new material attaches 
to the surface during crystallisation [80]. The method used in this work (Bravais-Friedel-
Donnay-Harker) uses this theory. This method assumes that the interplanar spacing (i.e. 
space between adjacent parallel hkl planes) is directly proportional to the bond length and 
indirectly proportional to the number of bonds. Faces that grow more slowly are more likely 
to appear in the final crystal structure (as the faster growing faces form the vertices). These 
slower growing faces will have larger interplanar spacing and lower attachment energies 
(hence more favourable surface energies) [79]. 
 
There are more detailed methods to predict the crystal morphology, (for example the 
periodic-bond chain method), yet they tend to rely on the use of either DFT simulations (and 
so are expensive) or forcefields (making the predictions dependent on the forcefield 
parameters) [80]. Because of its simplicity, BFDH is extremely quick (the only input is the 
bulk crystallographic structure, i.e. the unit cell and its symmetry operators) and it can 
correctly predict the morphology provided that the building units are uniformly distributed 
throughout the crystal [79]. Therefore, a reasonable morphology should be predicted since 
MOFs form crystalline lattices. Furthermore, (as mentioned) properly shaped nanoparticles 
cannot be modelled due to computational constraints, hence the use of expensive 
morphology predictions would be wasteful. On the other hand, BFDH can be used to screen 
faces likely to appear in the crystal. These faces can then be used in slab models to determine 
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CHAPTER 3. SIZE-DEPENDENT ADSORPTION AND FRAMEWORK 
FLEXIBILITY IN DUT-8(Ni) 
 
3.1. Motivation: importance of the external surface in nanoparticle models 
 
Compared to typical microparticles, MOF nanoparticles have large external surface areas 
per unit volume. Therefore, the external surface will be more influential on the performance 
properties of MOFs, such as their ability to uptake guest molecules and their guest-induced 
framework flexibility. This size-dependent adsorption and flexibility has been 
experimentally observed in a variety of different MOFs [1-3]. However, there have been 
very few computational studies to date [4] which explore the underlying thermodynamics 
behind why (or if) the external surface influences these performance properties.  
 
This chapter focusses on understanding the thermodynamics behind size-dependent 
adsorption and framework flexibility in DUT-8(Ni). Experiments have shown that “normal” 
synthesis conditions form DUT-8(Ni) microparticles that have very narrow pores when 
purged of guest molecules (gate-closing). Upon exposure to guest-molecules such as N2, the 
narrow pores open to accommodate guest molecules (gate-opening). This transition between 
the open (op) and closed (cp) pore form is reversible [5-7]. However, a slightly modified 
synthesis that enhances the rate of nucleation yields DUT-8(Ni) nanoparticles that cannot 
undergo gate-closing [5]. Simulations were used to understand the difference between 
flexible microparticles and rigid nanoparticles, and to determine whether it truly is the 
external surface that is responsible or if other factors are the cause of this discrepancy. 
 
3.2. Summary: GCMC and DFT simulations to predict N2 uptake and N2 – induced gate-
closing 
 
DUT-8(Ni) microparticles and nanoparticles were represented as the bulk unit cell 
(duplicated in PBCs) and 2-D infinite slab models as described in Figure 2.2. The latter was 
based on the most likely faces to appear in the final crystal structure, as calculated using the 
BFDH method (see Section 2.4.3 [8]) and validated from face-indexing of single crystals 
using a diffractometer. DFT cell optimisations (i.e. the relaxation of the atomic coordinates 
and unit cell parameters) were then used to equilibrate and subsequently calculate the 
internal energies of the empty bulk unit cells and slab models. Each equilibrated structure 
was then used to perform GCMC simulations to calculate the N2 adsorption isotherms and 
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determine how they differ with particle size. Experimental volumetric gas adsorption 
experiments allowed the computationally derived isotherms to be validated, hence the 
adsorption sites and interaction energies could also be validated. By combining the internal 
energies of the empty framework and GCMC derived adsorption isotherms into OFAST (see 
Section 2.4.2 [9]), the gate-closing pressure could be predicted and validated against 
experimental adsorption isotherms in the microparticles. 
 
3.3. Results: the external surface has limited influence on the performance properties, 
therefore MOF nanoparticles can be modelled using the bulk unit cell 
 
The GCMC simulations showed that the external surface of DUT-8(Ni) nanoparticles 
changes the shape of the N2 adsorption isotherm. Reduced DUT-8(Ni) – N2 interaction 
energies on the surface decrease the uptake at low pressures, smoothing the knee of the 
adsorption isotherm. Presence of the vacuum gap creates an inflection in the isotherms at 
high pressures, caused by extracrystalline adsorption as also seen experimentally. Although 
the external surface reduces the interaction energies and the amount adsorbed (at low 
pressures), its influence is short-ranged and does not significantly influence adsorption in 
the intact, non-cleaved pores regardless of how close they are to the external surface.  
 
OFAST reveals that a slightly modified conformational isomer of DUT-8(Ni) cannot 
undergo gate-closing regardless of the N2 pressure (this was also seen by Petkov et al who 
used ab-initio MD simulations [10]). It can also accurately predict the gate-closing pressure 
of the isomer obtained in experimental microparticles. The simulations show that the 
external surface can shift the gate-closing pressure, and this is something that can be 
manipulated by varying the capping groups used to coordinate the external surface. They 
further show that the external surface is not the cause of rigid nanoparticles because the 
variation in gate-closing pressure is within the experimentally used pressure limits. 
 
Ultimately (for the purpose of screening simulations in Chapters 4, 5, and 6), when 
modelling nanoparticles, it is valid to simply model the bulk unit cell without accounting for 
the external surface since its influence on interaction energies and guest molecule adsorption 
are short-ranged. However, it should be noted that this conclusion is based on very simplistic, 
flat, perfectly cleaved external surfaces with small capping groups. In reality, surface effects 
(i.e. imperfections) could penetrate deeper into the crystal and in biomedical applications the 
external surfaces would typically be capped with large groups (such as bio-receptors). 
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Another limitation is that this conclusion is based on simulations which do not account for 
the variation in diffusivity from the external surface to the bulk crystal. However, based on 
the short-ranged variation of MOF-guest interaction energies from the external surface into 
the bulk crystal, it is not likely that idealised surfaces such as those used in this work will 
significantly change diffusion regimes.  
 
3.4. Errata  
 
No errata at the date of submission 
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Flexible MOF nanoparticles, i.e. MOF nanoparticles that change their structure upon 
external stimuli such as guest uptake, are promising for numerous applications including 
advanced gas adsorption, drug delivery and sensory devices. However, the properties of 
MOFs are typically characterised based on the bulk material with no consideration of how 
the particle size and external surface influences their performance. This combined 
computational and experimental contribution investigates the influence of the particle size 
and surface functionalisation on the flexibility of DUT-8(Ni) (Ni2 (2,6-ndc)2 dabco, ndc = 
naphthalene dicarboxylate, dabco = 1,4-diazabicyclo[2.2.2]octane, DUT=Dresden 
University of Technology). In DUT-8, nanoparticles remain rigid in their open pore form 
while microparticles, synthesised under slightly different conditions, undergo gate opening  
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upon nitrogen adsorption. Simulations reveal that while the adsorption environment at the 
surface capped with modulators smaller than the 2,6-ndc ligand is very different compared 
to the bulk of the crystal with considerably weaker guest-framework interaction, the 
nanoparticles should close. We conclude that the size of the nanoparticles is not the major 
contributor for keeping DUT-8 nanoparticles open but that it is more likely that defects or 
nucleation barriers dominate. Moreover, our work reveals for the first time that 
functionalising the external surface of nanoparticles with different modulators or capping 
groups offers the opportunity to manipulate the gate opening / closing pressure. This 
principle is generally applicable and could be exploited to tune the gate openig / closing 




Metal-organic frameworks (MOFs) consist of metal nodes connected by organic 
ligands forming porous crystalline materials. They have record internal surface areas 
(up to ~7800 m2/g) [1], high porosities [2], and their properties can be systematically 
tailored by using different building units [3]. These properties have resulted in 
extensive research towards the application of MOFs in gas separation [4], storage [5], 
and catalysis [6].  
 
Some MOFs also exhibit framework flexibility due to their weak intramolecular 
bonding (for instance, π-π bonds, and hydrogen bonds). Framework flexibility is an 
exciting property whereby the crystal switches between stable structures upon 
exposure to external stimuli such as guest molecules, electromagnetic radiation, or 
changes in temperature or pressure [7]. Some MOFs are more flexible than others, 
and so the phase transition can cause marginal or major changes in the structure. ZIF-
8 (zeolitic imidazole framework), for example, is a relatively rigid structure that 
shows a reversible rotation of its 2-methyl-imidazole linkers during the phase 
transition. This modest structural change results in a relatively small step in the 
adsorption isotherm [8]. On the other hand, MOFs such as MIL-53 and DUT-8 show 
transitions between open and closed pore structures associated with larger volume 
changes, which results in a large change in the porosity and consequently pronounced 




Framework flexibility can have severe consequences for the use of MOFs in practical 
applications. For instance, finely tuned pore sizes and window diameters are used to 
exclude larger molecules in molecular sieving applications, which is forfeited if the 
pores can change shape [7]. On the other hand, framework flexibility also opens up 
new applications for MOFs, such as their use in sensory devices [11, 12], advanced 
gas separations [13] or as carriers for drug delivery [7, 14]. In sensing devices, the 
well-defined topologies and highly porous nature of MOFs means they offer enhanced 
sensitivity and selectivity towards the analyte [15]. Contact with the analyte typically 
induces a phase transition that can be detected by changes in the MOF’s optical 
properties [16] or conformational changes of a reporter molecule [17]. As carriers for 
drug delivery, flexible MOFs will adapt to optimize their geometric and energetic 
properties, so the guest-host interaction energies can be tailored to retain the drug and 
decrease its rate of release [18]. Finally, due to differences in gate-opening pressures, 
flexible MOFs offer the ability to separate gases with similar physiochemical 
properties at near ambient conditions [19].  
 
In many of these applications, it is preferable to use MOF nanoparticles. Whilst 
nanoparticles exhibit the physiochemical properties of typical microparticles, their 
properties are also largely governed by the external surface, which can be 
functionalized to improve the particle stability and incorporation into the system of 
interest. For example, in gas separation applications, the incorporation of smaller 
MOF nanoparticles into mixed-matrix membranes increases the MOF-polymer 
contact area. This reduces voids between the two materials, hence the structure retains 
its selectivity [20].  
 
It is clear from the previous examples that flexible MOF nanoparticles have a huge 
potential in many applications. However, MOFs are normally characterized based on 
the typical micrometre-sized particles, the properties of which are governed by the 
“bulk” crystal (i.e. the repeating unit cell) and surprisingly few studies have addressed 
the influence of particle size and the external surface on the properties of flexible 
MOFs. For several gating and breathing MOFs, particle-size dependent flexibility was 
observed, including MIL-53(Al) [21], DUT-49 [22], DUT-98 [23] and interpenetrated 
pillared layer MOFs such as Cu2(bdc)2(bpy) (bdc = 1,4-benzenedicarboxylate, bpy = 
4,4′-bipyridine) [24]. In a detailed experimental and simulation study Zhang et al. 
shed light on why the gate-opening pressure of ZIF-8 increases with decreasing 
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particle size [25]. From theory, it is well known that the pressure of the phase 
transition depends on: (a) the free energy of the empty framework, (b) the external 
work imposed on the system, and (c) the guest-host interaction energy [26]. In the 
case of ZIF-8, it was proposed that weaker adsorption energies at the external surface 
are the underlying cause for the crystal-size dependence on gate-opening [25].  
 
Another MOF for which particle size dependence on phase transition has been 
observed is the pillared layer MOF DUT-8(Ni) which consists of Ni2 paddle wheel 
units that are each coordinated by four 2,6-ndc (2,6-naphthalenedicarboxylate) 
anions, forming 2-D square nets. The 3-D structure arises from the axial coordination 
of Ni metal sites to dabco molecules (1,4-diazabicyclo[2.2.2]octane), connecting the 
neighbouring nets [10]. DUT-8 is unusual as it can be obtained as a flexible material 
when synthesised as micrometre-sized crystals or as a rigid material when synthesized 
as at submicron size (< 500 nm) [27-29]. 
 
Using a mixture of DMF, MeOH, and a defined dabco concentration during the 
synthesis results in micrometre-sized crystals in the open pore form (op). Immediately 
upon the removal of solvent, DUT-8(Ni) microparticles undergo a phase transition 
from the open pore (op) to the closed pore (cp) form. During the physisorption of N2 
at 77 K, CO2 at 195 K, n-butane at 273 K, ethane at 185 K or ethylene at 169 K, 
desolvated DUT-8(Ni) microparticles switch back to the op form, if a certain 
adsorptive pressure is reached which depends on the guest molecule [30]. This 
transition between a closed and open pore structure leads to a large change in pore 
volume and hence a large, abrupt step in the adsorption isotherm [10]. Moreover, it 
was shown that repeated adsorption/desorption in this system leads to the changes in 
flexibility and adsorption behaviour, manifested in the slope of the adsorption 
isotherms [31].  
 
However, if DUT-8(Ni) is synthesized using a somewhat modified preparation 
method in pure DMF with an excess of dabco, this results in the fast deprotonation of 
H2(2,6-ndc) ligands and rapid nucleation. This gives rise to DUT-8(Ni) nanoparticles 
(50 nm – 500 nm in size) that remain rigid in their open pore (presumably metastable) 
phase after solvent removal and gas physisorption [27, 28]. Synthesis of DUT-8(Ni) 
in a microreactor (which allows precise tailoring of the particle size) confirmed that 
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small particles remain rigid [27]. A comparable behaviour is observed for DUT-8(Co) 
demonstrating the stiffening effect for smaller particles [29]. 
 
It was recently found that the open pore form of the larger microcrystals of DUT-
8(Ni) exists in two conformational isomers, A and B [32]. However, these isomers 
only represent two limiting, ordered instances of a much larger configurational 
landscape [33]. As shown in Figure 1, conformer A describes the isomer in which all 
four 2,6-ndc ligands around a Ni2 unit point in the same direction. In conformer B, 
two pairs of adjacent 2,6-ndc ligands point in opposite directions around the metal 
node. X-ray diffraction experiments show that the “as-made” (i.e. solvent containing) 
larger op microparticles are either conformer B, or a disordered structure containing 
both conformers A and B. For example, a disordered phase, containing both 
conformers Aop and Bop, is initially observed after synthesis in DMF and methanol 
[29]. Desolvation of the microparticles transforms the “as-made” structure into 
conformer Bcp. During gas adsorption, the pores in the microparticles open forming 
a gas@Bop conformer, where the structures differ slightly depending on the 
accommodated guest molecules [30, 32]. In contrast, the exact conformation of the 
smaller, rigid (op) nanoparticles is still challenging to resolve due to peak broadening 
and hence limited information from X-ray diffraction analysis. However, electron 
diffraction demonstrates disordered superstructures to persist on the nanodomain 
level [29].  
 
 
Figure 1. Structures of (from left to right) Conformers Aop, Bop, and Bcp [30] [34]. Colour 
scheme: red = oxygen, grey = carbon, white = hydrogen, blue = nitrogen, green = nickel. 
 
Recent computational work has shown that the phase transition Aop → Acp is energetically 
unfavourable and that the phase transition from open to closed pore form has to go through 
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Bop → Bcp [32]. While these results show unequivocally that the closed pore form must be 
Bcp we cannot deduce that the rigid nanoparticles consist of Aop and therefore that the 
rigidity is caused by the conformer as there is preliminary experimental evidence that Aop 
can convert into Bop [29]. The different conformers of DUT-8(Ni) are therefore unlikely to 
be the origin of the different flexibility behaviour resulting from the different synthesis 
pathways. 
 
The different synthesis pathways, however, result in very different crystallization 
conditions. Supersaturation in the synthesis of the rigid nanoparticles leads to rapid 
nucleation and small crystals while the higher solubility during the synthesis of the 
flexible microparticles leads to slower crystallization and larger crystals [28]. Using 
continuous wave electron paramagnetic resonance (EPR) spectroscopy studies, 
Mendt et al. showed that the rigid nanoparticles contain considerably more defects in 
the form of missing 2,6-ndc2- and dabco linkers and defective paddle wheel units with 
only one Ni2+ ion [35]. 
 
Despite being generally accepted that defects play an important role in determining 
the flexibility behaviour it remains unclear what role the external surface plays. In 
this paper, we therefore investigate how the external surface influences the flexibility 
behaviour of the flexible microparticles and the rigid nanoparticles, and what 
influence surface groups capping the surface of the nanoparticles have. We use a 
combination of experiments, density functional theory (DFT) and grand-canonical 
Monte Carlo (GCMC) simulations to study the size-dependent uptake and phase 






Structural Models: For DUT-(Ni) two different conformers, A and B, can be 
considered as the limiting cases depending on the orientation of the 2,6-ndc2- linkers 
[32]. For both conformer A and B, the open and closed pore DUT-8(Ni) 
microparticles were modelled as the bulk unit cell duplicated in periodic boundary 
conditions to mimic the bulk behaviour. To understand how adsorption varies across 
the nanoparticles, the optimized conformer B (op and cp) bulk unit cells were 
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extended and cleaved to form (001) and (110) surfaces. These faces have high BFDH 
(Bravais Friedel Donnay Harker) morphological indices (full BFDH morphologies 
are given in the SI, Section S1) [36, 37] and are also observed experimentally. To 
ensure a fair comparison between the different phases, each slab type was cut to have 
the same number of atoms in the open and closed pore structure. This resulted in 2-D 
infinite slabs of length 40 – 70 Å (surface to surface). A vacuum gap of 20 Å was 
implemented either side of the external surface to prevent overlapping surface 
energies and to mimic adsorption in a nanoparticle surrounded by the “bulk” gas 
phase. During the surface creation coordination bonds were cleaved as opposed to 
covalent bonds which would be less energetically favourable. Uncoordinated nickel 
atoms on the surface were then saturated according to the surface termination – (001) 
surfaces were saturated with protonated dabco or DMF molecules, whereas (110) 
surfaces were saturated with monoprotonated 2,6-ndc or formic acid groups (see the 
SI, Section S2 for more information). The terminations were used to determine their 
influence on adsorption, and whether differences in strain and dispersion on the 
surface contribute to phase transition pressure of DUT-8 particles. 
 
Ab-initio cell and geometry optimizations: Prior to their use in GCMC simulations, 
all of the models were optimized in terms of their atomic positions and unit cell 
lengths using the Quickstep module in CP2K [38-43]. Quickstep uses a Gaussian and 
planewave (GPW) approach, in which Gaussian basis functions are centred on the 
atoms and the electron density is propagated with planewaves, resulting in efficient 
computation of the energy. Prior to optimization, appropriate values of the planewave 
cut-off and relative cut-off were determined based on the convergence of single-point 
static energy calculations. The cut-off and relative cut-off values used are 700 Ry and 
50 Ry for the slabs, and 600 Ry and 50 Ry for the bulk. Non-classical exchange 
correlation terms were approximated using the PBE functional [44] with DFT-D3 
dispersion corrections [45, 46]. To reduce computational cost, the core electrons were 
modelled using pseudopotentials derived by Goedecker, Teter, and Hutter (GTH) 
[47]. Quickstep solves the Kohn Sham matrix by representing the wavefunction as 
Gaussian type basis sets. Triple-zeta Gaussian type basis sets (TZV2P-MOLOPT) 
were used to describe all atoms with the exception of nickel which was described 
using double-zeta functions (DZVP-MOLOPT) [48]. As with the planewaves, core 
electrons were described by GTH pseudopotentials [49, 50]. All structures were fully 
relaxed (both in terms of the atomic coordinates and unit cell parameters) using a 
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BFGS optimizer. Tolerances for convergence were set to 0.003 and 0.0015 Bohr for 
the maximum and root-mean-square of atomic displacements, and 0.0004 and 0.0003 
Bohr/Ha for the maximum and root-mean-square of the atomic forces. During the 
minimizations, each bulk structure optimized to the same phase and conformer as the 
input (i.e. no gate-closing was observed). Hence, each phase and conformer are local 
minima on the DUT-8(Ni) energy landscape.  
 
Grand-canonical Monte Carlo simulations: N2 adsorption at 77 K was modelled 
using GCMC simulations as implemented in the multipurpose simulation code 
MuSiC [51] using rigid frameworks. N2 - DUT-8(Ni) non-Coulombic interactions 
were calculated using the Lennard-Jones (LJ) 12-6 potential, and N2 – DUT-8(Ni) 
Coulombic interactions were calculated using Ewald summation [52]. N2 – N2 
Coulombic and LJ interactions were calculated on-the-fly using the Wolf summation 
method [53] and the LJ 12-6 potential respectively. A cut-off radius of 18 Å was used 
for all interactions. DUT-8(Ni) partial atomic charges were taken as the Mulliken 
charges from DFT minimized structures. LJ parameters for the framework were taken 
from the Dreiding force field [54], with the exception of nickel, for which the 
parameters were taken from the Universal Force Field [55]. LJ parameters and partial 
atomic charges for the N2 molecules were taken from the TraPPE force field which 
describes N2 molecules as three spheres, with two nitrogen atoms (partial charges of 
-0.482 e) separated at a distance of 0.55 Å from a dummy atom at the centre of mass 
which neutralizes the overall charge and has Lennard-Jones parameters of nil [56]. 
Microstates were generated using four GCMC moves: insertion, deletion, translation 
and rotation. 10 million iterations were used for each pressure point, and the first 40 
% of microstates were neglected to ensure the ensemble average is taken at 
equilibrium. Finally, to calculate the fugacity, the Peng Robinson equation of state 
was used [57]. In the slab models, there is early onset condensation in the confined 
space of the vacuum gap and therefore the size of the vacuum gap influences the 
adsorption isotherm when extracrystalline adsorption begins. A simple normalization 
(as described in the SI, Section S3) was used to correct for the influence of the vacuum 
gap, meaning the high pressure region of the isotherm can be captured. 
 
Phase-transition pressure prediction: The osmotic framework adsorbed solution 
theory (OFAST) [26] was used to determine the phase-transition pressure of DUT-
8(Ni) microparticles and nanoparticles (see the SI, Section S4 for details). The free 
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energies of the empty frameworks were assumed to equal the internal energies 
calculated using ab-initio optimizations on the bulk and slab models. Isotherms used 





icrocrystals and nanoparticles were synthesised according to the published procedure 
[28]. The samples were characterised by powder X-ray diffraction to ensure the 
crystallinity and the phase purity of the synthetized materials. After synthesis, the 
solvent in the pores was exchanged to dichloromethane in case of microcrystals and 
to ethanol in case of nanoparticles for three days. After solvent exchange, the 
microcrystals were evacuated first at 25 °C for 16 h and additionally at 120 °C for 4 
h. The nanoparticles were desolvated at 150 °C in vacuum for 16 h.  
 
The cyclic nitrogen physisorption experiments on DUT-8(Ni) microcrystals at 77 K 
were performed on BELSORP-Max instrument (Microtrac BEL, Japan). Between the 
measurements the sample was evacuated for 2 h at 25 °C. Adsorption isotherms for 
DUT-8(Ni) nanoparticles were measured on Autosorb IQ gas sorption analyser 
(Quantachrome). Scanning electron microscopy (SEM) was performed with a 
HITACHI SU 8020 instrument. 
 
RESULTS AND DISCUSSION 
 
In order to contrast the N2 adsorption behaviour for the micro- and nanoparticles, we 
first look at N2 adsorption in the microparticles represented by infinite periodic 
structures in the GCMC simulations. Figure 2 shows negligible difference between 
the simulated Aop and Bop isotherms, in which the pores saturate at a loading of ~ 





Figure 2. Simulated adsorption isotherms of N2 in bulk conformers A and B, and the 
initial experimental N2 adsorption isotherm at 77 K on a fresh sample (large particles) 
without cycling. 
 
This maximum loading is similar to that observed experimentally in a fresh sample of 
DUT-8 (note that as previously reported [31], DUT-8 delaminates upon cycling which 
results in smaller domains, reduced maximum uptake, and an increase in the gate 
opening and closing pressures - see Section S5 in the SI). No adsorption is expected 
in Bcp as the maximum pore diameter (2.3 Å) is smaller than the collision diameter 
of N2 (3.7 Å).  
 
To illustrate the adsorption mechanism, Figure 3 presents the Boltzmann distribution 
as a probability map for N2 adsorption in the bulk conformer Bop at 77 K (note that 
the maps for Aop are nearly identical to those for Bop, see Figure S7 in the SI). The 
most favourable adsorption site (site 1) is situated in the pore corners next to the Ni2 
unit, at which N2 molecules experience overlapping interactions from adjacent 2,6-
ndc2- ligands, resulting in a relative adsorption probability of 1. There are weaker 
adsorption sites next to the dabco ligands (site 2) and next to the 2,6-ndc2- ligands 
(site 3). At sites 2 and 3, N2 molecules experience interactions from a high number of 
surrounding nitrogen and/or carbon atoms, resulting in relative adsorption 
probabilities of ~ 0.1. Finally, there is a non-distinct, low probability region for 
adsorption elsewhere in the pores, as indicated by the dark blue regions on the maps. 
These adsorption sites are the same as those observed by Hoffmann et al. who 





Figure 3. Boltzmann probability distribution for N2 at 77 K inside the bulk conformer Bop. 
The maximum probability (P=1) corresponds to an adsorption energy of -6.7 kJ mol-1. 
Showing (a) view down z-axis, and (b) view down x-axis. 
 
To represent the nanoparticles and capture the effect of the external surface, infinite 
slab models were used in the simulations where nickel exposed at the external surface 
of the slabs were coordinated with functional groups based on the synthesis mixture: 
H(2,6-ndc)-, dabco, DMF or formate. Due to the expense of the simulations and the 
negligible difference between adsorption in Aop and Bop, only conformer B was 
studied. Indexing of the single crystal faces on a diffractometer (Figure 4) shows the 
(110) and (001) faces dominate the shape of DUT-8(Ni), thus the slab surfaces were 







Figure 4. a) Assignment of the crystal faces for DUT-8(Ni) conformer Bop, b) Planes 
in the DUT-8(Ni) conformer Bop crystal structure, corresponding to the surface 
termination of crystal faces. 
 
Figure 5 shows that there is very little difference in the simulated isotherms in the 
slab models capped with different surface groups. Compared to the bulk, the uptake 
and slope of the slab isotherms are lower at pressures p/p0 < 0.25, because a lower 
density of framework atoms on the external surface reduces N2-DUT-8 interaction 
energies. As the pressure exceeds p/p0 =0.25, the bulk isotherm levels off whilst the 
slab isotherms continue to rise due to extracrystalline adsorption. This is also seen in 
the experimental isotherm for small, rigid DUT-8 particles (also shown for 
comparison). Extracrystalline adsorption is also responsible for the uptake observed 
in slabs of Bcp where the bulk pores, i.e. those not in direct contact with the surface 
and experiencing the same chemical environment as the period bulk unit cell, are too 





Figure 5. N2 adsorption isotherms at 77 K inside the simulated Bop slabs and bulk, 
and the experimental isotherm in rigid DUT-8 nanoparticles. Slabs are capped with: 
dabco, dimethylformamide (DMF), formate (FA), or H(2,6-ndc-) (NDC). 
 
Probability maps for N2 adsorption in the Bop slabs (Figure 6) show that N2 molecules 
occupy the same adsorption sites in the bulk pores of the slab, regardless of their 
position relative to the external surface. Hence, ignoring kinetic hindrance, the same 
amount will adsorb in all of the bulk pores regardless of their position in the particle. 
In contrast, adsorption sites on the external surface depend on the capping group. For 
Bop slabs capped with H(2,6-ndc-) or a dabco ligand, the same adsorption sites are 
present on the external surface as in the bulk, albeit, the interaction energies at the 
surface are weaker as half the groups that would contribute to the interaction energy 
are missing. Replacing the capping ligands with smaller capping groups (formate or 
DMF) further reduces the strength of interactions at the surface. These reduced 
interaction energies at the surface contribute to a shift in the gate-opening/closing 





Figure 6. Probability maps for N2 adsorption at 77 K in the conformer Bop slab 
models: a) 001 dabco, b) 001 DMF, c) 110 formate, and d) 110 ndc. 
 
In line with the results for the microcrystals, N2 is too large to fit inside the bulk pores 
of Bcp slabs (Figure 7 and Figure 8). On the external surface however, there is a strong 
and very localised adsorption site next to the narrow corner of the pore (site 1). In 
contrast, the probability of N2 adsorption in the wide pore corners (site 2) is lower 
because the 2,6-ndc2- ligands are further spread. At site 1, N2 interactions will 
overcome the dispersion interactions, likely acting as a driving force for gate-opening.  
 
 
Figure 7. Probability maps for N2 adsorption at 77 K in the Bcp slabs. Viewing the surface 
pores of a) 001 dabco, and b) 001 DMF capped Bcp slabs facing into the structure. *1 and 
*2 mark the adsorption sites in the “narrow” and “wide” pore corners. Note that the diameter 





Figure 8. Magnified probability maps for N2 adsorption at 77 K on one of the external 
surfaces of the conformer Bcp slabs, showing a) 001 dabco, b) 001 DMF, c) 110 FA 
(formate), and d) 110 ndc. (The slabs and probability distributions were generated in the 
same way as the Bop slabs shown in Figure 6). 
 
It is clear that weak N2-DUT-8 interaction energies on the external surface increase 
the gate-opening/closing pressure in the flexible microparticles. However, this does 
not explain why the rigid DUT-8 nanoparticles, obtained by changing the synthesis 
conditions, favour the op form. To get more insight, the osmotic framework adsorbed 
solution theory (OFAST) was applied to predict the gate-closing pressure. OFAST 
states that when two structures (e.g. the op and cp structures) are in equilibrium, those 
structures have equal osmotic potentials [26]. The calculations are based on the 
system energy when N2 molecules are present inside the pores, therefore they 
determine the gate-closing pressure. Gate-opening requires N2 molecules to open the 
pores from the external surface inwards, therefore is dominated by kinetics. For the 
periodic, bulk structure representing the microparticles, OFAST predicts a gate-
closing pressure of p/p0=0.005 (0.5 kPa), which is within the experimentally observed 
range for gate-closing in DUT-8(Ni) microparticles ~ 0.5-1 kPa (see the SI, Section 




Figure 9 shows the Bcp → Bop energy difference normalized with respect to the 
number of bulk unit cells (i.e. “complete” DUT-8 unit cells) in each slab which 
illustrates how capping groups influence the flexibility behaviour.  
 
 
Figure 9. Normalized Bcp → Bop energy differences inside the guest-free bulk and slab 
models 
 
As with the bulk, the internal energies show that each Bcp slab is more favourable 
than the corresponding solvent free Bop slab because of dispersion interactions 
between the ligands. If ligands are removed (i.e. by introducing an external surface), 
Bcp becomes relatively less favourable (i.e. the Bcp → Bop energy difference 
decreases). Similarly, if the size of ligands is reduced, reduced dispersion interactions 
decrease the Bcp → Bop energy difference. 
 
In a thermally induced phase transition the change in volume Gibbs free energy (GV) 







where for undercooling ΔT = Te – T with Te being the equilibrium phase transition 
temperature [59]. Hence, considering only the empty host, the reduced dispersion 
interactions decrease the energy difference and latent heat of the Bop → Bcp phase 
transition. As Δ𝐺𝑉 is the driving force for this phase transition, it is reasonable to 




Considering additionally host-guest interactions, this in turn means that overall, as the 
particle size decreases, weaker N2-DUT-8 interaction energies on the external surface 
will increase the gate-opening/closing pressure as more N2 molecules are needed to 
overcome the Bcp → Bop barrier. On the other-hand, weaker dispersion interactions 
on the surface reduce the energy difference between Bop and Bcp, reducing the gate-
opening/closing pressure. To determine which of the two effects dominate the shift in 
gate-opening/closing pressure, OFAST was applied to the slab models. Figure 10 
shows that the gate-closing pressure, i.e. the pressure where the relative osmotic 
potential (ΩBop-Bcp) is equal to zero, varies depending on the surface group but is in 
the same order of magnitude as calculated for the periodic bulk material (p/p0=0.005 
(0.5 kPa)). These results indicate that the influence of the surface is not a major 




Figure 10. Relative osmotic potentials, ΩBop-Bcp in the slab models with different capping 
groups as function of pressure. The gate closing pressure can be found at ΩBop-Bcp = 0. 
 
However, closer inspection of Figure 9 and Figure 10 reveals the complex interplay 
of two opposing effects: reduced N2 – DUT-8 interaction energies at the surface 
leading to an increase in the gate-transition pressure and reduced dispersion 
interactions between the capping groups, leading to a decrease in the gate-transition 
pressure which can be exploited to modify the gate closing pressure. Compared to the 
bulk (p/p0 =0.005; p = 0.5 kPa), the transition pressure is slightly reduced for the 001-
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DMF slab (p/p0 = 0.003; p = 0.3 kPa). This slab has the smallest capping group, and 
hence the lowest Bcp → Bop energy barrier (Figure 9). Since the other slabs have 
larger capping groups which result in larger dispersion interactions, the reduced N2-
framework interaction energies on the surface outweigh the decreased Bcp → Bop 
energy difference compared to the bulk. Hence relative to the bulk the gate-closing 
pressure increases up to p/p0 = 0.05 (p = 5 kPa) for ndc (see Table S1 in the SI for the 
energy differences and the actual values of the gate closing pressures). Overall, these 
results show that the targeted capping of flexible nanoparticles could in general 
provide a powerful handle to modify the gate closing pressure in a systematic way 




We used a combination of experimental and simulation techniques to study N2 
adsorption in DUT-8(Ni). In particular we looked at the influence of the external 
surface on the gate opening / closing behaviour of DUT-8(Ni) comparing 
nanoparticles, which experimentally remain rigid in their op form, to microparticles, 
synthesized using slightly different conditions, which undergo N2 induced gate-
opening/closing. Cyclic adsorption of these flexible DUT-8 microparticles leads to 
their disintegration and mosaic structure formation leading to an increase in the gate-
opening pressures. Simulations in slabs of DUT-8, to account for surface effects, 
reveal that on the surface, where paddle wheel units are capped with modulators 
substantially smaller than the 2,6-ndc ligands, the adsorption environment for guest 
molecules is very different with considerably weaker guest-framework interaction. 
This effect is, however, short-ranged and as soon as the nitrogen molecules encounter 
paddle wheel units with four coordinated linkers even in the pores exposed at the 
surface the adsorption environment is nearly identical to the bulk material.  
 
Calculations using the osmotic framework adsorbed solution theory (OFAST) [26] 
using slabs capped with different surface groups representing DUT-8(Ni) 
nanoparticles revealed that the nanoparticles should close. Therefore, we conclude 
that the size of the nanoparticles and the capping of the surface with surface group is 
not a major contributor to keeping DUT-8(Ni) nanoparticles open as observed 
experimentally and that it is more likely that defects and/or nucleation barriers 
dominate [35]. However, the reduced energy difference between the open and the 
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closed form (EBop-Bcp) in nanoparticles reduces the driving force for the op→ cp 
transition increasing the probability to obtain metastable op polymorphs as a result of 
a kinetically hindered nucleation. Moreover, our results reveal, for the first time, that 
surface groups capping nanoparticles offer the opportunity to manipulate the gate 
opening / closing pressure. For the four surface groups that we investigated, the 
complex interplay between guest-framework and framework interactions lead to a 
lower (0.3 kPa for DMF) or increased (5 kPa for ndc) gate closing pressure compared 
to the bulk (0.5 kPa). This principle is generally applicable and could be exploited to 
tune the gate opening / closing pressure for the application of interest. 
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Section 1. Crystal morphology prediction 
 
Bravais-Friedel-Donnay-Harker calculations were performed in Mercury to determine the 
equilibrium structures of DUT-8(Ni) (op) and DUT-8(Ni) (cp) [1, 2]. The CCCD number 
for the structures are 1056823 and 1034317 [3]).  From this, the most dominant 
crystallographic planes could be determined to make the surfaces of the nanoparticle models. 
Figure S1 shows the resulting structures and relative surface areas that are inversely 




















(b) (c)  
Figure S1. BFDH morphologies for (a) DUT-8 (op) and (b) DUT-8 (cp) with (c) relative 














100 0.160 001 0.207 
-100 0.160 00-1 0.207 
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-1-10 0.102 0-10 0.118 
1-10 0.102 -100 0.055 
-110 0.102 100 0.055 
00-1 0.071 10-1 0.050 
001 0.071 -101 0.050 
011 0.022 1-10 0.034 
0-11 0.022 -110 0.034 
0-1-1 0.022 0-11 0.018 
01-1 0.022 01-1 0.018 
-101 0.013 1-1-1 0.015 
10-1 0.013 -111 0.015 
0-20 0.001 - - 
020 0.001 - - 
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Section 2. Creation of models to represent DUT-8 microcrystals and nanoparticles 
 
Microcrystals have negligible external surface area to volume ratios; therefore, the influence 
of the external surface was neglected by implementing the bulk unit cell in periodic 
boundaries. As the particle size decreases, the surface area to volume ratio increases, so the 
external surface becomes more influential on the adsorption mechanism. Therefore, infinite 
slabs were used to model the surface effects in DUT-8 nanoparticles (Figure S2). 
 
a)   b)  
Figure S2. Schematic of (a) the bulk/microcrystal and (b) the slab/nanoparticle models. Red 
arrows indicate that periodic boundary conditions were applied in all three directions. 
 
It was observed via face indexing single crystals that the (110) and (001) planes are most 
dominant, so slab models where cut with external faces along these planes. Coordination 
bonds between the nickel - nitrogen or nickel - oxygen atoms were cut, and uncoordinated 
metal sites were capped with either hydrogenated dabco, physisorbed DMF molecules, 
hydrogenated 2,6-ndc, or formate. These surfaces are shown in Figure S3. 
 
Vacuum 
> 20 Å 
Slab 
length 
> 50 Å 
Vacuum 
> 20 Å 
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a)   b)  c)  d)  
Figure S3. External surfaces of the slabs: (a) (001) DMF, (b) (001) dabco, (c) (110) formate, 
(d) (110) H(2,6-ndc). 
 
Section 3. Isotherm normalization 
 
Using the slab models results in inaccurate isotherms once the pores saturate due to 
extracrystalline adsorption in the vacuum gap leading to discrepancies between the 
experimental and simulated results. To account for this, a simple normalization can be 
applied to remove the influence of N2 molecules in the vacuum gap: Figure S4 shows the 
difference in isotherms when normalized. 
 
Firstly, the difference in volume due to the vacuum gap needs to be accounted for by 
introducing a ratio, R, that scales the volume of the slab (Vslab) to the total volume of the 
slab unit cell (Vtotal). Since the volume of the slab is arbitrary, it is much easier to calculate 










Up to the point where extracrystalline adsorption occurs, the change in the excess amount 
adsorbed, Δnex, is equal to the change in the total amount adsorbed, Δntotal: 
 
∆nex = ∆ntotal 
 
When extracrystalline adsorption begins, the ratio is used to calculate the actual excess 
adsorption whilst removing the influence of the vacuum gap: 
 





Figure S4. N2 adsorption isotherms at 77 K in the slab models (and the experimental isotherm 
for comparison): a) original, and b) normalized to remove the influence of the vacuum gap. 
 
Section 4. Phase transition prediction using osmotic framework adsorbed solution theory 
To investigate the particle size dependence on phase transition, the osmotic framework 
adsorbed solution theory (OFAST) was used. In OFAST Equation S1 is used to determine 
the osmotic potential Ωk of the closed and open pore structures [4]. 
 






    Equation S1 
 
Here, Fk is the free energy of the empty structure in phase k (kJ/UC), P is the total external 
pressure (kPa), Vk is the unit cell volume of the empty framework (m
3/UC), R is the ideal 





adsorbed in the unit cell (mol/UC). At the phase transition pressure, the osmotic potential of 
the closed and open pore structures should be equal, therefore at phase transition Equation 
S2 holds true [4]: 
 






− P∆V   Equation S2 
 















= −RTMLN(1 + KP)    Equation S3 
 
The nanoparticles do not exhibit Langmuir isotherms because of the extracrystalline 
adsorption at high pressures. For this reason, a correction was added to fit the high pressure 






) (where α is a fitted variable). 
 
Section 5. Cyclic adsorption 
 
Experimentally, cyclic adsorption of N2 (amongst other guest molecules [5]) in the flexible 
DUT-8 microparticles causes their domain size to decrease, as shown in Figure S5. After 
seven cycles of N2 adsorption at 77 K, the particle size decreases by over ten-fold, suggesting 
that the stress exerted on DUT-8(Ni) as it undergoes opening/closing causes the flexible 
crystals to undergo delamination.  
 
a)  b)  
Figure S5. SEM images of flexible DUT-8(Ni) microparticles a) before and b) after seven 




As the particle size decreases, the gate-opening/closing pressures increase because the cp 
structure becomes relatively more stable. Figure S6 shows that after each cycle, there is a 
marginal decrease in the maximum uptake as well as in the slope of the isotherm. Such trends 
are indicative of weaker N2 – DUT-8(Ni) interaction energies. 
 
  
Figure S6. Experimental, cyclic adsorption of N2 in the flexible microparticles at 77 K 
(showing seven cycles, c1 – c7) 
 
Section 6. Boltzmann distributions 
 
Figure S7 shows the Boltzmann distributions for N2 adsorption in DUT-8, bulk conformer 
Aop and Bop at 77 K. There are no significant differences between the adsorption energy 





(b)    
Figure S7. Boltzmann probability distribution for N2 at 77 K inside the bulk conformer (a) 
Aop and (b) Bop. 
 
Section 7. Why do the slabs models have a higher surface area to volume ratio than the 
experimental nanoparticles? 
 
DUT-8(Ni) nanoparticles have a particle size of less than 500 nm. Assuming a spherical 
experimental nanoparticle of size equal to the thickness of the infinite slab models (i.e. 5 










3 = 1.2 nm
2/nm3 
 




2 × 2 × 5
= 2.5 nm2/nm3 
 
Increasing the size of the real-life spherical nanoparticles decreases the external surface area 
to volume ratio since the surface area scales with r2, whereas the volume scales with r3. 
Therefore, the slabs always have a larger external surface area to volume ratio compared to 
the experimental crystals. 
 
Section 8. OFAST gate-closing prediction for the bulk 
 
Ab-initio minimisations were used to calculate the internal energy differences of the empty 
frameworks. Figure S8 shows that Aop and Bop have similar internal energies 
(∆EA𝑜𝑝−B𝑜𝑝 = 6  kJ mol
−1). The strain penalty associated with closing conformer A is 
greater than the change in dispersion interactions, and so Aop cannot spontaneously close 
into Acp (∆EA𝑜𝑝−A𝑐𝑝 = 37 kJ mol
−1). Bcp is more favourable than either op structure as the 
dispersion interactions dominate. The calculated energy difference between the conformer 
B structures (∆EB𝑐𝑝−B𝑜𝑝 = −76 kJ mol
−1); is slightly smaller than the energy difference 
calculated by Petkov et al, (∆EB𝑐𝑝−B𝑜𝑝 = −102  kJ mol
−1), who used different 
pseudopotentials and basis sets [6]). Both sets of results however are consistent with the 




Figure S8. Relative internal energies of the empty bulk crystals 
 
Figure S9 shows that the relative osmotic potentials of the conformer B structures overlap at 
a nitrogen pressure of p/p0 = 0.005. This is the pressure at which the N2-DUT-8 systems are 
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in equilibrium (i.e. the gate-closing pressure) [4]. Regardless of the pressure, ΩAop is always 
more favourable than ΩAcp, and so the Aop conformer of DUT-8 cannot transform into the 
Acp isomer.  
 
 
Figure S9. Relative osmotic potentials for N2 adsorption at 77 K in the bulk framework 
 
Section 9. Energy difference and gate closing pressures for different capping groups 
 
OFAST was used to predict the gate-closing pressure in the bulk and slab models. Table S1 
shows the internal energy differences and the gate-closing pressure for each system. 
 
Table S1. Normalized (solvent free) Bcp → Bop energy differences and the gate closing 
pressures for each capping group  
System EBop-Bcp/Bulk (kJ/mol) p/p0
closing 
001-DMF 33 0.003 
110-FA 53 0.01 
001-dabco 59 0.03 
110-H(2,6-ndc) 69 0.05 
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CHAPTER 4. CISPLATIN UPTAKE AND RELEASE IN UiO-66 AND UiO-66(NH2) 
 
4.1. Motivation: test existing simulation techniques to model cisplatin uptake and release in 
MOFs 
 
Existing computational studies on drug encapsulation in MOFs mainly use pure-component 
GCMC simulations [1-3], ab-initio simulations [4], or a combination of both [5-8]. However, 
very few of these studies account for water which is present both during drug molecule 
uptake and release, furthermore GCMC and DFT simulations can only provide limited 
information which is not directly relatable to experimentally derived release rates. In this 
chapter, a variety of classical and ab-initio simulation techniques are used to determine the 
uptake and release of cisplatin (CPT) in UiO-66 and a functionalised variant UiO-66(NH2). 
These MOFs in particular were selected because of the available experimental data needed 
to validate the tested methodologies [9].  
 
4.2. Summary: classical and ab-initio simulations with and without water 
 
Cisplatin uptake was initially quantified using pure-component GCMC simulations. Due to 
the high packing density of water inside the pores of UiO-66 and UiO-66(NH2), GCMC 
simulations could not be used to quantify mixed cisplatin + water adsorption. Instead, 
cisplatin adsorption in the solvated system was quantified using the BAR method (Section 
2.3.4 [10]) at various cisplatin and water loadings. As discussed in Section 4.6, BAR was 
used to analyse the feasibility of cisplatin adsorption in the different pore types of each 
framework, by calculating the change in Gibbs free energy when decoupling cisplatin from 
bulk water and coupling it into the MOF + water + cisplatin system.  
 
Release rates depend on cisplatin diffusivity through the framework. There are two methods 
of decreasing diffusivity: enhancing either the MOF – drug interaction energies that 
contribute to the intrapore diffusion, or the energy penalties associated with movement 
through the pore windows. Interaction energies calculated from GCMC simulations were 
compared to those calculated using ab-initio optimisations of various cisplatin 
configurations inside the pores. The interaction energies were also compared to rates of 
diffusion calculated using MD simulations with and without water, to investigate how much 




The interpore diffusivity cannot be quantified using normal MD simulations due to high 
energy barriers associated with cisplatin movement through the pore windows. Instead, a 
combination of SMD and the geometric analysis and simulation of polyhedra software 
(GASP [11]) were used to look at the individual contributions of the framework bonded 
interactions and cisplatin – framework interaction energies on the “pore-hop” energy barrier. 
Umbrella sampling (which allows the system to be equilibrated at each interval along the 
reaction coordinate) was also used for comparison. 
 
4.3. Results: for polar guest molecules water plays a crucial role in uptake and release. The 
most suitable simulation tool depends on the required information  
 
GCMC simulations can calculate the maximum achievable uptake (which is predominantly 
based on the pore volume); however, it is important to understand that when water is present 
this may not be the uptake achieved experimentally. BAR simulations indicate that the pore 
volume needs to be able to favourably accommodate both cisplatin and its solvation shell, 
else there is a driving force to displace cisplatin from the framework and back into solution. 
This substantially decreases the uptake compared to GCMC simulations. Compared to 
experimentally achieved uptake from solution [9], the BAR method is substantially closer to 
the experimentally observed loading, however it still overestimates results which is likely 
caused by diffusion limitations – something that neither BAR nor GCMC can capture. 
 
Polar functional groups increase the MOF – CPT interaction energy (as calculated using 
pure-component GCMC or ab-initio simulations) which hypothetically reduces release rates. 
However, care must be taken as these results have no temporal aspect and they do not 
account for water, the presence of which decreases the MOF – CPT interaction energies. 
Instead, MD simulations show that water diffusivity decreases with polar groups, which in 
turn decreases cisplatin diffusivity. 
 
Unbiased equilibrium techniques (such as normal MD simulations) are problematic in the 
case of MOFs with small window diameters because they cannot easily capture rare-events 
(i.e. pore-hopping). SMD simulations and umbrella sampling can capture the energy barriers 
associated with movement through the framework, however the limitations of each 
technique need to be considered when analysing results. In particular, SMD simulations do 
not let the system equilibrate, and hence potential energy barriers are only approximate. 
Umbrella simulations do let the system equilibrate, yet in this unique case (regardless of the 
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constraints used) equilibration results in an unphysical pathway through the framework 
which is described in depth in Section 4.6. 
 
Overall, the work in this chapter helped aid the choice of simulation methods used in 
Chapters 5 and 6, which heavily depended on the information that needed to be gathered and 
what limitations were acceptable to draw meaningful conclusions. In Chapter 5 for instance, 
ideally diffusion data would have been gathered using normal MD simulations with water. 
However, small pore window diameters and reduced diffusivity in the presence of water 
requires unfathomably large simulation times to adequately sample the system. As a work 
around, non-solvated MD simulations could be used (with the limitation that there is no 
longer the influence of water which forms a solvation shell that affects the MOF – CPT 
interaction energies) or bias MD simulations could be used (with the limitation that 
equilibration cannot be obtained while retaining a sensible simulation path). Alternatively, 
by understanding the limitations of both techniques and comparing the results from each of 
them, it is possible to draw conclusions regardless of the short-comings because it was 
possible to see how much they actually influenced the results. 
 
4.4. Errata  
 
Not applicable as paper not yet submitted 
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Metal-organic frameworks are highly promising drug delivery carriers for chemotherapy due 
to their tailorable properties. To design a MOF for drug delivery, we need to understand its 
drug loading capacity and whether it can retain cisplatin in healthy parts of the body and 
only release it in the vicinity of the tumour. In this paper, we investigate cisplatin delivery 
in biocompatible MOFs UiO-66 and UiO-66(NH2) to determine whether standard molecular 
simulations used to screen potential chemotherapeutic drug carriers (pure-component 
GCMC and DFT simulations) are adequate, or if we need to change our methodology to 
better capture experimental conditions. Pure-component GCMC simulations capture the 
maximum uptake which predominantly depends on the pore volume, however this 
significantly exceeds the experimental loading. Alchemical simulations with implicit water 
molecules show that the solvation shell/pore size relationship is largely responsible for 
reduced uptake seen experimentally, and that at high enough water loading there is a driving 
force to push cisplatin out of the framework. Comparing this driving force to the interpore 
energy barrier, at a threshold water loading cisplatin will be displaced from both MOFs. As 
well as the interpore energy barrier, release rates can be quantified by intrapore diffusion 
coefficients, which significantly vary depending on the water loading. Stronger CPT-MOF 
interaction energies in UiO-66(NH2) reduce diffusion rates at the optimal water loading 
compared to the parent structure. These results have been validated against experimental 







Chemotherapy patients are typically treated by the intravenous administration of 
chemotherapeutics such as cisplatin (Figure 1), which is one of the most widely used 
chemotherapy drugs as it is effective against various types of cancer. It is a cytotoxic drug 
that cross-links with purine bases within DNA, preventing cell replication and growth, and 
inducing controlled self-destruction [1]. Unfortunately, the mechanism of cisplatin 
cytotoxicity is non-specific, and this causes the harmful side effects of chemotherapy [2]. 
Furthermore, indirect drug administration can reduce the dosage reaching the tumour, 
increasing its ability to develop a resistance to cisplatin [3].  
 
 
Figure 1. Structure of cisplatin (cis-diamminedichloroplatinum (II), Pt(NH3)2Cl2) 
 
Targeted chemotherapy can be accomplished using cancer-specific drugs or drug 
nanocarriers. For example, one of the primary differences between cancer and healthy cells 
are their mitochondrial functions, hence most cancer-specific drugs target these organelles 
[4] [5]. Alternatively, a non-toxic nanocarrier can be used to carry World Health 
Organisation approved cytotoxic drugs (such as cisplatin [6]) past healthy parts of the patient 
to the tumour. If the carrier can release the drug in the vicinity of the tumour whilst retaining 
it in healthy parts of the body, higher more localised doses can be achieved whilst reducing 
the harmful side effects of chemotherapy. Both cancer-targeting drugs and nanocarriers 
enable the accumulation of drugs in the vicinity of the tumour, enhancing the payload and 
reducing cytotoxic effects on healthy cells. Additionally, nanocarriers also increase the drug 
half-life, control release kinetics, and protect the drugs from degradation – further increasing 







Nanocarriers that have been designed for targeted drug delivery include organic materials 
(such as nanostructured lipids [8], polymeric micelles [9], liposomes [10], peptides [11]), 
and inorganic materials (such as mesoporous silica [12] and oxide carriers [13]). Organic 
carriers have the advantage of being biocompatible, yet their storage capacity for drug 
molecules is limited. Inorganic carriers can offer enhanced storage capacity because of their 
larger specific surface areas and tuneable properties such as their porosity, interaction with 
guest molecules and external surface chemistry. However, they are often toxic and inert, 
making them non-biocompatible [14].  
 
Metal-organic frameworks (MOFs) are hybrid materials which consist of metal nodes 
coordinated to organic ligands. These building units self-assemble into porous crystalline 
materials with well-defined internal surface areas, porosities and pore window sizes. By 
changing the primary building units or synthesis conditions, it is possible to fine-tune the 
properties of MOFs, such as their guest-host interactions [15], framework flexibility [16] 
and pore window sizes [17]. When scaled down from typical microcrystals to nanoparticles, 
surface functionalisation is also a feasible strategy to adjust the properties of the MOF such 
as its framework flexibility [18], to incorporate guest molecules onto the particle for example 
in combination therapy [19], or to improve the ease of incorporation of the MOF into the 
system of interest (for example, Chen et al incorporated nucleic acid polyacrylamide 
hydrogel onto the surface of UiO-68 to induce the release of an anthracycline, anticancer 
drug – doxorubicin – in the presence of adenosine triphosphate, ATP [20]). Such capabilities 
have resulted in the investigation of biocompatible MOFs as promising cisplatin carriers [19, 
21]. Ideally a cisplatin carrier would be biodegradable, capable of large specific cisplatin 
uptake, retain cisplatin in healthy regions of the patient and release it only in the vicinity of 
the tumour. One method of achieving this would be to target the acidic microenvironment 
surrounding a tumour (pHe < 6.8 compared to healthy cells pHe = 7.2 [22]), resulting from 
higher glycolysis rates in cancer cells. As summarised in the review by Howarth et al, some 
MOFs such as members of the ZIF (=zeolitic imidazole framework) family are stable in 
pH>6.8 and will degrade in more acidic conditions [23]. This makes them promising 
candidates as cisplatin carriers. At the time of writing surprisingly few computational studies 
have been carried out to screen metal-organic frameworks for this purpose [24].  
 
Previous computational studies include the use of ab-initio simulations to calculate host-
guest interaction energies and the most favourable adsorption sites. For example, Filippousi 
et al used ab-initio molecular dynamics (AIMD) simulations to shed insight of cisplatin 
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uptake in UiO-66 and UiO-67 with missing ligand defects. In the case of UiO-66, they were 
able to depict the most favourable conformation of cisplatin uptake [25]. However, the 
accuracy of ab-initio calculations comes with the price that they are computationally very 
expensive. Alternatively, at an accuracy strongly determined by the forcefield parameters, 
classical forcefield approaches can be used to quickly screen MOF – drug behaviours at 
relatively low computational cost. As reported in the review by Kotzabasaki et al [24], 
several groups have used grand-canonical Monte Carlo and/or molecular docking 
simulations to investigate Fluorouracil (5-FU) drug delivery in various frameworks [26-28]. 
Research so far has focussed on the uptake and adsorption energies of pure drug molecules, 
concluding that the uptake mainly depends on the pore volume and that the rate of release 
mainly depends on the drug-MOF interaction energies. However, experimental studies of 
cisplatin uptake and release are usually carried out in an aqueous solution where cisplatin 
adsorption can be achieved using encapsulation (the passive diffusion of cisplatin from a 
solution to the MOF) or conjugation (similar to encapsulation, except using a functionalised 
ligand and pro-drug that can form CPT – MOF covalent bonds) [21].  
 
In this paper, we explore whether the standard pure-component screening techniques (ab-
initio optimisations and grand-canonical Monte Carlo simulations) used in previous research 
are good enough to model cisplatin drug delivery under experimental lab and ultimately 
physiological conditions, or whether we need to account for water to better mimic real-life 
conditions. We further investigate what types of simulation most efficiently capture the 
effects of water on cisplatin uptake and release. Because of the available experimental data 
[21, 29], the computational methods of characterising cisplatin delivery were validated using 
the biocompatible MOFs UiO-66 and UiO-66(NH2), the structures of which are shown in 
Figure 2. Both MOFs have the same basic structure, namely 1,4-benzenedicarboxylate 
ligands coordinated to zirconium clusters into a framework consisting of 11 Å octahedral 
pores connected by triangular windows to 8 Å tetrahedral pores [30]. The structures differ 
because the ligands in UiO-66(NH2) are functionalised with amine groups, which in turn 
will influence the interaction energy and/or binding strength to cisplatin and reduce the 
pore/pore-window size and hence void space and energy barrier associated with movement 




(a)             (b)   
(c)  (d)  
Figure 2. Crystal structures of (a) UiO-66 [Zr6O4(OH)4BDC6] and (b) UiO-66(NH2) 
[Zr6O4(OH)4(BDC(NH2))6]. Colour representations are: Zr=turquois, C=grey, O=red, 
N=blue. Hydrogens are omitted for clarity. Representation of the accessible pore volume for 





Structural Models: The crystallographic structure of UiO-66 was obtained from literature 
[32], and an amine group was added to each BDC ligand to create UiO-66(NH2). To 
represent the bulk crystal, periodic boundary conditions were used in all directions.  
 
Classical Simulations: Classical simulations offer a relatively cheap method to model drug 
molecule uptake and delivery in MOFs, however the results depend on the forcefield used. 
In this work, the Lennard-Jones 12-6 potential and bonded parameters for the MOFs were 
taken from the Universal Force Field (UFF [33]). Partial charges were obtained as Mulliken 
charges from ab-initio static energy calculations on the initial structures (the validation for 
which is described in the SI, Section 1). Cisplatin (CPT) was modelled using the “standard 
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topology” developed by Yesylevskyy et al who used ab-initio methods [34]. Since this 
forcefield was tested with TIP3P, the same water model was also used in this research [35]. 
A cut-off radius of 12.5 Å was used to truncate all short-ranged interactions. 
 
Most computational drug – MOF uptake studies are carried out using pure-component grand-
canonical Monte Carlo (GCMC) simulations. We modelled pure-cisplatin uptake at 310 K 
(body temperature) using GCMC simulations as implemented in the multipurpose simulation 
code MuSiC [36]. During the GCMC simulations all cisplatin molecules and the MOFs were 
kept rigid. CPT-MOF Coulombic interaction energies were calculated using Ewald 
summation [37]. CPT-CPT Coulombic and Lennard-Jones interactions were calculated on-
the-fly using the Wolf summation method [38] and the LJ 12-6 potential respectively. 
Microstates were generated using four GCMC moves: insertion, deletion, translation and 
rotation. 10 million iterations were used for each pressure point, and the first 40 % of 
microstates were discarded carefully ensuring that the ensemble averages are taken once the 
simulations have equilibrated. 
 
Drug delivery carriers are normally modelled without accounting for water [25-28]. 
Experimentally however, cisplatin uptake and release are carried out in the presence of water 
or water-based simulated body fluids [21]. Due to the high loadings involved, GCMC 
simulations will not efficiently equilibrate water and cisplatin adsorbed in UiO-66/UiO-
66(NH2) at 1 bar, since the high loading will make insertion, deletion and ID-swap moves 
near impossible. Instead, molecular dynamics (MD) simulations were used. 
 
All molecular dynamics (MD) simulations were carried out using the Groningen Machine 
for Chemical Simulations (GROMACS, 2019.2) code [39-44] keeping the MOF framework 
flexible. Topologies for the MOFs were generated by extending the orthogonal face-centred 
cell into a 2x2x2 supercell and using OBGMX which models all interactions using the 
Universal Force Field [33, 45]. No additional constraints were imposed on the framework. 
Long-ranged electrostatic interactions were calculated using the particle mesh Ewald 
algorithm [46, 47]. Long range dispersion corrections were applied to the energy and 
pressure terms. Prior to all MD simulations, the structures were pre-equilibrated using a 
steepest decent energy minimization followed by a 100 ps NVT equilibration. Separate 
temperature coupling baths were used for cisplatin and the framework, along with a modified 
Berendsen coupling method [48]. Depending on the ensemble used during production 
simulations a further 100 ps NPT equilibration was carried out. A Parrinello-Rahman 
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barostat was used for pressure coupling during equilibration. During the production 
simulations, temperature and (depending on the ensemble) pressure coupling was achieved 
using a Nosé-Hoover thermostat and a Parrinello-Rahman barostat [49, 50]. 
 
The Bennett’s Acceptance Ratio (BAR) algorithm as implemented in GROMACS was used 
to calculate the equilibrium loading of cisplatin accounting for water [51]. At equilibrium 
there is no net transfer of cisplatin between System (a) (a = cisplatin in bulk water), and 
System (b) (b = MOF + cisplatin + water). Hence, the net change in Gibbs free energy when 
moving a cisplatin molecule between (a) and (b) is nil, as shown conceptually in Figure 3. 
 
 
Figure 3. Schematic of models used in alchemical simulations (a = one cisplatin molecule in 
bulk water, b = varied number of cisplatin and water molecules in UiO-66/UiO-66(NH2)). 
∆Ga→b and ∆Gb→a are the changes in Gibbs free energies when moving one cisplatin 
molecule from a→b and b→a. At equilibrium ∆Ga→b = ∆Gb→a. 
 
By gradually decoupling a single cisplatin molecule from Systems (a) and (b), it is possible 
to use the BAR method to calculate the free energy change associated with cisplatin uptake 
















Figure 4. Hess cycle used to determine the equilibration loading of cisplatin and water in 
UiO-66 and UiO-66(NH2). 𝜆 = 0 and 𝜆 = 1 refer to the beginning and end states of cisplatin 
during decoupling. 
 
To decouple cisplatin, (corresponding to turning off all non-bonded interactions between 
cisplatin and the rest of the system), a series of configurations were generated between the 
fully coupled and decoupled states. The BAR algorithm [51] was then used to calculate the 
change in Gibbs free energy between the two states: 
 






      (1) 
 
Where H is the parameterized Hamiltonian and λ refers to the position along an integration 
path between states 0 and 1. In this work, state 0 corresponds to a cisplatin molecule that 
fully interacts with the system, and state 1 corresponds to no interactions between cisplatin 
and the system [52]. To prevent molecules of opposite charge becoming trapped, the 
Coulombic interactions were decoupled before the LJ interactions. In total, 20 configurations 
were used to decouple the non-bonded interactions with varying λ between 0-1 in intervals 
of 0.1 to ensure each stage of decoupling shares part of the same phase space. 
 
A single cisplatin molecule was decoupled from system (a), consisting of a 3 nm3 box of 
water, and system (b), the MOF + water + cisplatin system at various water and cisplatin 
loadings. Each configuration was pre-equilibrated prior to a production run in the NPT 
ensemble for 1 ns at 298 K (encapsulation temperature [21]). The free energy difference was 
calculated using the BAR algorithm [51]. Adsorption energies for each water/cisplatin 
loading were calculated (for the fully coupled systems) as: 
 






System (a), λ=0 
 
1 CPT + x SOL 
System (b), λ=0 
 
MOF + NCPT CPT + NSOL SOL 
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Where Utotal is the energy of the MOF + cisplatin + water system, UCPT is the energy of a 
single cisplatin molecule in a 3 nm3 box, NCPT is the number of cisplatin molecules, USOL is 
the energy of a single water molecule in a 3 nm3 box, NSOL is the number of cisplatin 
molecules, and UMOF is the energy of the empty framework. Each term was taken to be the 
average energy over a 1 ns MD simulation which was pre-equilibrated. 
 
Normal (unbiased) MD simulations cannot capture movement through the pore windows 
which is a rare event due to the high associated energies. Instead, steered MD (SMD) and 
umbrella sampling simulations were used to quantify the energy barrier associated with 
moving one cisplatin molecule from an octahedral pore to the same chemical environment 
in another octahedral pore (from herein termed “pore-hopping”). It was assumed that the 
bulk of the crystal would confine a unit cell to a near constant volume, and that a single 
cisplatin molecule moving through the framework would not influence that volume 
significantly. For this reason, the SMD and umbrella sampling simulations were confined to 
the constant volume (NVT) ensemble.  
 
A single cisplatin molecule was centred in the middle of one of the octahedral pores in UiO-
66 and UiO-66(NH2). Following pre-equilibration, SMD simulations were used to pull the 
cisplatin molecule into an adjacent octahedral pore along the [101] plane for 300 ps, using a 
pull rate of 0.01 nm/ps and a time step of 0.001 ps. A spring constant of 1,000 kJ mol–1 nm–
2 was used to constrain cisplatin using a harmonic potential. Stronger spring constants and 
slower pull velocities were tested, however the simulation path and resulting energy barrier 
remained constant. 
 
Sampling windows for the umbrella sampling simulations were collected every 0.1 nm along 
the SMD trajectories. As discussed with the results, individual windows were not pre-
equilibrated but were subject to 10 ns MD simulations within the sampling window, bound 
by the same harmonic potential as used in the SMD simulations [53]. The final results were 
analysed using the weighted histogram analysis method (WHAM [54]). A total of eight pull 
and umbrella sampling simulations per MOF were carried out moving cisplatin in alternating 
directions through the framework. The starting configuration for each repeat was taken as 
the final position of the previous repeat’s pull simulation. 
 
Ab-initio simulations: SMD simulations can be used to calculate the potential energy barrier 
associated with pore-hopping, however for classical simulations the results strongly depend 
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on the forcefield. Ab-initio MD simulations remove the reliance on force fields, however 
they are expensive. Instead, the geometric analysis and simulation of polyhedra software 
(GASP [55]) was used investigate the intrinsic flexibility of UiO-66 and UiO-66(NH2), and 
to determine whether such a technique can produce potential energy barriers associated with 
pore-hopping at relatively low cost whilst avoiding the dependency on forcefields. We used 
GASP to determine the intrinsic flexibility of UiO-66 and UiO-66(NH2). In this approach, 
local atomic geometries (such as bond lengths and angles) are constrained using a series of 
superimposed templates whilst the unit cell parameters vary. The framework is within the 
limits of its “flexibility window” for any global variations in which the local geometry 
remains unaltered. The local geometry constraints in UiO-66 and UiO-66(NH2) involved 
maintaining effectively rigid zirconium clusters whilst letting the carboxyl and aromatic 
groups rotate to different planes. All structures identified within the flexibility windows were 
analysed using PoreBlazer [56] to determine the pore-limiting diameter (PLD). The potential 
energy difference between each variant and the original structure were calculated based on 
the change in internal energy determined using relatively cheap ab-initio static energy 
calculations (as detailed in the SI, Section 2). By comparing the PLD at the time of pore-
hopping (from the SMD simulations) to that of the structures generated within the flexibility 
window, we could compare the potential energy barriers calculated from classical SMD 
simulations and GASP/static energy calculations. 
 
We performed static energy calculations on the GASP variants (to determine the potential 
energy barrier associated with opening the pore windows for cisplatin pore-hopping), and 
on the original UiO-66 and UiO-66(NH2) structures (to determine the partial atomic charges 
used in classical simulations). During classical simulations, partial atomic charges of the 
framework and guest molecules are fixed despite their motion. To validate using static 
charges with polar guest molecules such as cisplatin and water, ab-initio geometry 
optimisations of cisplatin in UiO-66 and UiO-66(NH2) were carried out. This allowed for 
the comparison of pre and post optimisation charges, framework charges with and without 
cisplatin, and cisplatin – MOF interaction energies calculating using DFT and GCMC 
simulations (see the SI, Section 1 for details). 
 
RESULTS AND DISCUSSION 
 
To date, the majority of MOF – drug simulation papers utilise pure component grand-
canonical Monte Carlo simulations to determine the uptake [24]. Following this approach 
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Figure 5 shows the adsorption isotherms of pure CPT in UiO-66 and UiO-66(NH2). For UiO-
66 and UiO-66(NH2), the maximum uptake is 0.67:1 and 0.56:1 CPT:Zr respectively. The 
uptake is lower in UiO-66(NH2) because amine groups reduce the overall free volume from 
0.46 cm3/g to 0.42 cm3/g (calculated using Poreblazer [56]).This ratio of free volumes of 
1.11 to 1 for UiO-66 vs. UiO-66(NH2) is the same as that reported by Zhang et al [57]. More 
specifically, due to the orientation of amine groups only one cisplatin molecule can fit into 
the octahedral pores (o-pore), whereas in UiO-66 two cisplatin molecules can fit into each 
o-pore. For both MOFs, one cisplatin molecule can fit into each 8 Å tetrahedral pore (t-pore) 




Figure 5. Adsorption isotherms of pure cisplatin in UiO-66 (▲) and UiO-66(NH2) (○) at 310 
K. Error bars show the standard deviation obtained from three independent repeat 
simulations. 
 
The GCMC loadings are tenfold higher than the uptake achieved experimentally by 
encapsulation (cisplatin uptake via diffusion from solution ~ 0.06:1 CPT:Zr in UiO-66 and 
UiO-66(NH2)). This suggests that water co-adsorption and diffusion limitations interfere. 
On the other hand, conjugation of a cisplatin pro-drug in UiO-66(NH2) (i.e. the diffusion and 
covalent bonding of a functionalised, pre-activated cisplatin molecule into the MOF from 
solution) achieves a maximum loading that matches the simulated result (0.56:1 CPT:Zr) 
[21]. This implies that the maximum loading mainly depends on the available pore space, 
which is something that can be captured using GCMC simulations, as also shown in previous 


























To capture the uptake via encapsulation where the co-adsorption of the solvent plays an 
important role, pure component GCMC simulations are therefore not appropriate and mixed 
water/cisplatin simulations are required. GCMC simulations of water/cisplatin mixtures will 
however not be efficient at capturing the effect of the solvent because most moves will be 
rejected due to the high loading of guest molecules. Alternatively, the Bennett’s Acceptance 
Ratio algorithm [51] was used to get information about the mixed system. 
 
To investigate the influence of water on cisplatin uptake, a single cisplatin molecule was 
decoupled from (a) the bulk water, and (b) the MOF + cisplatin + water system at different 
loadings of guest molecules. Figure 6 shows the change in Gibbs free energy (∆GCPT-removal) 
when decoupling a single cisplatin molecule from the bulk water and the solvated MOFs. 
Based on the Hess cycle in Figure 4, if (∆GCPT-removal)MOF > (∆GCPT-removal)SOL, there is a 
driving force to move cisplatin from the solution into the framework, and vice versa.  
 
 (a)  (b)  
Figure 6. Change in Gibbs free energy as function of the number of water molecules (NSOL) 
when decoupling a single cisplatin molecule from bulk water (dashed line), and solvated (a) 
UiO-66 and (b) UiO-66(NH2) (T = 298 K, 0.005:1 CPT:Zr ≈ 0.54 wt%) for the two different 
types of pores present in both MOFs. 
 
Both UiO-66 and UiO-66(NH2) show similar trends in Figure 6: In the absence of water co-
adsorption, cisplatin is more favourable in solution because of its solvation shell. For the 
larger o-pores, as the water loading (NSOL) increases cisplatin is more favourable in the 
framework than in the bulk due to the combined interaction energies with water molecules 
in the solvation shell and the MOF. In contrast, the uptake into the smaller t-pores is never 
favourable (i.e. (∆GCPT-removal)MOF < (∆GCPT-removal)SOL) because there is not enough space in 

























































shell and taking water into account. After a maximum, the framework begins to saturate 
which induces structural deformation of the framework. Therefore (∆GCPT-removal)MOF 
decreases and it becomes easier to decouple cisplatin at higher water loadings. The same 
trends are seen for higher cisplatin loading (NCPT), except the framework starts to deform at 
a lower water uptake because of the reduced void space (as shown in the SI, Section 4). 
 
Beyond the maxima in Figure 6, the frameworks distort considerably to accommodate more 
water molecules. In turn, as more water molecules are added the overall adsorption energy 
(Uads) becomes more favourable because there are more interacting bodies. As shown in 
Figure 7, this is the case up to a minimum that is the water loading which achieves the most 
favourable overall adsorption energy for a given cisplatin uptake (at which ~ ∆GCPT-removal = 
0 kJ/mol). After the minimum it is unfavourable to add further guest molecules due to 
excessive framework distortions. 
 
(a)  (b)   
Figure 7. Overall adsorption energy (per unit cell – 192 Zr) as a function of water loading in 
(a) UiO-66 and (b) UiO-66(NH2) at T=298 K (1:1 SOL:Zr = 6 %wt) for cisplatin loadings 
ranging from 0.01 CPT:Zr (1 %wt) to 0.26 CPT:Zr (28 %wt). 
 
The maximum water loading that can be achieved before the framework starts to deform (i.e. 
the minima in Figure 7) increases with decreased cisplatin loading. Interpolation of these 
minima as a function of cisplatin loading indicates that in the absence of cisplatin, the 
equilibration loading of water is NSOL=6.3:1 SOL:Zr (39 %wt) in both frameworks. This 
equilibrium water loading (39 %wt ≈ 21 mmol/g) is in close agreement with the experimental 


















































minima become more negative (and adsorption more favourable) as the cisplatin loading 
decreases and hence the water loading increases. This suggests that water will displace all 
cisplatin molecules driving the system to a more energetically favourable state, which is the 
case for release experiments but in contrast to encapsulation during which the uptake of 
cisplatin is driven by equilibrium between cisplatin in solution and inside the framework. As 
captured by alchemical simulations (i.e. the crossover of lines shown in Figure 6 where 
(∆GCPT-removal)MOF = (∆GCPT-removal)SOL), equilibrium with cisplatin in solution occurs at 
relatively low water loadings, and only when cisplatin is situated inside the o-pores. 
Therefore, the theoretical loading at equilibrium is one cisplatin per o-pore or 0.17:1 CPT:Zr, 
which is about three times the experimental loading by encapsulation of 0.06:1 CPT:Zr [21]. 
The discrepancy between the simulated and experimental results is likely caused by other 
factors such as diffusion limitation, which is not captured by these simulations. Nevertheless, 
they paint a much more realistic picture than GCMC simulations of the uptake of pure 
cisplatin 
 
For drug delivery, not only the uptake of the drug but also its release rate plays an important 
role. Experimentally, release rates are fourfold higher in UiO-66 compared to UiO-66(NH2). 
It was speculated that this is due to enhanced interaction energies with the amine group 
and/or the energy barrier associated with interpore movement (“pore-hopping”) [21], two 
aspects we will investigate next.  
 
Figure 8 shows that CPT-MOF interaction energies, determined from pure component 
GCMC simulation, in UiO-66(NH2) (average = - 60 kJ/mol) are stronger than those in UiO-
66 (average = - 44 kJ/mol) because of enhanced electrostatic interactions between cisplatin 
and the amine groups ([N-Hδ+]MOF - [Cl
δ-]CPT). This result agrees with the hypothesis that the 
difference in release rates between UiO-66 and UiO-66(NH2) is caused by cisplatin 
anchoring to the functionalised BDC ligands. However, these pure component GCMC 
energies cannot provide information on how much the interaction energies will alter the 
release timing, nor how they will change when water is introduced to the system, as is the 
case during release experiments. 
 
The alchemical simulations (Figure 6) showed that cisplatin adsorption is more favourable 
in the o-pores compared to the confined space in the t-pores, and therefore the interaction 
energies in the o-pores should be more favourable. On the other hand, potential energy maps 
generated from pure-cisplatin GCMC simulations (Figure 8a) show that this is not the case 
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in UiO-66, as the CPT-MOF interaction energies are less favourable in the o-pores compared 
to the t-pores. As illustrated in the potential energy histograms (Figure 8b), the pore types 
result in peaks at -10 - -40 kJ/mol in the o-pores compared to -40 - -80 kJ/mol in the t-pores. 
This is because Coulombic interactions between the [N-Hδ+]CPT - [Cl
δ-]CPT groups pull the 
two cisplatin molecules that share an o-pore further away from the framework atoms and 
closer to each other in UiO-66, as illustrated by the snapshot in Figure 8d.  
 
Figure 8b shows that both the o-pores and t-pores in UiO-66(NH2) contain (relatively) low 
energy adsorption sites, producing the first peak in the Figure 8c (-40 – -60 kJ/mol). As well 
as this, both pore types have strong adsorption sites depending on the position of the amine 
groups which form hydrogen bonds with cisplatin leading to the higher energy peaks in the 
histogram (-60 – -80 kJ/mol). As shown in Figure 8e, hydrogen bonds in the o-pores fix 
cisplatin in position. Combined with the reduced pore volume, this immobility makes it 
energetically favourable to only have one cisplatin in each o-pore, and therefore the grouping 




Figure 8. CPT-MOF interaction energy maps in UiO-66 (a) and UiO-66(NH2) (b). CPT-
MOF interaction energy histograms (c). Snapshots at maximum loading in UiO-66 (d) and 
UiO-66(NH2) (e). (P=1 kPa, T=310 K) 
 
Another, but computationally more expensive, method of determining the adsorption energy 
is to use ab-initio geometry optimisation. For this purpose, cisplatin molecules were 






pore and 2 t-pore), and each configuration was optimised. Figure 9 shows the adsorption 
energy normalised per cisplatin molecule.  
 
The average adsorption energy increases with more cisplatin molecules due to enhanced 
non-bonded interactions. In UiO-66, the lowest adsorption energy occurs at the maximum 
loading (two cisplatin molecules in the o-pore and two in the t-pore, 2o2t). In UiO-66(NH2), 
the lowest adsorption energy occurs at a loading 2o1t because the addition of a further 
cisplatin molecule results in unfavourable framework distortions that outweigh the energy 
gained by addition of a fourth molecule. In both MOFs, the o-pores are a more favourable 
adsorption site compared to the smaller t-pores. Considering a single cisplatin molecule 
travelling through the framework, it needs to pass between the favourable o-pores and less 
favourable t-pores. To do so, the energy difference that cisplatin needs to overcome is 9 
kJ/mol and 49 kJ/mol in UiO-66 and UiO-66(NH2) respectively (corresponding to going 
from 1o to 1t, Figure 9). This difference in energy is a barrier to pore-hopping corresponding 
to a ratio of 1:5.4 (UiO-66:UiO-66(NH2)). This is consistent with the four-fold faster release 
rate from the parent compared to the amine structure [21]. 
 
 
Figure 9. Total (bonded + non-bonded), average adsorption energy for cisplatin in UiO-66 
( ) and UiO-66(NH2) ( ). XoYt refers to X cisplatin molecules in the single o-pore and Y 
molecules per two t-pores (note that each unit cell consists of one o-pore and two t-pores). 
 
Using ab-initio simulations, we can carefully place a single cisplatin molecule in the 
adsorption site of interest thus determining the energy difference associated with the o-pores 
and t-pores, whereas in the GCMC simulations these energies are influenced by the presence 



































simulations (Figure 8) and ab-initio optimisations (Figure 9) are not directly comparable as 
the latter allows the framework to relax around cisplatin molecules revealing more 
favourable adsorption sites. On the other hand, Equation 2 can be used to directly compare 
the adsorption energies calculated from ab-initio optimisations and forcefield-based MD 
simulations in a non-solvated system but fully flexible system. There is a 40 % difference 
between the calculated energies (shown in Table 1), yet both levels of theory show the same 
trend: stronger adsorption energies in UiO-66(NH2) compared to UiO-66. Ab-initio 
optimisations are a higher level of theory, however they are expensive and hence not suitable 
to model solvated frameworks (at the equilibrium loading ~ 6.3 SOL:Zr would be needed). 
Furthermore, they are run at 0 K and do not account for the temperature of the system. 
Therefore, when screening large numbers of MOFs as drug delivery carriers, classical 
simulations are the more effective tool. 
 
Table 1. Cisplatin adsorption energies in UiO-66 and UiO-66(NH2) from classical MD 
simulations (T=298 K) and ab-initio geometry optimisations (T=0 K). Calculated at loadings 
of NCPT = 0.2:1 CPT:Zr, NSOL = 0:1 SOL:Zr. 
System 
Uads (kJ/mol) 
ab-initio MD % difference 
UiO-66 -133 -90 39 
UiO-66(NH2) -182 -126 36 
 
So far, analysis of the interaction energies has clearly shown that UCPT-MOF is more 
favourable in UiO-66(NH2) compared to UiO-66. But how does this influence the release 
rate of cisplatin? MD simulations were used to calculate the intrapore diffusivity of cisplatin 
in UiO-66 and UiO-66(NH2) at different water loadings and at a constant cisplatin loading 
of one CPT molecule per o-pore (which corresponds to the loading predicted by alchemical 
simulations discussed previously). As shown in Figure 10, water molecules significantly 
influence the diffusivity of cisplatin and the intrapore diffusivity decreases as the water 
loading increases in both MOFs, because water limits the motion of cisplatin in the confined 
pore space. For a given water loading, cisplatin movement is lower in UiO-66(NH2) 
compared to UiO-66. Note that as shown in Figure 7, the optimal water loading for a given 
cisplatin uptake is approximately the same in both frameworks due to their similar free 
volumes (UiO-66=0.46 cm3/g and UiO-66(NH2)=0.42 cm
3/g). If this was not the case, it 
would not be fair to compare diffusivities based on a constant water loading because of 
confinement effects in smaller pores. Instead, the diffusivities should be compared at the 
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optimal water loading in each framework. The restricted movement of cisplatin in UiO-
66(NH2) is due to the stronger cisplatin/framework interaction energies and a series of 
cisplatin – water – BDC(NH2) hydrogen bonds that anchor it in position. This anchoring to 
amine groups provides a further reason for the slower cisplatin release from UiO-66(NH2) 
[21]. 
 
 (a)  
(b)  
(c)     
Figure 10. MSD for cisplatin (1 CPT / o-pore) at different water loadings in (a) UiO-66 and 
(b) UiO-66(NH2). Individual repeats are shown in the SI, Section 5. (c) Snapshot of cisplatin 
(black) anchoring in UiO-66(NH2) (grey) via hydrogen bonding (dotted lines) between water 
molecules (pink) and NH2 (green) functionalised BDC ligands. Heavy atoms are filled, 
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The previous techniques used (GCMC, ab-initio optimisations, MD simulations) can capture 
the variation of behaviour in the different pores, but they cannot provide information 
regarding energy barriers during interpore movement. Although MD simulations can be used 
to determine intrapore diffusion rates, pore-hopping is a rare event due to the unfavourable 
energies when cisplatin is passing through the narrow pore windows. Instead, the interpore 
movement of cisplatin was quantified by calculating the total potential energy barrier (= non-
bonded + bonded) associated with its movement through the triangular pore windows of 
UiO-66 and UiO-66(NH2) using steered MD (SMD) simulations. The total potential energy 
barrier was calculated as the difference between the least favourable and average energies 
over the course of the trajectories. 
 
Of course, the energy barriers obtained from classical SMD simulations heavily depend on 
the forcefield. Ab-initio SMD could be used instead, yet this would be computationally 
prohibitively expensive especially for cisplatin in the presence of water molecules. Instead, 
classical SMD energy barriers were compared to those calculated using ab-initio static 
energy calculations on structures within their “flexibility window” (i.e. the limit to which 
the unit cell parameters can be varied without compromising the local geometry) generated 
using the software GASP which allows us to identify the intrinsic flexibility of UiO-66 and 
UiO-66(NH2) [55]. Not only does this provide a relatively computationally cheap sanity 
check for our forcefield generated energy barriers, but it also allows us to determine without 
breaking bonds in our framework or imposing large artificial forces (as in SMD) how far the 
pore windows can open and whether they can open far enough for cisplatin diffusion. We 
carried out ab-initio static energy calculations on the GASP structures to determine the 
relative potential energy of each structure compared to the lowest energy variant. As there 
are no cisplatin molecules present in the GASP structures, we considered this energy 
difference to be the bonded contribution to the pore-hopping energy barrier. PoreBlazer [56] 
was used to determine the pore-limiting diameter of the frameworks from the SMD 
simulations (at the time of pore-hopping), and for each GASP variant. 
 
Figure 11 shows the total potential energy barrier as a function of the pore limiting diameter 
in the highest energy SMD configuration and the bonded potential energy difference to 
achieve each GASP variant. Firstly, the pore-limiting diameter calculated from SMD 
simulations at the time of pore-hopping is within the bounds set by the flexibility window 
(i.e. GASP simulations show that the window size can be further expanded whilst 
maintaining the local geometry). Secondly, SMD simulations show that the overall change 
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in potential energy is dominated by bonded interactions within the framework, and since the 
total SMD barrier agrees with the GASP / ab-initio energy differences, both methods can be 
used to obtain the bonded contribution to the intercell energy barrier.  
 
Based on Figure 11, the bonded potential energy barrier is higher in UiO-66 because 
electrostatic repulsion between amine groups and the carboxyl groups aids ligand rotation in 
UiO-66(NH2). This is in line with the trend observed by Pakhira et al. who argued that the 
energy barrier to rotate polar ligands is lower due to electrostatic repulsion [64]. 
Experimentally, release rates from UiO-66 are faster than from UiO-66(NH2), suggesting 
that the bonded barriers are not the primary reason for the differences seen between the 
release rate of cisplatin in the two frameworks. However, by comparing the pore-limiting 
diameter at the time of pore-hopping to the maximum diameter determined within the 
flexibility window, these simulations can inform us whether (or not) structural deformation 
(i.e. compromising the local geometry) is required for interpore movement of cisplatin. 
 
 (a)  (b)  
Figure 11. Bonded potential energy barrier of the frameworks as a function of the pore-
limiting diameter (PLD). Shown for the GASP structures generated within the flexibility 
window (○) and an average across seven repeated SMD simulations (▲– error bars showing 
standard deviation are within the symbol size). (a) UiO-66 and (b) UiO-66(NH2). 
 
A more meaningful approach to compare release rates is by looking at the change in CPT-
MOF non-bonded interaction energies during pore-hopping as determined by the SMD 
simulations. As with the total potential energy barrier (= non-bonded + bonded), the CPT-
MOF non-bonded barriers were calculated as the difference between the least favourable 




















































UiO-66 and UiO-66(NH2), the average non-bonded barriers (and standard deviations across 
seven repeat simulations) are 34(±6) kJ/mol and 48(±4) kJ/mol respectively. Stronger 
interaction energies between the polar arms of cisplatin and the amine groups in UiO-
66(NH2) result in higher non-bonded CPT-MOF energy barriers compared to the parent 
structure. Unlike the bonded contribution to the total energy barrier, this is in agreement with 
the higher release rates from UiO-66 [21]. This again emphasises the importance of 
including water molecules in the simulation as they provide the energy to open pore windows 
in the MOF to the extent needed for pore-hopping. In this case, the CPT-MOF interaction 
energies are more important than the bonded contribution to the pore-hop energy barrier and 
hence the release rate. 
 
As opposed to the potential energy barrier discussed so far, the total Helmholtz free energy 
barrier (∆Aporehop) takes into consideration entropic contributions to the pore-hop energy 
barrier. To compare the pore-hop free energy barrier to the driving force to displace cisplatin 
from the framework back into solution (∆GCPT-removal calculated using alchemical 
simulations, Figure 6), umbrella sampling pull simulations were used. Figure 12 shows the 
potential mean force (PMF) for cisplatin movement through UiO-66 and UiO-66(NH2) after 
1 ns of simulation time. Peaks in the PMF are indicative of unfavourable MOF – CPT 
energies as cisplatin passes through the narrow pore windows. Troughs designate more 
favourable energies as cisplatin passes through the o-pores and t-pores, as labelled on Figure 
12. The pore-hop energy barrier is the change in energy as cisplatin moves from a pore 





Figure 12. PMF for a cisplatin molecule moving through empty UiO-66 and UiO-66(NH2) 
structures.  
 
During the pull simulations used to generate configurations for the umbrella sampling in 
Figure 12, pore-hopping induces structural deformations in the framework, resulting in 
increasingly less favourable energies with more pore-hops. Clearly, the pore-hopping 
phenomena is energetically unfavourable (as expected from the previous discussion). After 
moving from the o-pore to the t-pore, there are significant deformations in the framework, 
and so if the system equilibrates cisplatin moves out of the deformed t-pore into an o-pore 
within the same sampling window. This results in an unphysical pathway through the 
framework which cannot be analysed as a PMF (see the SI, Section 6 for detail). Therefore, 
a shorter simulation time was used to analyse the PMF. 
 
While after 1 ns of simulation time cisplatin has not equilibrated in the adsorption sites 
(within the o-pores and t-pores) and therefore the energy difference between adsorption sites 
cannot be directly compared to equilibration simulations such as GCMC and geometry 
optimisations, the simulation path remains sensible and therefore, we can estimate pore-
hopping energy barriers from the PMF. 
 
As shown in Figure 2, in UiO-66(NH2) some but not all of the pore windows are narrowed 
by the presence of amine groups. Considering the larger windows in the amine structure, the 
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pore-hop energy barrier is approximately 10 – 20 kJ/mol in both UiO-66 and UiO-66(NH2). 
If cisplatin attempts to move through the smaller window in UiO-66(NH2), the energy barrier 
is significantly higher (~ 30 kJ/mol). These values compare well to the π-flip energy barrier 
of empty UiO-66 calculated using nuclear magnetic resonance experiments reported by 
Kolokolov et al (~30 kJ/mol per BDC [65]). The larger energy barrier in the amine structure 
indicates reduced movement through UiO-66(NH2) compared to UiO-66. 
 
At an energy barrier of ∆Aporehop = 20 kJ/mol, cisplatin is highly unlikely to pass through one 
of the triangular pore windows (P = 0.04 %) and so cisplatin cannot pass through an 
otherwise empty framework. As seen experimentally [21], at sufficient water loading there 
is enough of a driving force to overcome the pore-hopping energy barrier in both MOFs. 
Therefore, water must provide the activation energy for the MOF windows to open wide 
enough and based on the alchemical simulations, enough activation energy (∆GCPT-removal > 




A variety of computational methods have been assessed for their suitability to model 
cisplatin uptake and release in biocompatible MOFs, UiO-66 and UiO-66(NH2). All 
simulations make use of standardised methods, and the methods that we recommend should 
be applicable to predict the uptake and release properties of other MOF - drug delivery 
systems. 
 
Pure-component GCMC simulations (often used in computational screening papers) can 
provide the maximum theoretical loading of cisplatin as well as the adsorption energies at 
the maximum loading. However, such information can be misleading because they do not 
account for the presence of water. In contrast, BAR simulations with water show that there 
is a net driving force to displace cisplatin from the smaller pores within the frameworks 
(otherwise shown during GCMC simulations to be a favourable adsorption site), indicating 
the importance of the solvation shell when predicting the experimental loading. The impact 
of water is often overlooked in computational drug screening papers; however, where highly 





Insight into cisplatin release rates were gained from the variation in intrapore and interpore 
energies. Pure component GCMC and ab-initio simulations show stronger CPT-MOF 
interaction energies and a higher o-pore to t-pore energy difference in UiO-66(NH2) 
compared to UiO-66, both of which are indicative of a slower release rate. However, they 
provide limited information on how these interaction energies are influenced by water, nor 
to what extent they will influence the release rate as they sample energies at the minima / 
equilibrium and provide no concept of time dependent movement. MD simulations highlight 
the decrease in intrapore diffusion with increased water loading, and that (in agreement with 
experimental results) at the optimal water loading cisplatin diffusivity is higher in UiO-66 
compared to UiO-66(NH2). The interpore diffusivity cannot be quantified using equilibrium 
techniques such as unbiased MD because pore-hopping is a rare event, however the pore-
hop energy barrier determined using steered MD/GASP or umbrella sampling simulations 
indicates whether diffusion through the system is possible without structural deformations. 
By comparison of the energy barrier and driving force to displace cisplatin, it can also be 
inferred that cisplatin will not be released from either framework until a threshold water 




Details of the partial atomic charges, ab-initio simulation details, cisplatin size 
approximations, additional BAR simulation results at higher cisplatin loadings, MSD repeats 
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Section 1. Partial atomic charges 
 
Labels were used to classify framework atoms into different groups based on their chemical 
surroundings (Figure S1). The partial atomic charges used in the classical simulations were 
the group averages shown in Table S1: 
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(a) (b)  (c)  
Figure S1. Groups used to average the partial atomic charges in (a) BDC, (b) BDC(NH2), 
and (c) Zr6O4(OH)4 
 
Table S1. Partial atomic charges used in the classical simulations 
 
The purpose of this paper was to compare and validate the methods used to screen metal-
organic frameworks for cisplatin uptake and release. For screening purposes, it is important 
to reduce the computational cost, and therefore the partial atomic charges were obtained 
from static energy calculations on the initial (non-optimised) primitive unit cells.  
 
Charges in the framework will be influenced by subtle changes in the atomic arrangement. 
Furthermore, cisplatin itself has highly electronegative groups, and therefore its position 
inside the framework could influence the charge distribution. To determine if these issues 
will influence the classical simulations that make use of the partial atomic charges, ab-initio 






C1 0.253 0.250 
C2 -0.013 -0.020 
C3 -0.104 -0.105 
C4 - 0.077 
H1 0.145 0.133 





H3 - 0.132 
N1 - -0.222 
O1 -0.288 -0.293 
O2 -0.580 -0.581 
O3 -0.543 -0.538 





Figure S2. Comparison of partial atomic charges in (a) UiO-66 and (b) UiO-66(NH2) 
calculated using different methods and conformations of cisplatin: Initial=static energy of 
empty structure, optimised=minimisation of empty structure, XoYt = X cisplatin/1 o-pore, 
Y cisplatin/2 t-pores. 
 
Overall there are no significant changes in the partial atomic charges calculated for the 
optimised structures with different loadings of cisplatin. When comparing the static energy 
and minimised charges of the empty structures, there are insignificant differences for all 




















































































structures respectively. Though Coulombic interactions between O3 and cisplatin will be 
influenced by this discrepancy, the charge is the same sign as in the optimised structure and 
the overall charge of the zirconium nodes are the same (3.04 and 3.03 in the optimised and 
initial structures respectively). Therefore, it is highly unlikely that this will significantly 
influence the classical simulation results. 
 
Section 2. Ab-initio simulation details 
 
The Quickstep module in CP2K [1-6] was used for both the static energy calculations and 
the geometry optimisations. Quickstep uses an efficient Gaussian and Planewave approach 
in which the electron density and wavefunctions are represented by planewaves and 
Gaussian orbitals respectively. Planewave cutoff and relative cutoff values of 500 Ry and 50 
Ry were used respectively. Exchange correlation energies were approximated using the 
Perdew-Burke-Ernzerhof functional [7] with DFT-D3 dispersion corrections [8, 9]. 
Goedecker, Teter and Hutter (GTH) pseudopotentials were used to model core electrons [2]. 
Triple-zeta Gaussian type basis sets were used to describe all atoms with the exception of 
zirconium and platinum which were described using double-zeta functions [10]. As with the 
planewaves, core electrons were described by GTH pseudopotentials [11, 12]. A tolerance 
of 10-6 was used for the convergence of the wavefunction in both types of ab-initio 
simulation. For the optimization, convergence tolerances were set to 0.003 and 0.0015 Bohr 
for the maximum and root-mean-square of atomic displacements, and 0.0004 and 0.0003 
Bohr/Ha for the maximum and root-mean-square of the atomic forces. 
 
Section 3. Size of cisplatin 
 
As a “back of the envelope” calculation, the cisplatin uptake in a pore of a given size can 
be determined based on its the collision diameter. As shown in Figure S3, this was 




Figure S3. Approximation for cisplatin collision diameter using the LJ sigma values 
presented by Yesylevskyy et al [13]. 
 
Section 4. BAR simulations for various cisplatin loadings 
 
During encapsulation, the co-adsorption of water (as well as diffusion limitations) will 
decrease cisplatin uptake. Alchemical simulations were used to predict the uptake whilst 
accounting for the influence of water. Figure S4 and Figure S5 show that the overall trends 
between solvation and the Gibbs free energy are the same as those described in the main text 
regardless of the cisplatin loading. 
 
(a)  (b)  
Figure S4. Gibbs free energy of decoupling one cisplatin molecule from an o-pore in (a) 


























































(a)  (b)  
Figure S5. Gibbs free energy of decoupling one cisplatin molecule from solvated (a) UiO-




















































































Section 5. Individual repeats for cisplatin MSD at various water loadings 
 
 (a)   
(b)   
Figure S6. Mean square displacement for cisplatin at different water loadings in (a) UiO-66 
and (b) UiO-66(NH2). Different lines of the same colour represent independent repeats 




































































Section 6. Time-dependent free energy profiles 
 




Figure S7. Simulation time dependent PMFs of cisplatin moving through (a) UiO-66 and (b) 
UiO-66(NH2) at T=310 K.  
 
Pull simulations were used to generate the configurations for umbrella sampling. During 
these simulations, the framework distorts due to the high energy associated with cisplatin 
movement through the pore windows. This means that after 1 ns of simulation time, the 
system is not fully equilibrated. If allowed to equilibrate, cisplatin in distorted t-pores will 
move into adjacent o-pores within the same sampling window. This results in a non-physical 

































































trajectory which cannot be analysed as a PMF. For this reason, the PMFs shown in the main 
body of the text were analysed prematurely. Although the sampling windows are not fully 
equilibrated after 1 ns, the trajectories show a physical path, and therefore despite not being 
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CHAPTER 5. TAILORING DEFECTS OR BUILDING UNITS FOR CONTROLLED 
CISPLATIN DRUG DELIVERY 
 
5.1. Motivation: narrow down the better method of tailoring MOFs to reduce release rates 
while increasing uptake 
 
If a framework is promising for drug delivery, it makes sense to tailor that framework to 
enhance its uptake and retention. This can be done using reticular synthesis (i.e. using 
different building blocks and similar synthesis conditions to achieve predetermined 
structures based on a prototype [1]), or by incorporating defects into the framework [2]. 
However, the current literature does not indicate which method produces better drug delivery 
carriers.  
 
This section addresses the aforementioned gap using the biocompatible UiO-66 with and 
without missing ligand defects, mainly because of the well-established literature and 
experimental data [3-6]. For comparison, non-functionalised and NH2 functionalised defect 
free variants of UiO-66 with larger pore sizes (UiO-67 and UiO-68) were also used and 
compared to the defective structures. Particular attention was attributed to the level of control 
over cisplatin diffusion each structure could provide. Based on the calculated diffusivities, 
the aim of this work was to recommend whether it is better to tailor MOF drug delivery 
carriers using defects or different building units. 
 
5.2. Summary: MD simulations without water and SMD with water to look at diffusion 
mechanisms 
 
Since pore volume is the determining factor for cisplatin uptake (see Chapter 4), this was 
calculated using Poreblazer [7]. In the non-solvated systems, MD simulations were used to 
produce mean-square displacement (MSD) curves of cisplatin from which the diffusivity 
could be calculated (Section 2.3.4). Diffusivities calculated at various temperatures were 
used to determine activation energies associated with diffusion in each system. As discussed 
in Chapter 4, water has a large impact on the MOF-CPT interaction energies as well as the 
diffusivities, however when water is present the rate of diffusion is too slow to witness 
interpore movement. For this reason, the non-solvated energy barriers were compared to the 
solvated energy barriers calculated using SMD simulations to determine how well each 




5.3. Results: defect-free MOFs with polar functional groups are recommended as opposed 
to defects  
 
Both the MD and SMD results (with and without water) show that cisplatin retention is 
equally achievable in frameworks with larger functionalised pores (i.e. UiO-68(NH2)) as it 
is in the defective UiO-66 models. Cisplatin diffusion in the defective UiO-66 structures is 
usually predictable: namely if the modulator size decreases or if polar modulators are used 
diffusion decreases. However, there are unexpected results which are not intuitive, for 
example larger step sizes between favourable adsorption sites caused by specific positions 
of modulators and ligands significantly decreases diffusivity. These simulations indicate that 
defect free, functionalised structures are a better way forward to derive an ideal drug delivery 
carrier. 
 
5.4. Errata  
 
Not applicable as paper not yet submitted 
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One third of the worldwide population will be diagnosed with cancer at some point in their lives, yet 
it remains one of the hardest diseases to combat because of the non-specificity of treatment. Targeted 
chemotherapy using nanocarriers is a promising method for improving the welfare of cancer patients, 
yet the hunt for an ideal nanocarrier continues. In this work we compare two methods for tailoring a 
highly promising category of nanocarriers – metal-organic frameworks, MOFs, to achieve good drug 
loading and retention properties, namely incorporation of defects and altering building units. 
Focussing on a well-known series of biocompatible MOFs (UiO-66, UiO-67 and UiO-68), we use 
molecular simulations to highlight the complex interplay between different structural characteristics 
such as variations in host-guest energies throughout the framework, pore size, and pore window 
diameter. Our simulations show that similar levels of cisplatin retention can be achieved in the wider 
pores of functionalised UiO-67 and UiO-68 compared to the defective UiO-66 structures. 
Furthermore, it is not possible to finely tune defects, yet their precise configuration has a major 
influence on cisplatin diffusivity. Our recommendation is that further studies involving MOFs as 
nanocarriers should focus on functionalising frameworks with wider pores (to enhance uptake and 





Cancer is a disease whereby abnormal cells rapidly mutate into tumours, which can continually 
invade and damage other healthy areas of the body via metastasis, and one in three people are 
diagnosed with cancer in their lifetime. Unfortunately, cancer is extremely difficult to treat for a 
variety of reasons, including the issue of metastasis, a lack of biomarkers and drug resistance abilities 
[1]. One of the most common forms of treatment to date is chemotherapy during which 
chemotherapeutics are injected into the patient. Often the chemotherapeutics are cytotoxic drugs 
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which interfere with DNA causing apoptosis (programmed cell death) which mainly effects rapidly 
growing cells such as those in a tumour. However, the majority of World Health Organisation 
approved chemotherapeutics are non-specific and also very damaging to rapidly growing normal 
healthy cells causing severe side effects [2, 3]. To reduce toxicity to normal healthy cells and improve 
dosage in the vicinity of a tumour, targeted drug delivery has become a popular area of research. The 
idea is that the subtle physiochemical properties specific to tumours (for instance changes in the 
extracellular pH [4, 5] or antigens that are overexpressed by tumours [6]) are targeted for instance 
using a drug delivery carrier.  
 
Existing nanocarriers can be subcategorised into inorganic carriers (e.g. quantum dots or carbon 
nanotubes) and organic carriers (e.g. micelles or liposomes). Typically however there is a trade-off 
between the drug loading capacity and nanocarrier biocompatibility / biodegradability [7]. Metal-
organic frameworks are hybrid materials that can be tailored to avoid such a trade-off. They consist 
of metal nodes coordinated by organic ligands resulting in porous crystalline materials which 
typically have large pore volumes and internal surface areas. Furthermore by changing the building 
units, we can strategically tailor properties such as the pore window size, cavity volume, and MOF 
– guest molecule interaction energies in order to enhance uptake or control guest molecule diffusivity 
[8]. Depending on their building units, MOFs can be biocompatible, and some MOFs are only stable 
within a given pH range. This property can be exploited for drug delivery where the MOF nanocarrier 
is stable in normal healthy parts of the body and but unstable in the acidic extracellular area 
surrounding a tumour [9]. As well as this, it is possible to conjugate antibodies onto the external 
surface of MOFs allowing them to target antigens that are specifically overexpressed by tumours 
[10]. 
 
An ideal MOF for drug delivery will have a high loading capacity coupled with a fast uptake rate as 
well as a slow release rate. Unfortunately, most studies show that high loading is mainly governed 
by the accessible pore volume [11-13] which often equates to larger window apertures and faster 
release rates. To overcome this, it is possible tune MOF – guest interactions to increase retention 
time as well as the loading. For example, Rojas et al found that the release rate of ibuprofen (which 
is hydrophobic) is slower than the release rate of aspirin (which is hydrophilic) in UiO-66 
(hydrophobic) [12].  
 
As summarised in the extensive review by Kotzabasaki et al [14], most theoretical studies on drug 
delivery quantify uptake using grand-canonical Monte Carlo simulations, arriving at a common 
conclusion that the loading is governed by the pore volume [15, 16]. However, when we applied the 
same technique to quantify cisplatin uptake in UiO-66 [17], the loading was significantly higher than 
that reported experimentally [18], indicating the importance of water coadsorption and diffusion 
hinderance during encapsulation. Release rates are normally quantified based on the use of non-
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temporal simulations (e.g. geometry optimisations or GCMC) to derive MOF – drug interaction 
energies [15, 16, 19]. However, the lack of temporal aspect could result in unforeseen discrepancies 
between the interaction energy and experimental release rates. To the best of our knowledge, the only 
group to use time-averaged molecular dynamics (MD) simulations to determine chemotherapeutic 
release rates in MOFs is Kotzabasaki et al who performed MD simulations of gemcitabine diffusion 
in solvated mesoporous IRMOF-74-III (with and without polar functional groups). They found a 
slight reduction in diffusivity when polar functional groups are used, and that diffusivity decreases 
at higher loadings due to the formation of drug aggregates [20].  
 
In this work we focus on characterising and controlling diffusion of one of the main cytotoxic drugs 
used in chemotherapy – cisplatin (cis-diamminedichloridoplatinum (II) shown in Figure 1), in 
variations of one of the most widely studied microporous MOFs – UiO-66. UiO-66 is a 
biocompatible MOF [21] that consists of zirconium clusters (Zr6O4(OH)4) coordinated by the 
carboxyl groups of twelve BDC ligands (BDC=benzenedicarboxylic acid) per cluster [22]. It is 
arranged into larger octahedral pores (1.1 nm) and smaller tetrahedral pores (0.8 nm), which are 
connected by narrow triangular windows with 0.36 nm diameter. Depending on the synthesis 
conditions (e.g. modulators used to slow down crystallisation), UiO-66 normally has 1 – 4 missing 
BDC ligands per cluster [23], and the maximum concentration of defects reported in crystalline 
structures experimentally is 4.3 monocarboxylate acids per node, (though up to 6 defects/node can 
be achieved in the crystalline structure using different types of modulators [24]) [25]. Missing ligand 
defects can be systematically tuned to alter the structural and chemical properties [26]. For drug 
delivery applications, defects can be advantageous, as they increase the free volume (hence loading 
capacity) and the defective sites can be used for anchorage to prevent premature drug release [27, 
28]. Another strategy to increase the free volume is to use larger ligands, for example in isoreticular 
MOFs UiO-67 and UiO-68 which differ from UiO-66 in that larger biphenyldicarboxylate (BPDC) 
and terphenyldicarboxylate (TPDC) ligands connect Zr6O4(OH)4 nodes [22]. The larger ligands 
increase the tetrahedral and octahedral pore sizes to 1.0 and 1.2 nm in UiO-67, and 1.2 and 1.4 nm 
in UiO-68 (calculated using PoreBlazer [29]). Compared to UiO-66, these frameworks are less likely 
to have missing ligand defects [30, 31]. In this work, we investigate the level of cisplatin retention 





Figure 1. Structure of the polar drug, cisplatin. Colour scheme: green = chlorine, grey = 
platinum, blue = nitrogen, white = hydrogen. 
 
Our aims are to understand how the properties of these microporous frameworks (e.g. pore 
volume, window diameter, and polar functionality) influence cisplatin diffusion and to 
determine which property dominates retention under different circumstances. For example, 
if the pore window diameter is larger than the diameter of cisplatin, then how do other 
properties such as the pore volume influence diffusivity? We also look at the influence of 
polar functional groups by comparing cisplatin diffusion in non-functionalised structures 
compared to frameworks with NH2 functionalised ligands. Furthermore, we investigate what 
route (e.g. incorporating defects, adding functional groups, or varying ligand size) results in 
the best control of achieving slow release rates whilst retaining a large pore volume to 




Structural Models: Structures of defect-free UiO-66, UiO-67, and UiO-68 were taken from the 
Cambridge Structural Database [32-34], and amine groups were added to the ligands using Mercury 
[35]. Missing ligand defects in UiO-66 were modelled by removing 2, 4, and 6 BDC/node and 
coordinating the metal sites using the carboxyl groups of methanoic acid (MA), ethanoic acid (EA) 
or trifluoroethanoic acid (TFA). We will denote the missing linker defects as XMA, XEA, XTFA 
where X represents the number of missing BDC linkers per node, and MA, EA and TFA stands for 
the node capped with methanoic acid, ethanoic acid or trifluoroethanoic acid, respectively. For 
example, 2MA stands for two missing ligands per node capped with methanoic acid. When creating 
defects, adjacent BDC were removed (Figure 2) to emphasize the change in pore window diameter 





Figure 2. UiO-66 defect model, showing the order of BDC ligands removed: 2, 4, 6 
defect/node = black, pink, green. For clarity, MA modulators have been used as an example 
and hydrogen atoms have been omitted. 
 
Molecular dynamics simulations: Bias and unbiased MD simulations were used to determine 
the interpore and intrapore diffusion behaviours of cisplatin in each framework. For all MD 
simulations, the forcefield parameters for cisplatin were taken from the work of Yesylevskyy 
et al [36] and for water the TIP3P was used [37]. Mulliken charges for each framework were 
obtained using static energy calculations in CP2K (see below), and Lennard Jones / bonded 
interaction parameters were taken from the Universal Forcefield [38] using the topology 
builder OBGMX [39]. To model “perfect defects”, the structures used to build topologies 
were not optimised prior to use in OBGMX. This is discussed in more detail with the results, 
however in brief when optimised some of the structures closed (though the bonding remained 
intact). It is unlikely that such structures would close when exposed to water because 
favourable host-guest interaction energies would mean that the lowest energy state would 
enhance the loading (hence the structure should reopen) [40]. For this reason, we modelled 
diffusion in the open pore (non-optimised) structures only. Either a single cisplatin molecule 
was randomly inserted into the frameworks, or they were carefully positioned to achieve a 
loading of one cisplatin molecule per octahedral pore. Details for obtaining the optimal water 
loading can be found in the SI, Section S1.  
 
MD and SMD simulations were carried out using the Groningen Machine for Chemical Simulations 
(GROMACS) [41-46]. Under the assumption that the bulk crystal would confine a unit cell to 
constant volume, the NVT ensemble was employed during all simulations. The framework and guest 
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molecules were treated as fully flexible. Electrostatic interactions were modelled using the particle 
mesh Ewald algorithm [47, 48], and the 12-6 Lennard Jones potential was used to model non-
Coulombic interactions. A Verlet cutoff scheme was used in the neighbour search and cutoff values 
for the Coulombic and Van der Waals terms were set to 1.25 nm. Dispersion corrections were applied 
to the energy and pressure terms, and the temperature was set to 298 K. Periodic boundary conditions 
were employed in all directions. 
 
Normal MD simulations have the advantage that they can sample an equilibrated system, however 
when water is present the rate of cisplatin diffusion is too slow to witness interpore movement within 
reasonable simulation times. Instead, steered-MD (SMD) simulations were used. SMD allows us to 
look at the process of interpore movement in the presence of water, though these simulations are only 
equilibrated in the limit of infinitely slow pull velocities. Therefore, the SMD results can only provide 
an initial estimate for how the interaction energies will vary along the coordinate path when water is 
present. Based on these pros and cons, for the non-solvated systems we calculated the diffusivity 
(DNoSol) and considered the activation energy (QEQ) based on the gradient of diffusivities as a function 
of temperature, calculated using more reliable equilibrium MD simulations. For the solvated system, 
we considered the maximum diffusion energy barrier (QSMD), estimated from the change in 
interaction energies calculated using steered-MD simulations. If water does not influence the 
conclusions then the diffusivity in the absence of water, DNoSol should be inversely proportional to 
the energy barrier, QSMD. 
 
For all MD simulations, each system was energy minimised and pre-equilibrated prior to the 
collection of data. A steepest decent minimisation was initially carried out using a tolerance of 1,000 
kJ mol–1 nm–2 and a step size of 0.01 nm. Next, the systems were pre-equilibrated for 200 ps using a 
timestep of 1 fs and a modified Berendsen thermostat to regulate the temperature [49]. For the 20 ns 
normal MD production runs, Nose-Hoover temperature coupling was employed [50, 51]. This 20 ns 
timescale was deemed appropriate since mean-square displacement (MSD) plots were linear and 
frequent interpore movement was witnessed. Based on the gradients of MSD plots, the diffusion 
coefficient (DNoSol) was calculated as DNoSol=MSD/6t (where t is the simulation time). By calculating 
the diffusion coefficient at various temperatures (T = 298 K – 798 K), Arrhenius plots were generated 
and used to calculate the activation energy (QEQ) and pre-exponent (D0, which is a function of 
successiveness of atom jumps, the jump frequency, and the characteristic diffusion length) [52]. 
 
For the solvated SMD simulations, cisplatin was pulled along the [0 -1 1] plane for 10 ns (that is the 
plane in which a moveable path is created in the 2 defects/node model, Figure 2). A harmonic spring 
constant of 5,000 kJ mol–1 nm–2 was used to constrain cisplatin to the auxiliary pull atom which 
moved along the coordinate path at a velocity of 0.0025 nm/ps (the choice of these parameters is 
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justified in the SI, Section S2). The activation energy, QSMD, was approximated from the change in 
interaction energy as cisplatin moves through the framework. 
 
Ab-initio simulations: CP2K was used to carry out static energy and optimisation simulations. Static 
energy calculations of the non-optimised structures yielded the Mulliken charges used in the MD and 
SMD simulations while each structure was also optimised to determine how defects will influence 
the structure (compared to the idealised defect models). In both cases, the Gaussian and Planewave 
approach as implemented in the Quickstep module was used [53-58]. Goedecker, Teter and Hutter 
(GTH) pseudopotentials were used to model the core electrons [54, 59, 60], and all atoms were 
modelled using triple-zeta Gaussian basis sets except for zirconium for which double-zeta functions 
were used [61]. Cutoff and relative cutoffs of 600 Ry and 50 Ry were used, and exchange correlation 
terms were approximated using the Perdew-Burke-Ernzerhof functional [62] with DFT-D3 
dispersion corrections [63, 64]. Convergence of the wavefunction was set to a tolerance of 10-6 and 
optimisation tolerances were set to: maximum atomic displacement = 0.003 Bohr, root-mean square 
atomic displacement = 0.0015 Bohr, maximum atomic force = 0.0004 Bohr/Ha, and root-mean 
square atomic force = 0.0003 Bohr/Ha. 
 
RESULTS AND DISCUSSION 
 
To understand the interplay between cisplatin diffusion and different MOF properties, we initially 
simulated single cisplatin molecules in otherwise empty frameworks. This removes all other 
influences on the rate of diffusion (e.g. guest – guest molecule interactions), so we can focus solely 
on the framework properties. At 298 K, all structures except for defect-free UiO-66 and 4TFA show 
normal diffusivity (as shown by MSD plots in the SI, Section S3). In UiO-66, comparatively rigid 
BDC ligands form a pore window diameter of 0.36 nm which is smaller than the collision diameter 
of cisplatin (≈ 0.5 nm). The causes of sub-diffusivity in 4TFA at 298 K are discussed in more detail 
below, but it is worth pointing out that normal diffusion is seen in 4TFA as the temperature increases 
(≥ 398 K).  
 
Figure 3a compares cisplatin diffusivity in the defective UiO-66 structures. In general, cisplatin 
diffusivity is slower (hence retention is better) if larger modulators are used (comparing EA to MA), 
or if modulators derived from stronger acids are used (comparing similarly sized TFA and EA). 
Surprisingly the rate of diffusivity at 298 K decreases going from 2 → 6 → 4 defects/node for all 
capping types at 298 K. It should be noted however that (as shown in the SI, Section S3) at higher 
temperatures diffusivity decreases going from 6 → 4 → 2 defects/node as expected. The decrease in 
diffusivity with modulators derived from stronger acids or larger modulators are still observable at 
higher temperatures. The diffusivity is inversely proportional to the activation energy (Figure 3b) 




(a)  (b)  (c)  
Figure 3. Diffusivity of a single cisplatin molecule at 298 K inside non-solvated UiO-66 
defective structures (a). No diffusivity is shown for 4TFA as normal diffusion was not 
observed. Arrhenius-based diffusion activation energies (QEQ) and pre-exponential factors 
(D0) for a single cisplatin molecule in the non-solvated structures (b/c). For 2MA, the 
activation energy is ~ 0 kJ/mol, hence no bar can be seen in (b). Colour scheme: yellow = 
MA, blue = AA, red = TFA modulated UiO-66. 
 
The diffusivities in Figure 3a can be explained in terms of the activation energies in Figure 3b. Firstly, 
it should be noted that the diffusion activation energy is associated with the variation in energy as 
cisplatin moves between favourable adsorption sites via less favourable sites in the framework (such 
as the pore windows). As shown in the SI, Section 4, the most favourable adsorption sites are 
associated with the aromatic and carboxyl groups of the BDC ligands (hence to maximise the 
adsorption energy, cisplatin adsorbs in the pore corners). At 2 defects/node, there is zero activation 
energy in 2MA (hence high diffusivities) because the short alkyl chains do not intrude the pore 
window and weak interaction energies with the modulators equate to less anchorage in the pore 
corners. The activation energy is higher (hence the diffusivity is lower) in 2TFA compared to 2EA 
because cisplatin interacts more favourably with the carboxyl group associated with the TFA 
modulators (as it is a stronger acid the oxygen atoms are less negatively charged and so the 
electronegative atoms in cisplatin experience less Coulombic repulsion). 
 
As the number of defects increase, interaction energies associated with the modulator chain (MA = 
H atom, EA = methyl group, TFA = trifluoromethyl group) become more influential on the activation 
energy. For example, a high density of unfavourable groups pertaining to the modulators will 
increase the variation in energy (hence the activation energy) associated with cisplatin movement 
through the framework. At 4 defects/node, the activation energy in the TFA structure remains the 























































interaction energies with the chain (fluorine atoms repel the electronegative atoms in cisplatin). The 
activation energy is higher in 4MA compared to 4EA because in the former there are weak interaction 
energies associated with the modulator chain, and in the latter, there are relatively strong interaction 
energies with the chain (as methyl groups are larger, the interaction energies are more favourable, 
and this reduces the variation in activation energy that cisplatin must overcome). At 6 defects/node, 
the same trend is seen in the MA and EA structures. 6TFA however has a surprisingly low activation 
energy, which arises from opposing interaction energies from the modulators and ligands. More 
specifically, when cisplatin is in the pore corners next to the ligands, it experiences unfavourable 
interaction energies with the electronegative groups of the TFA modulators (see the SI, Section 4).  
 
Figure 4 shows the cisplatin diffusivity and Arrhenius based diffusion constants inside defect-free 
UiO-67 and UiO-68 (defect-free UiO-66 was excluded from these results because sub-diffusion was 
observed). As seen in Figure 4, cisplatin diffusivity is slower in non-functionalised UiO-67 compared 
to UiO-68 (the phenomena of larger pores and enhanced diffusivity is commonly seen in various 
other systems [65, 66]), yet both defect-free structures show a similar magnitude of cisplatin 
diffusivity as the defective UiO-66 structures (~ 10-6 cm2/s). As in the experimental work by Mocniak 
et al [18], if polar NH2 functional groups are added to the defect free structures we can significantly 
reduce diffusivity (hence control release rates) compared to the majority of defective UiO-66 
structures due to enhanced interaction energies with cisplatin (UiO-67 = 66 %decrease, UiO-68 = 91 
%decrease). In the amine functionalised variants, diffusivity is slower in UiO-68(NH2) compared to 
UiO-67(NH2). 
 
(a)  (b)  (c)  
Figure 4. Diffusivity of a single cisplatin molecule at 298 K inside non-solvated UiO-67 and 
UiO-68 structures with and without NH2 functionalised ligands (a). Arrhenius-based 
diffusion activation energy (QEQ) and pre-exponential factors (D0) for a single cisplatin 
























































































































































Diffusivities in non-functionalised UiO-67 and UiO-68 are on par with those in the defective UiO-
66 structures (Figure 3). As shown in Figure 3b/c and Figure 4b/c, they have higher activation 
energies than the defective structures (because larger pores increase the distance between favourable 
adsorption sites resulting in a larger variation in energy), but they also have larger D0 values (because 
the distances moved in successive steps are larger). If amine groups are added, the activation energy 
further increases resulting in lower diffusivities. This is more pronounced in UiO-68(NH2) because 
the larger pore size creates bigger gaps between the favourable NH2 sites. 
 
Figure 5 summarises how the properties of MOFs are linked to D0 and Q
EQ. If the window 
diameter is less than 4 Å (i.e. as in 2 – 4 EA and TFA), there is a sharp increase in the 
activation energy because interpore movement requires the displacement of framework 
atoms. At such small window diameters, the activation energy significantly increases if the 
number of defects increase (because as mentioned, there is a high density of unfavourable 
modulator – cisplatin interactions) or if the modulators are derived from TFA (because of 
the anchoring/repulsion caused by polar groups). In other words, the release rates decrease 
if cisplatin has to pass through highly unfavourable regions of the framework (i.e. large 
concentrations of unfavourable modulators). Slower release rates in TFA modulated 
structures are expected as similar phenomena have been seen experimentally, namely 
hydrophilic drug release decreases significantly in frameworks with hydrophilic groups [12, 
18]. However, the decrease in release rates going from 2 to 4 defects/node at 298 K is not 
intuitive. 
 
If the window size increases beyond 4 Å, both the preexponential factor and activation 
energy increase because the pore size (hence distance between favourable adsorption sites) 
increases. This increase is particularly enhanced when polar functional groups are added to 
the ligands. As shown by the diffusivities in Figures 3 and 4, this indicates that we can 
achieve the same controlled release rates using functionalised MOFs with larger pore sizes 
as we can using MOFs with small pore sizes. Such a finding would be important as it may 
enable us to achieve a higher loading of cisplatin, faster encapsulation rates as well as good 
retention of the drug. The validity of this conclusion is further analysed in the following 











Figure 5. Diffusion activation energy, QEQ, (■) and preexponential factor, D0, (×) as a 
function of (a) the window diameter and (b) the pore volume. Results gathered from non-
solvated simulations of a single cisplatin molecule in each structure, at temperatures ranging 
from 298 – 798 K, with seven repeats at each temperature 
 
So far, single cisplatin molecules have been modelled inside otherwise empty frameworks to solely 
investigate the influence of MOF properties on cisplatin mobility. However, experimentally cisplatin 
loadings of 5 – 26 %wt are achievable in UiO-66 (depending on the uptake method and defect 
concentration), and release/uptake experiments are carried out in aqueous solutions [18, 28].  
 
When modelling a single cisplatin molecule, all structures (except for UiO-66) permit interpore 
movement, and normal diffusion regimes are generally observed. When the loading increases from 
1:8 to 1:1 CPT:octahedral pore, clusters of cisplatin molecules form inside the pores due to strong 
electrostatic interactions between the chlorine and amine groups (snapshots are available in the SI, 
Section S5). As shown in Figure 6, this hinders mobility and changes the diffusion regime from 
normal (<r2> ∝ tα where α = 1), to a combination of normal/sub-diffusive (<r2> ∝ tα where α < 1), 





















































































needs to break away from the clusters to achieve interpore movement. These results indicate that the 
release rate per cisplatin molecule decreases at higher loadings. Steric hinderance caused by guest 
molecule grouping is a well-known effect that increases with loading [67] [68], and the clustering 
effect is also seen in other MOF – drug systems [20]. 
 
For both high and low cisplatin loadings, diffusion increases with pore window diameter (UiO-66 → 
TFA/EA → MA → UiO-67 → UiO-68). In contrast to the simulations with just one CPT molecule, 
changing the modulator polarity or the number of defects does not have an effect at a loading of one 
CPT:octahedral pore, suggesting the window diameter is the rate-limiting factor for the diffusion at 
higher loading. 
 
(a)  (b)  
(c)  (d)  
Figure 6: Comparison of MSD for cisplatin loadings of 1CPT/8 octahedral pores (red) and 1CPT/1 
octahedral pore (purple) at 298 K in the defective UiO-66 structures modulated with (a) MA, (b) EA, 
(c) TFA (solid line 2 defects / node, dashed line 4 defects / node, dotted line 6 defects/node) and (d) 
defect free UiO-66 (solid line), UiO-67 (dashed line) and UiO-68 (dotted line).  The expected 
gradients for normal and sub diffusion are represented by the black dotted lines, where <r2> is 
proportional to tα (α = 1 and α = 0.5 respectively). 
 
As release and uptake experiments are typically carried out in aqueous solution, we added explicit 
water molecules to the system to look at the influence of water on the rate of cisplatin diffusivity. 
Compared to the non-solvated system, Figure 7 shows that cisplatin diffusivity decreases by several 







































































agreement with the solvent-free results, smaller cavities (UiO-68 → UiO-67 → UiO-66) and smaller 
pore window sizes (MA → EA) decrease diffusion and hence the release rates. Diffusivity also 
decreases with modulator polarity (EA → TFA), though this is more likely due to MOF – water 
interaction energies as opposed to UMOF-CPT (which is significantly reduced in all systems due to the 
formation of a solvation shell, see the SI, Section S6).  Figure 7 also shows that there is a strong 
correlation between water and cisplatin diffusivity, caused by hydrogen bonding between the 
cisplatin and water molecules – namely cisplatin is “carried” through the system by water. The 
outlier, UiO-68(NH2), has particularly low cisplatin diffusivity compared to water which is caused 
by strong NH2 – CPT interaction energies (evident from the energy landscapes shown in the SI, 
Section 7) and a relatively large free volume for water molecules (that are not part of the solvation 
shell) to move. 
 
Figure 7. Diffusivity of cisplatin and water at 298 K in each system at a loading of one 
cisplatin molecule per octahedral pore.  Marker scheme (defect free):  UiO-66,  UiO-67, 
 UiO-67(NH2),  UiO-68,  UiO-68(NH2). Marker scheme (UiO-66 defect structures): 
diamond, triangle, square = 2, 4, 6 defects/node respectively. Colour scheme (UiO-66 defect 
structures): yellow, blue, red = MA, AA, TFA modulated nodes respectively. 
 
When water is present, interpore diffusion cannot be quantified within reasonable MD time scales 
because of reduced cisplatin mobility. Instead, SMD simulations were used to determine the interpore 
energy barrier of the solvated system. Energy barriers calculated in the solvated system (QSMD, Figure 
8) are overall inversely proportional to the diffusivity of a single cisplatin molecule in the non-
solvated system (DNoSol). We therefore draw the same conclusions as in the non-solvated equilibrium 
MD simulations, namely cisplatin diffusivity decreases with the modulator size and polarity. UiO-
67 and UiO-68 offer an energy barrier similar to those seen in the non-polar defect models, 
particularly so when functionalised with NH2 groups. By having a larger distance between favourable 
adsorption sites (UiO-68 compared to UiO-67), the energy barrier increases (a phenomenon which 























barriers to the frameworks with small pore-window diameters by manipulating the MOF-CPT 
interaction energies in MOFs with larger pores. (See energy landscapes in the SI, Section S2). 
 
 
Figure 8. Comparison at 298 K of the cisplatin diffusivity in non-solvated systems (DNoSol, 
calculated from equilibrium MD simulations) and the energy barrier associated with cisplatin 
movement through the solvated frameworks (QSMD, calculated from SMD simulations). 
Marker scheme (defect free):  UiO-66,  UiO-67,  UiO-67(NH2),  UiO-68,  UiO-
68(NH2). Marker scheme (UiO-66 defect structures): diamond, triangle, square = 2, 4, 6 
defects/node respectively. Colour scheme (UiO-66 defect structures): yellow, blue, red = 
MA, AA, TFA modulated nodes respectively. 
 
We have shown that the influence of defects on release rates depends substantially on their relative 
positions in the crystal as well as more controllable factors such as the size and chemical functionality 
of capping modulator. Due to the lack of controllability, it is much easier to achieve the same level 
of retention (and most likely a better uptake and encapsulation rate) using functionalised defect free 
MOFs with larger pore volumes such as UiO-68(NH2). Furthermore, we have modelled ideal 
structures with defects (i.e. taking the defect-free UiO-66 structure and removing n ligand per node 
which are then capped with different modulator). While it may be intuitive that adding defects will 
increase the pore size hence enhance drug loading, ab-initio geometry optimisations shows that the 
pores of 4MA and 6MA close (although it should be noted that the bonds stay intact, as seen in the 
SI, Section S8). Non of the other structures close upon optimisation. Comparing the pore window 
diameters and volumes before and after optimisation (non-optimised → optimised | pore window 
diameters: 4MA: 4.82 → 2.98 Å, 6MA: 5.09 → 2.87 Å | pore volumes: 4MA: 0.562 → 0.256 cm3/g, 
6MA: 0.615 → 0.206 cm3/g) this would lead to significantly lower diffusivity but also significantly 



































In this work we have contrasted the main methods of increasing the pore volume and hence drug 
loading (the use of defects and variable building units) in a set of isoreticular, hydrophobic MOFs 
(UiO-66, UiO-67, and UiO-68) for their influence on release rates.  
 
Defects allow to tailor  the diffusion of cisplatin. For example by increasing the modulator’s polarity 
the interaction energies with polar drug molecules (such as cisplatin) increase, thus decreasing the 
rate of diffusion and drug release. By increasing the size of modulator, the pore window diameter 
decreases thus forming a barrier to drug molecule diffusion and hence release rates. However, release 
rates also depend on effects that we have less control over – such as the defect/ligand arrangement. 
As well as this, ab-initio optimisations show that even if we are able to fine tailor defects, unexpected 
structural changes (such as pore closing) may lead to unexpected results.  
 
Another strategy to tailor the diffusion of cisplatin is to use structures with larger or functionalised 
linkers. Defect-free isoreticular MOFs with larger pore sizes (hence drug molecule capacity) and 
larger pore window sizes (which should equate to easier movement through the framework) lead to 
faster drug molecule diffusivities. However, when the MOFs are functionalised with polar NH2 
groups, the polar drug molecule diffusivities are on par with those in the structures where the 
diffusivity is limited by the pore window sizes due to enhanced framework – guest interaction 
energies which anchor the polar drug molecules. 
 
To achieve enhanced uptake and retention times, it is overall more promising to focus on using 
functionalising defect-free MOFs as opposed to trying to fine tune defects, as it is more predictable, 
can offer similar retention rates using the MOF-guest interactions as opposed to the pore window 
size, and therefore we can get away with using larger pore volumes which would enhance loading 




Details of the optimal water loading, spring constant and SMD pull velocity, raw data 
(including energy landscapes and MSD plots), interaction energies and snapshots can be 
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Section S1. Optimal water loading 
 
To determine the optimal water loading, cisplatin molecules were initially positioned in each 
system to achieve a loading of 1CPT/octahedral pore. Next, GROMACS was used to solvate 
the system, and this was followed by a 200 ps NVT equilibration. These steps of solvation 
– equilibration were carried out over 20 times for each system, and plots of the system 
potential energy against solvation were used to determine the water loading which achieves 
the optimal energy (Figure S1). For most systems, the optimal loading was taken to be when 
the average energy per water molecule is at its minima. The loading in UiO-66 is in 
agreement with experimental results (7CPT/Zr = 25 mmol/g as opposed to experimental 
results of 20 – 25 mmol/g [58-62]). 
 
 
Figure S1. Average potential energy normalised with respect to the number of water 
molecules as a function of the number of water molecules. Shown for (a) defective UiO-66 
structures (yellow=MA, blue=EA, red=TFA), and (b) defect-free UiO-66 (black), UiO-67 
(brown, NH2 variant = gold), and UiO-68 (blue, NH2 variant = light blue) 
 
In the case of TFA, no such equilibrium point is seen due to strong energy sites within the 
framework caused by the TFA groups. Instead, the average energy per water molecule 
gradually becomes less favourable with increased loading. As a best estimate, we used the 
maximum achievable loading (which is also the minima for the average potential energy not 
normalised with respect to the number of water molecules). This may reduce the cisplatin 
movement in each TFA model compared to the other systems, however the conclusions 















































Figure S2. Average potential energy as a function of the number of water molecules in the 
TFA modulated UiO-66 structures. 
 
Section S2. Spring constants and pull velocity 
 
For a fair analysis, the spring constant (which determines the strength of the Harmonic 
potential acting on the SMD atoms) was kept constant across all systems. Its value was 
chosen based on the optimal for UiO-66, which based on its small and comparatively rigid 
pore-windows would have the highest pore-hopping energy barrier and would also require 
the tightest constraint (Table S1). The pull velocity was also kept constant across all systems, 
however due to the variation in channel sizes multiple values were tested for each framework 
to check that reproduceable paths were formed (which are shown in Figure S3). 
 
Table S1. Energy barriers for UiO-66 obtained using a variety of spring constants and pull 
velocities 
v (nm/ps) / 
k (kJ/mol.nm2) 
0.0025 0.005 0.01 0.05 
1000 70 70 70 70 
2000 90 90 90 90 
3000 100 90 90 90 
4000 80 100 100 100 
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(m)  (n)  
Figure S3. Non-bonded potential energy barrier (consists of UMOF-CPT, UMOF-SOL, USOL-SOL, 
UCPT-SOL) along the coordinate path of the pull simulations. Shown for (a) UiO-66, (b) UiO-
67, (c) UiO-67(NH2), (d) UiO-68, (e) UiO-68(NH2), (f) 2MA, (g) 4MA, (h) 6MA, (i) 2EA, 
(j) 4EA, (k) 6EA, (l) 2TFA, (m) 4TFA, and (n) 6TFA. (k=5,000 kJ/mol.nm2, v=0.0025 
nm/ps). Black horizontal lines show the maximum energy barrier observed. Different 
coloured series are independent SMD simulations. 
 
Section S3. Cisplatin MSD (no solvent, 1CPT/unit cell) 
 
All figures in this section of the SI refer to the systems whereby a single cisplatin molecule 
is simulated in an otherwise empty structure. At least seven repeats were carried out for each 
dataset. Figure S4 shows the MSD plots for a single cisplatin molecule inside each non-
solvated structure at 298 K. Figure S5 shows the MSD plots for a single cisplatin molecule 
inside each non-solvated structure at temperatures ranging from 348 K – 798 K. Figure S6 



































(a)  (b)  
(c)  (d)  
Figure S4. MSD plots of cisplatin in each structure at 298 K in (a) UiO-66, UiO-67, UiO-
68, (b) 2MA, 4MA, 6MA, (c) 2AA, 4AA, 6AA, and (d) 2TFA, 4TFA, 6TFA. Line style for 
each series in order as given = solid, dashed, dotted. The expected gradients for normal and 
sub diffusion are represented by the black dotted lines, where <r2> is proportional to tα (α = 





















































(a)  (b)  
(c) (d)  
Figure S5. MSD for a single cisplatin molecule in (a) 2MA, 4MA, 6MA, (b) 2AA, 4AA, 
6AA, (c) 2TFA, 4TFA, 6TFA, and (d) UiO-66, UiO-67, and UiO-68, averaged over at least 
seven repeats. Line style for each series in order as given = solid, dashed, dotted. Colours: 


































































Figure S6. Diffusivities of a single cisplatin molecule inside otherwise empty structures at 
temperatures between 298 K and 798 K. 
 
Section S4. Cisplatin – modulator & cisplatin – ligand interaction energies in empty 
frameworks 
 
All of the interaction energies in this section refer to the systems in which a single cisplatin 
molecule is in an otherwise empty framework at 298 K. Figure S7 shows average cisplatin 
interaction energies with the functional groups of the modulators and ligands. Figure S8 
shows the relationship (described in the main text) between cisplatin CPT – [COO-]modulator, 
CPT – [chain]modulator and the activation energy. Figure S9 shows an example of the variation 



















2TFA 4TFA 6TFA 2AA 4AA
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UiO-67 UiO-68 UiO-67(NH2) UiO-68(NH2)
175 
 
(a) (b) (c)  
Figure S7. Normalised, average cisplatin interaction energies with the functional groups in 
the BDC ligands and modulators in defective UiO-66 structures. (Group colour scheme: 
white/black stripes = [COO-]BDC, black fill = [C6H4]BDC, red/black stripes = [COO
-]modulator, 
red fill = [C6H4]modulator). 
 
Figure S8. Activation energy as a function of the ratio of CPT – [COO-]modulator and CPT – 
[chain]modulator energies. 6TFA has been excluded (for reasons explained in the main text). 

















































































Figure S9. Example of variation in interaction energies between CPT – [F]modulator and CPT 
– [COO-]BDC in 6TFA. 
 
Section S5. Cisplatin agglomeration snapshots 
 
 (a)  (b) (c)  
(d) (e)  (f)  























































(j)  (k) (l)  
(m) (n)  
Figure S10. Equilibrated snapshots of cisplatin (green) at 298 K in non-solvated (a-n) 2MA, 
4MA, 6MA, 2AA, 4AA, 6AA, 2TFA, 4TFA, 6TFA, UiO-66, UiO-67, UiO-67(NH2), UiO-
68, and UiO-68(NH2) respectively (grey). Loading of 1CPT per octahedral pore 
 
Section S6. MOF – cisplatin interaction energies with and without water 
 
 
Figure S11: Average CPT-MOF interaction energy with and without water from equilibrium 


































Section S7. MOF – cisplatin only potential energy landscapes 
 
Figure S12 shows the potential energy variation as cisplatin is pulled through each solvated 
structure. Compared to Figure S3 (which was generated using the same solvated SMD 
simulations at 298 K) Figure S12 shows only the MOF – CPT interaction energies (as 
opposed to the full non-bonded potential energies). 
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(e)  (f)  
(g)  (h)  
































































































(k)  (l)  
(m)  (n)  
Figure S12. MOF - CPT potential energy barrier along the coordinate path of the pull 
simulations. Shown for (a) UiO-66, (b) UiO-67, (c) UiO-67(NH2), (d) UiO-68, (e) UiO-
68(NH2), (f) 2MA, (g) 4MA, (h) 6MA, (i) 2EA, (j) 4EA, (k) 6EA, (l) 2TFA, (m) 4TFA, and 
(n) 6TFA. (k=5,000 kJ/mol.nm2, v=0.0025 nm/ps). Different coloured series are independent 
SMD simulations. 
 
Section S8. Closing of the MA structures upon optimisation 
 
Figure S13 shows the structures of 4MA and 6MA before and after geometry and cell 



































































(a)   
(b)  
Figure S13. Structure of (a) 4MA and (b) 6MA, before and after (left to right) optimisation. 





CHAPTER 6. CISPLATIN UPTAKE AND RELEASE IN PH SENSITIVE ZEOLITIC 
IMIDAZOLE FRAMEWORKS 
 
6.1. Motivation: screen pH sensitive zeolitic-imidazole frameworks for targeted 
chemotherapy 
 
Tumours exhibit lower pH compared to the rest of the body [1, 2], and this is something that 
can be targeted using pH sensitive ZIFs. The ZIFs selected for screening in this work (ZIFs 
– 8/11/68/70/78/79/82) are stable at pH 7, and will break down in more acidic environments 
[3]. This chapter uses the conclusions previously derived in this thesis to screen these ZIFs 
and make recommendations for future experimental studies.  
 
6.2. Summary: Maximum uptake and interaction energies from GCMC simulations and 
pore-hop energy barriers from SMD and umbrella sampling 
 
Each ZIF was screened based on the properties of the pristine bulk crystal (since Chapter 3 
shows that the effects of the external surface on uptake and adsorption energies are 
negligible). GCMC simulations were used to get a (relatively) quick screening of the 
maximum uptake and interaction energies, though as shown in Chapter 4 and as discussed 
in Section 6.6 experimentally these values will be significantly lower depending on the 
uptake method used.  
 
Release rates were quantified based on the energy barriers calculated using SMD + GASP 
and umbrella sampling simulations carried out on single cisplatin molecules in otherwise 
empty frameworks (as shown in Chapter 5, the diffusivities and energy barriers directly 
correlate in systems with and without water).  
 
Based on the results, a MOF was selected based on how well it uptakes cisplatin during 
encapsulation and how well it will retain cisplatin in healthy parts of the patient. 
 
6.3. Results: polar MOFs with large window diameters are ideal for enhanced encapsulation 
and retention 
 
As before, the maximum uptake is governed by the pore volume. There are two ways of 
increasing the pore-hop energy barrier, either by decreasing the pore window size (thus 
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inducing energy penalties associated with displacing framework atoms), or by enhancing 
MOF – CPT interaction energies. However, based on the conclusions drawn from previous 
chapters, the interaction energy should be enhanced using polar groups as it will enhance 
uptake from solution (as opposed to hydrophilic groups) and it will slow down the diffusivity 
of water (hence cisplatin). The benefit of manipulating interaction energies as opposed to 
the pore window size is that the latter will hinder both release and encapsulation. 
 
6.4. Errata  
 
Not applicable as paper not yet submitted 
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Cancer remains one of the hardest diseases to treat, partially due to the non-specificity of 
chemotherapeutics. Metal-organic frameworks as drug delivery carriers are a promising 
method for achieving targeted chemotherapy, however to date there have been very few 
detailed studies to systematically enhance the uptake while maintaining controlled release 
rates. In this work a series of biocompatible, pH sensitive ZIFs have been computationally 
screened for their ability to retain cisplatin in healthy parts of the patient and release it in the 
vicinity of a tumour. Molecular simulations highlight that the uptake depends on the pore 
volume, and retention can be controlled either using the pore window diameters or by 
manipulating framework – cisplatin interaction energies. The ZIFs best suited for cisplatin 
drug delivery are ZIFs 8, 70, and 82. Of these ZIF-82 is the most promising because it shows 
large cisplatin uptake and large energy barriers associated with cisplatin interpore 
movement. While ZIF-70 also exhibits good drug delivery properties, its lack of polar groups 
means that hydrophilic cisplatin will preferentially move into solution as oppose to the 
framework. ZIF-8 exhibits large uptakes and energy barriers, yet the latter is caused by a 
small pore window diameter which will also slow down the rate of encapsulation, 




In 2018, the World Health Organisation (WHO) reported that cancer is responsible for 17 % 
deaths globally [1], and the number of cases are expected to rise by 2030 [2]. Chemotherapy 
is one of the primary cancer treatment methods, during which cytotoxic drugs such as 
cisplatin (cis-diaminedichloroplatinum (II), CPT) are usually administered intravenously. 
186 
 
Once incorporated into a cell, cisplatin activates and is able to form covalent bonds with 
nucleotides [3]. This damages DNA, preventing cell mitosis and activating apoptosis (i.e. 
the controlled self-destruction of cells). 
 
Unfortunately, intravenous administration is non-specific and therefore cisplatin (amongst 
other cytotoxic drugs) can have adverse impacts on normal healthy cells. This causes the 
harmful side effects of chemotherapy such as haemorrhages, fatigue, damage to the nervous 
system, kidneys, bladder and so on. Furthermore, indirect administration reduces the dose 
reaching cancerous cells, increasing the chance of the tumour developing CPT resistance. 
To combat these issues, a non-toxic carrier can be used to deliver cisplatin directly to the 
tumour.  
 
Existing drug delivery carriers can be subcategorised as organic and inorganic. Organic 
carriers are typically biocompatible, and they include materials such as polymeric structures 
[4], liposomes [5], and nanocapsules [6]. However, they usually have low loading efficiency 
and slow drug release. Inorganic carriers include materials such as ferromagnetic [7], gold 
[8] and mesoporous silica nanoparticles [9], the properties of which can be easily tailored 
for targeted drug delivery and high loadings. However, they tend to be inert and non-
biocompatible [10]. Metal-organic frameworks can offer the best of both worlds. MOFs 
consist of metal nodes coordinated by organic ligands forming highly porous materials with 
large specific internal surface areas, and easily tuneable compositions and functionalities. 
Weak coordination bonds between the primary building units allow some MOFs to 
deconstruct inside the body, and their large pore volumes and internal surface areas enable 
high drug loading capacities [11]. 
 
Various experimental groups have successfully loaded cisplatin into metal-organic 
frameworks, which enabled them to achieve controlled release rates. For example, Lin et al 
successfully loaded CPT into MIL-101(Fe), and to reduce the release rate they coated the 
MOF nanoparticles with sodium metasilicate which slowed down the deconstruction of the 
framework [12]. Several groups have focussed on using members of the UiO series of MOFs 
(Zr6O4(OH)4 nodes) because the strong Zr – O bonds and high connectivity of the nodes 
increases their stability in aqueous environments. For example, He et al incorporated 
cisplatin into UiO nanoparticles via conjugation (i.e. the covalent binding of a cisplatin 
prodrug to functional groups in the framework), and functionalised the surface for the 
attachment of small interfering RNAs to achieve CPT/siRNA co-delivery [13]. Lin et al 
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incorporated missing ligand defects in UiO-66 to increase the specific cisplatin uptake 
compared to the defect free structure [14]. Mocniak et al compared encapsulation and 
conjugation as methods to uptake a cisplatin pro-drug into UiO-66 and the amine 
functionalised variant UiO-66(NH2). They achieved a higher uptake and a slower release 
rate using conjugation as opposed to encapsulation, since the conjugation method involves 
the formation of pro-drug framework covalent bonds. Compared to encapsulated cisplatin 
which can passively diffuse through the framework, conjugated cisplatin can only move 
through the framework provided the peptide bonds are broken via hydrolysis [15].  
 
Whilst a slow release rate is beneficial in healthy parts of the body, when in the vicinity of 
the tumour it could be problematic, particularly if the carrier is not anchored in its vicinity. 
One way to speed up delivery is to induce framework degradation. Some MOFs undergo 
structural changes in response to variations in external stimuli, for example changes in pH 
can hydrolyse metal – ligand bonds [16]. For the application of chemotherapy, this is 
advantageous as the extracellular pH (pHe) of tumour tissues are often acidic (pHe = 6.5 – 
6.9) due to their enhanced lactate secretion from anaerobic glycolysis [17]. On the other 
hand, the pHe surrounding normal healthy cells is heavily regulated at pHe = 7.2 – 7.5 [18]. 
If the carrier MOF can retain cisplatin whilst intact in normal areas of the body, and rapidly 
release it in the vicinity of a tumour as the framework degrades, this could result in effective 
targeted drug delivery. 
 
In this work we computationally screen a series of biocompatible, pH sensitive zeolitic 
imidazole frameworks (ZIFs – 8/11/68/70/78/79/82) that are stable at pH > 7 and that will 
deconstruct in more acidic environments [16] and highlight property – performance 
relationships with respect to the ability of each ZIF to uptake and retain cisplatin.. Out of the 
ZIFs screened, ZIF-8 (Zn2(mIm)12) has been the most widely investigated material for 
multiple applications. It has a sodalite (SOD) topology that consists of uniform 11.6 Å pores 
constructed of 24 vertices (Zn nodes) each coordinated by four methyl imidazole ligands 
(mIm) forming eight 8 MR and six 4MR per cavity. ZIF-11 consists of 14.6 Å cavities 
constructed of benzene imidazole ligands (bIm) that coordinate 48 Zn nodes into a RHO 
topology. This forms pores that consist of six octahedral, eight hexagonal, and 12 square 
windows, and octagonal channels that connect the main cavities [19] The structures are 




(a)  (b)  
Figure 1. Structure of (a) ZIF-8, and (b) ZIF-11. Hydrogens are omitted for clarity. (Grey = 
carbon, blue = nitrogen, purple = zinc) 
 
ZIFs-68/70/78/79/82 consist of three cage types: (i) hpr, (ii) gme, and (iii) kno. The cages 
consist of Zn nodes, each coordinated to four imidazole ligands (two nIm and two substitute-
Im, as shown in Figure 2). Each structure consists of channels formed by the larger kno cages 
(24 Zn connecting of three 4MR, three 8MR, two 12MR) down the c-axis. These channels 
are surrounded by four parallel rows of gme cavities (18 Zn connecting nine 4MR, two 6MR, 
















    
 
Figure 2. Top: Ligands used in  ZIFs-68/70/78/79/82 [20]. (Pink = hydrogen, black = carbon, 
blue = nitrogen, red = oxygen). Bottom: The structure of ZIF-70 as a representative example 




We use the methodologies validated in our previous work where we compared simulation 
results to available experimental data for cisplatin uptake and release rates in UiO-66 and 
UiO-66(NH2) [21].  
 
For cisplatin, the model developed by Yesylevskyy et al was used [22]. For the frameworks, 
















conditions were used in all directions to model infinite crystals. Non-bonded Lennard Jones 
and bonded parameters for the frameworks were obtained from the Universal forcefield [23]. 
Electrostatic interactions were calculated using Mulliken charges, determined using ab-initio 
static energy calculations on fragments of the bulk (as described in the SI, Section 1).  
 
Grand-canonical Monte Carlo (GCMC) simulations were used to characterise cisplatin 
adsorption at 310 K (representing body temperature) inside the static frameworks using the 
multipurpose simulation code (MuSiC) [24]. ZIF – CPT and CPT – CPT Coulombic 
interactions were calculated using Ewald summation [25] and the Wolf summation method 
respectively [25]. All non-Coulombic interactions were calculated using the Lennard-Jones 
12-6 potential. 10 million iterations of insertion, deletion, translation and rotation moves 
were used for each pressure point, and the first 40 % of microstates were ignored to ensure 
that the microstates sampled are at equilibrium. 
 
Molecular dynamics (MD) simulations were used to pre-equilibrate the structures, and 
characterise the movement and associated energy barrier of intracell and intercell cisplatin 
movement. For this purpose, the Groningen Machine for Chemical Simulations 
(GROMACS) [26-31] was used, and the framework topologies were generated using 
OBGMX [32] which implements the Universal Forcefield [23]. The framework was fully 
flexible during the simulations. The particle mesh Ewald algorithm [33, 34] was used to 
model long ranged electrostatic interactions. Separate temperature coupling baths set to 310 
K were used for cisplatin and the framework. 
 
Free energy landscapes (used to calculate the energy barriers for cisplatin moving between 
cavities though the frameworks), were calculated using umbrella sampling. Since the bulk 
crystal would confine the volume of a unit cell, these simulations were conducted using the 
NVT ensemble. A single cisplatin molecule was placed in the centre of the largest pore and 
the structure was relaxed using a steepest descents energy minimization and pre-
equilibration for 100 ps in the NVT ensemble. The temperature was regulated using a 
modified Berendsen coupling method [35]. 
 
Cisplatin was then dragged through the most accessible channels using the GROMACs pull 
code. The simulation time was adjusted to ensure cisplatin moves from one pore to the same 
position in a neighbouring pore. For all simulations, a pull rate of 0.01 nm/ps was used with 
a time step of 0.001 ps. A spring constant of 1000 kJ/mol.nm2 was used for all ZIFs with the 
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exception of ZIF-11 for which a tighter constraint potential was needed to adequately sample 
cisplatin movement at the window. Sampling windows for the umbrella simulations were 
collected at least every 0.1 nm along the simulation path, though more sampling windows 
were taken as necessary in the high energy regions of the pore windows. As in our previous 
work [21], the sampling configurations were not pre-equilibrated, but each were subjected 
to 10 ns of MD simulations in which cisplatin is constrained by the harmonic potential [36]. 
The weighted histogram method was used to obtain the free energy profiles along the pull 
direction [37]. At least six pull and umbrella sampling repeats were carried out for each MOF 
(more repeats were used in systems where the PMFs were less consistent). During both the 
pull and umbrella simulations, separate temperature coupling of CPT and the framework was 
achieved using a Nosé-Hoover thermostat [38, 39]. 
 
The intrinsic flexibility of the ZIF frameworks were determined using the GASP (geometric 
analysis and simulation of polyhedra) software [40].GASP was used in combination with 
the SMD simulations to determine the potential energy barrier associated with cisplatin 
moving through the frameworks, identify the bonded and non-bonded contributions to this 
energy barrier, and to determine whether cisplatin can pass through the pore windows 
without breaking the localised bonding. In this approach, the local atomic geometry of the 
input structure is constrained by a series of superimposed templates, while the simulation 
cell parameters are varied. This identifies a range of cell parameters, termed a "flexibility 
window", within which the global geometry can vary without alterations to the local 
geometry. (Detailed information on the GASP simulations can be found in the SI, Section 
2). The variants produced using GASP were then analysed using PoreBlazer [41] and ab-
initio static energy calculations. 
 
RESULTS AND DISCUSSION 
 
Both the maximum loading and the strength of the interaction of cisplatin with the MOF 
carrier are important properties for drug delivery. The adsorption energy will act as a driving 
force for cisplatin to move out of solution and into the framework during encapsulation, and 
a high interaction energy will improve retention during drug release (preventing the 
premature release of cytotoxic drugs in healthy areas of the patient). The specific maximum 
cisplatin loading (nMAX) should be as high as possible to increase the dosage to the tumour 
for a given amount of MOF which will later need to decompose inside the patient. The 
maximum loading is governed by accessible pore volume since more cisplatin molecules 
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can pack into larger void spaces, as shown in Figure 3a. (For calculated and experimental 
structural properties, see the SI, Section 3). ZIF-70 displays the highest uptake due to its 
relatively small nIm + Im ligands resulting in larger pore volume. This in turn leads to 
relatively weak interactions. In contrast, ZIF-78 has the strongest average adsorption energy 
at the maximum loading (UAVE) attributed to its polar ligands in combination with small pore 
sizes (Figure 3b). However, since UAVE decreases with a higher cisplatin loading and a lower 
density of framework atoms, there is a clear trade-off between nMAX and UAVE.  
 
 (a) (b)  
Figure 3. Maximum loading of cisplatin, nMAX, as a function of (a) accessible pore volume, 
and (b) average adsorption energy at maximum loading, UAVE. Symbols: UiO-66 (X), UiO-
66(NH2) (△) [21], ZIF-8 (□), ZIF-11 (○), ZIF-68 (+), ZIF-70 ( ), ZIF-78 (◇) ZIF-79 (▬), 
ZIF-82 (-) 
 
Before recommending a MOF as a drug delivery carrier, we need to consider that nMAX will 
not necessarily be the loading achieved experimentally due to the issue of accessibility. For 
example, in UiO-66 and UiO-66(NH2) the maximum loading of cisplatin calculated using 
GCMC simulations is 1:1.5 Pt:Zr and 1:2.0 Pt:Zr respectively. Cisplatin (d ≈ 5 Å) takes over 
48 hours to encapsulate in UiO-66 (pore limiting diameter, PLD = 3.6 Å) and UiO-66(NH2) 
(PLD = 3 Å) due to diffusion hinderance through narrow windows and/or unfavourable 
energies in the MOF as opposed to solution [21]. Eventually a small loading of 1:15.9 Pt:Zr 
(UiO-66) and 1:17.4 Pt:Zr (UiO-66(NH2)) is achieved via encapsulation [15]. If on the other 
hand, there are strong bonds between the MOF and cisplatin (for example using the 
conjugation method where cisplatin covalently binds to functional groups on the framework) 













































yield a loading of 1:1.8 Pt:Zr (≈ nMAX = 1:2.0 Pt:Zr) [15]. Therefore, to enhance 
encapsulation our next criteria is for the MOFs to have strong adsorption energy sites (e.g. 
hydrophilic channels that cisplatin will favourably move into from solution) as well as large 
pore window sizes. It should be emphasised at this point that screening based solely on pore 
window sizes is not enough as most frameworks show at least some degree of flexibility (i.e. 
the local geometry can move whilst retaining bonds) which can change the window diameter. 
 
Looking closer at ZIF-8, the Type 1 adsorption isotherm (Figure 4a) shows a pore filling 
mechanism with weak MOF-CPT interaction energies (UMOF-CPT) of -36 kJ/mol due to the 
hydrophobic nature of the 11 Å pore cavities (Figure 4b-d). In ZIF-11, UMOF-CPT is strongest 
at the cavity edges where larger bIm ligands form rings (< -90 kJ/mol Figure 4d). These sites 
are the first to become occupied at low pressures and then there is pore filling (leading to the 
steps in Figure 4a-b and dual peaks in Figure 4c). Windows connecting the cavities in ZIF-
8 (PLD = 2.9 Å) and ZIF-11 (PLD = 2 Å) are narrower than those in the UiO-66 structures. 
Combined with weak UMOF-CPT, there is little driving force and a large energy barrier for 
cisplatin to enter the cavities of these MOFs. We therefore conclude that these structures will 


















(c)  (d)           
Figure 4. (a) Adsorption isotherms (error bars show the standard deviation from three repeat 
simulations), (b) UAVE as a function of pressure, (c) UMOF-CPT histograms, and (d) UMOF-CPT 
maps in ZIF-8 and ZIF-11 (top and bottom) at 310 K. Open triangles/dashed line = ZIF-8. 
Filled triangles/solid line = ZIF-11. 
 
ZIFs-68/70/78/79/82 consist of large kno channels (diameter ≈ 3.7 – 12.9 Å [20]) surrounded 















































































gme-hpr channels (diameter ≈ 3.6 Å [42]) is attributed to the nIm ligands, whereas kno pores 
in ZIFs 68, 70, and 79 are hydrophobic because they consist of non-polar ligands and the 
nbIm and cnIm ligands in ZIFs 78 and 82 improve the hydrophilicity in their kno pores [20]. 
Adsorption isotherms and interaction energies (Figure 5a-b) show a small step in the uptake 
at low pressures as cisplatin occupies the high energy adsorption sites (typically UMOF-CPT = 
-150 kJ/mol in the smaller hydrophilic gme pores – except in ZIF-78 where it initially fills 
the high energy sites next to nbIm ligands in its hydrophilic kno pores). At higher pressures, 
there is a larger step in the isotherms due to adsorption in the low energy sites (UMOF-CPT < -
100 kJ/mol typically in the larger hydrophobic kno cages). This “two step” behaviour is 
similar to that seen by Van der Perre who performed adsorption experiments of polar guest 
molecules in ZIF-68 [42].  Compared to ZIF-8 and ZIF-11, the window diameters of the kno 
channels are larger and so there would be less diffusion limitation during encapsulation. 
There is however no interconnectivity between the larger kno and smaller gme channels, and 
hence uptake into the gme pores will face hinderance. Strong MOF-CPT interactions in these 
polar cavities however will act as a driving force to encapsulate polar guest molecules such 
as cisplatin, and furthermore Van der Pierre witnessed the filling of the gme pores of ZIF-68 
using for example TMB molecules  which are larger than cisplatin and contain similar 
functional groups [42]. Out of the ZIFs screened in this work, ZIF-70 and 82 show the 
highest uptake due to the smaller ligand size. ZIF-82 also has polar groups in the kno channel, 











Figure 5. (a) Adsorption isotherms (error bars show the standard deviation from three repeat 
simulations), and (b) UMOF-CPT histograms in ZIF-68, ZIF-70, ZIF-78, ZIF-79, and ZIF-82 
at 310 K. (Corresponding energy maps and energies as a function of pressure are shown in 
the SI, Section 4). 
 
The benefits of large cisplatin uptakes are forfeit if the payload is released prematurely in 
the healthy parts of chemotherapy patients. To maintain good retention (in healthy parts of 
the patient where the framework stays intact) it is important to decrease cisplatin diffusivity 
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Diffusivity will be lower (hence retention will be higher) in ZIFs with large pore-hopping 
energy barriers. Figure 6 shows that the total (bonded + non-bonded) Helmholtz free energy 
barrier (∆APH) is relatively constant in MOFs with PLD ≥ PLDUiO-66 (≈ 4 Å). As the PLD 
decreases below 4 Å, ∆APH increases rapidly due to the energy associated with displacing 
framework atoms during pore-hopping. ZIF-11 has the smallest PLD out of the frameworks 
screened (2 Å), and hence the highest energy barrier – therefore the best retention properties. 
The issue is that (as shown in the SI, Section 5) pore-hopping requires the pore windows in 
ZIF-11 to open beyond the extent of its flexibility window (i.e. pore-hopping is likely to 
break the localised bonding). Therefore, we remove this framework from our list of potential 
drug delivery carriers as encapsulation would be limited. On the other hand, cisplatin can 
pass through the pore windows of ZIF-8 causing structural changes that are within its 
flexibility window (i.e. pore-hopping is feasible without breaking the localised bonding). 
Furthermore, as seen in Figure 6b ZIF-8 exhibits a good combination of a large ∆APH and 
nMAX, therefore it would appear to be a promising candidate for cisplatin drug delivery. 
However, (as mentioned) cisplatin encapsulation will be hindered in ZIF-8 due to a 
combination of weak UMOF-CPT and high ∆APH. 
 
(a)  (b)   
Figure 6. (a) Difference in the Helmholtz free energy, ∆APH, associated with cisplatin 
movement through the largest channel in the framework at 310 K. (b) Maximum uptake, 
nMAX, as function of ∆APH (red: PLD > 4 Å | blue: PLD < 4 Å | white = rejected from 
screening process). Symbols: UiO-66 (x), UiO-66(NH2) (△), ZIF-8 (□), ZIF-11 (○), ZIF-68 
(+), ZIF-70 ( ), ZIF-78 (◇) ZIF-79 (▬), ZIF-82 (-) 
 
The pore-hopping energy barrier in Figure 6a becomes constant (≈ 30 kJ/mol) for PLD > 4 









































promising drug delivery carrier since its rate of release is ideal for reducing tumour cell 
viability [15]. UiO-66 has pore windows which are slightly smaller than the collision 
diameter of cisplatin, therefore the pore-hop energy barrier in UiO-66 is governed by its PLD 
and the energy penalty associated with framework flexibility induced as cisplatin moves 
through the windows [21]. Since the gme channels are generally larger than the pore 
windows in UiO-66, it would be expected that they pose an even lower pore-hop energy 
barrier, however this is not the case as the MOF-CPT interaction energies (UMOF-CPT) 
dominate the pore-hop energy barrier as opposed to framework flexibility. (This is also 
evident from the higher MOF – CPT interaction energy barriers for MOFs with PLD > 4 Å, 
as shown in Figure 7 and discussed next). In other words, stronger UMOF-CPT result in similar 
∆APH in frameworks that have large open kno cages as in UiO-66 (in which the energy barrier 
is governed by the PLD). This is important as it would enhance encapsulation whilst 
maintaining similar levels of cisplatin retention as UiO-66.  
 
However, the issue is that when water is present, strong hydrogen bonds between water and 
the polar arms of cisplatin result in the formation of a solvation shell. Unless there are equally 
strong MOF – cisplatin interaction energies, the solvation shell has the potential to displace 
cisplatin from the favourable adsorption sites and carry it through the large open kno pores 
[21]. In this work, water was not included in the simulations, since the scope is to screen a 
variety of MOFs to identify promising candidates for further investigation. As shown in our 
previous work [43], the diffusivity in water is substantially reduced, even if small polar 
groups are present (e.g. NH2 functionalised UiO-68). Therefore, our final screening criteria 







Figure 7. MOF-CPT potential energy barrier and the maximum cisplatin uptake in UiO-66 
(X), UiO-66(NH2) (△), ZIF-8 (□), ZIF-11 (○), ZIF-68 (+), ZIF-70 ( ), ZIF-78 (◇) ZIF-79 
(▬), ZIF-82 (-). (Red: PLD > 4 Å | blue: PLD < 4 Å | white = rejected from screening 
process). 
 
The interaction between cisplatin and the MOF framework, UMOF-CPT is enhanced in the kno 
pores with larger ligands (ZIF-79) or polar functional groups (ZIF-78 and ZIF-82) (Figure 
5). However, there needs to be a large variation in UMOF-CPT (i.e. strong adsorption sites 
spread out between weak adsorption sites) to increase the potential energy barrier. As seen 
in Figure 7, the potential energy is uniformly distributed in ZIF-78 and ZIF-79, and so 
despite favourable interaction energies the potential energy barriers (ΔUMOF-CPT) are low, 
meaning cisplatin can move relatively freely in these frameworks. In ZIF-82 however, there 
are strong interaction energies in the vicinity of the C≡N groups and weak interaction 
energies elsewhere which enhances ΔUMOF-CPT. The phenomena of large steps between 
favourable adsorption sites (i.e. large variations in energy) increasing the energy barrier was 
also seen by Amirjalayer et al who simulated benzene diffusion through variants of IRMOF-
1 [44]. 
 
We therefore draw the following recommendation: In situations where cisplatin uptake is 
hindered by encapsulation, encapsulation in the larger kno pores can be enhanced whilst 
retaining a similar rate of retention (∆APH) as in UiO-66 which has been shown to have ideal 
release rates for killing cancer cells [15]. To further enhance encapsulation and to prevent 
premature release rates caused by water displacement, ΔUMOF-CPT can be enhanced by the 

























diffusivities would need to be calculated in the presence of water to fully determine the 
influence of the solvation shell prior to experimental screening. However, such calculations 
are computationally expensive and beyond the scope of this paper (which is to screen ZIFs 
and identify promising materials that can be further investigated in more detail). 
 
Table 1. Summary of cisplatin uptake and release properties in the screened MOFs. Colour 
scheme: green = more promising values, white = less promising values. Colour scale is based 
on columns (not rows). 
System 













UiO-66 No 3.7 15 30 0.582 0.0018 
UiO-66(NH2) Yes 3 25 40 0.55 0.0014 
ZIF-8 No 2.9 20 50 0.602 0.0025 
ZIF-11 No 2 60 71 0.567 0.0018 
ZIF-68 No 7.6 45 32 0.587 0.0017 
ZIF-70 No 12.9 30 30 0.694 0.0027 
ZIF-78 Yes 3.7 20 43 0.529 0.0011 
ZIF-79 No 4.4 40 20 0.548 0.0014 
ZIF-82 Yes 10.4 50 22 0.636 0.0021 
 
Table 1 summarises the findings for each framework screened and emphasises the 
importance to include a variety of properties even in an initial screening process to identify 
promising materials. Overall, cisplatin uptake depends on the available pore volume, and 
small pore window diameters can be used to improve retention. Based on this, ZIF-8 
appeared to be a promising drug delivery carrier, however in hindsight the small pore 
window diameters will also hinder the rate of encapsulation. Instead, as in the case of ZIF-
70 and ZIF-82 (which also show good uptake due to their large pore volumes) the rate of 
retention can be enhanced (without substantially compromising uptake) by adding functional 
groups to MOFs with large open cavities. As a next step, the strength of the functional group 
– cisplatin interaction energy will need to be tested in the presence of water to ensure the 
solvation shell does not simply displace it. The spacing in between strong adsorption sites is 
also very important with respect to the energy barrier associated with interpore movement. 
Overall, the properties in Table 1 are important for uptake and release, and by combining 






In this work we have screened a selection of biocompatible pH sensitive MOFs for their 
ability to achieve a high maximum loading of cisplatin as well as a high energy barrier to 
increase the payload reaching the tumour in chemotherapy patients and decrease release rates 
in healthy parts of the body. The maximum uptake is predominately governed by the 
accessible pore volume. The pore-hop energy barrier (i.e. the energy barrier associated with 
cisplatin movement between pores, which is inversely proportional to the drug molecule 
release rates from the framework) can be enhanced by decreasing the pore window diameter 
at a compromise that this will reduce accessibility of cisplatin entering the framework during 
encapsulation. Instead, similar energy barriers can be achieved without compromising 
encapsulation rates in frameworks with large open pores but with enhanced MOF-cisplatin 
interaction energies.  
 
Ultimately this work has highlighted the structural properties to aim for when designing an 
ideal cisplatin drug delivery carrier. From the MOFs screened in this work, ZIF-8, ZIF-70, 
and ZIF-82 all exhibit good maximum uptakes. Out of these, the pore window diameter in 
ZIF-8 is the bottleneck for diffusion thus reducing release rates, yet this will also hinder 
encapsulation i.e. the uptake cisplatin into the drug carrier. In ZIF-70, there are fewer polar 
groups and therefore weaker interaction energies will hinder encapsulation whilst enabling 
premature release rates. ZIF-82 is the most promising material due to its large uptake, 
variation in interaction energies and the addition of polar groups to anchor cisplatin and 
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Section S1. Static energy calculations  
 
Static energy calculations were used to determine the partial atomic charges of each 
framework. They were also used to determine the internal energy of each GASP variant. The 
Quickstep module in CP2K [1-6] was used to carry out the static energy calculations. 
Quickstep uses Gaussians to model the core electron density and planewaves to model the 
valence electron density. All atoms were modelled using triple-zeta Gaussian basis sets with 
the exception of zinc and platinum which were modelled using double-zeta basis sets [7]. 
The planewave cutoff and relative cutoff were set to 500 Ry and 50 Ry, and exchange 
correlation energies were determined using the Perdew-Burke-Ernzerhof functional [8] with 
DFT-D3 dispersion corrections [9, 10]. For both the Gaussians and the planewaves, core 
electrons were described using pseudopotentials derived by Goedecker, Teter and Hutter [2, 




Partial atomic charges were calculated using static energy simulations on fragments of each 
MOF. The fragments consisted of the ligand for which the charges were being calculated, 
bonded to two Zn nodes, which were coordinated to three hydrogen capped “dummy” 
monodentate ligands (the charges for which were not used). 
 
Table S1. Partial atomic charges for each atom type used in this work. 
ZIF 8 11 68 70 78 79 82 
C1 0.138 0.108 0.134 0.140 0.029 0.218 -0.046 
C2 -0.122 0.015 0.052 -0.081 -0.096 -0.069 0.205 
C3 -0.403 -0.146 -0.126 0.216 -0.116 0.117 0.001 
C4   -0.153 -0.136 -0.103 0.050 0.024 -0.001 
C5     0.196   0.041 -0.109 -0.102 
C6     -0.021   -0.076 -0.137 0.120 
C7         0.125 -0.021   
C8         0.192 -0.360   
C9         -0.040 -0.087   
C10           0.029   
H1 0.143 0.092 0.134 0.171 0.166 0.127 0.155 
H2 0.120 0.133 0.128 0.133 0.123 0.115 0.149 
H3   0.142 0.146 0.122 0.121 0.109 0.134 
H4     0.122   0.118 0.149   
H5         0.134 0.140   
H6           0.090   
N1 -0.175 -0.186 -0.141 -0.231 0.149 0.071 -0.125 
N2     -0.104 -0.259 -0.179 -0.198 0.058 
N3     -0.290 -0.009 -0.186 -0.159 -0.302 
N4         0.058 -0.157 -0.145 
N5         -0.145   -0.214 
O1     -0.135 -0.227 -0.240 -0.226 -0.169 
O2         -0.171     




(a)  (b)  (c)    
(d) (e)  
(f)  (g)  
Figure S1. Atom label references in (a) – (g) ZIF 8 – 82. Colour scheme: black = carbon, red 
= oxygen, pink = hydrogen, grey = zinc, blue = nitrogen. 
 
Section S2. GASP simulation details 
 
We have investigated the intrinsic flexibility of ZIF frameworks using the GASP (geometric 
analysis and simulation of polyhedra) software [13]. In this approach, the local atomic 
geometry (e.g. bond lengths and angles) of the input structure is constrained by a series of 
superimposed templates, while the simulation cell parameters are varied. This identifies a 
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range of cell parameters, termed a "flexibility window", within which the global geometry 
can vary without alterations to the local geometry.  
 
ZIF frameworks consist of zinc nodes tetrahedrally coordinated by the nitrogen atoms of 
imidazolate rings in the ligands. In geometric simulations, we treat the ligand as an 
essentially rigid unit (constraining all the bond lengths and angles in the ligand to have the 
same values as in the input structure), and the coordination around each zinc centre as a rigid, 
approximately tetrahedral, cluster (constraining the bond lengths and angles around the zinc 
atom). The Zn-N-C angles and associated dihedral angles, however, are not explicitly 
constrained. As a result, ZIF frameworks display substantial internal flexibility enabled by 
cooperative rotations and displacements of the ligands and nodes. 
 
GASP includes a "search" functionality which systematically varies the cell parameters of 
the simulation cell while geometrically relaxing the cell contents to maintain bonding 
geometry and steric exclusion. This identifies a range of cell parameters, termed a "flexibility 
window", within which the cell contents can display global flexibility while retaining local 
rigidity. Outside this "window", distortions of the geometry are inevitable. Various search 
schemes are available, from the very simple "cubic" search which increases or decreases all 
the cell edge lengths together, and the "six fold" scheme in which each cell parameter is 
varied individually, to the lengthy and deprecated "triclinic" scheme which attempts every 
possible combination of variations of the six cell parameters. In this case, we have found it 
convenient to represent each framework in an orthorhombic form and to explore an 
orthorhombic search strategy, where the cell angles are all held constant at 90 degrees while 
the three cell edge lengths are permitted to vary independently. 
 
Bonds are assigned around bonding centres as follows. From a zinc atom to any nitrogen 
atom within 2.0 Å; from a carbon atom to any carbon, nitrogen or oxygen atom within 1.8 
Å, and to any hydrogen atom within 1.3 Å; from a nitrogen atom to any carbon atom (and, 
if the structure contains -NO2 groups, to any oxygen atom) within 1.8 Å. Our set of 
frameworks did not include any with hydroxyl groups in the ligands; were such a group 
present, bonds should likewise be assigned from oxygen to carbon and to hydrogen. The 
default behaviour of GASP is to identify any carbon or nitrogen atom with three or fewer 
bonded neighbours as an sp2 hybridised centre, and unite sp2 bonded atoms into a single rigid 
cluster. This behaviour correctly rigidifies each imidazolate ligand into a rigid unit whose 
bonding geometry is defined by a single template. During geometric simulations, the 
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following steric radii are assigned to atoms by species: carbon and nitrogen, 1.4 Å; oxygen, 
1.35 Å; hydrogen, 1.0 Å; zinc, 1.5 Å. A geometric relaxation of as ZIF structure is terminated 
if the largest "mismatch" in the structure - the deviation of atomic positions from the template 
bonding geometry of the input structure - is less than 0.01 Å; or, alternatively, if the largest 
"move" of an atomic position being proposed is less than 10-6 Å. If the relaxation is 
terminated by the mismatch criterion, then the structure is considered to be within the 
flexibility window, while if it is terminated by the move criterion, the relaxation has jammed 
without being able to satisfy the bonding geometry, and thus lies outside the flexibility 
window. 
 
A GASP search generates as output a series of (serially numbered) CIF files representing the 
"edges" of the flexibility window, that is, the greatest variations of the structure before 
distortions become inevitable.  
 
The ZIFs display substantial cooperative rotations of the ligands and nodes as the cell 
parameters are varied in the GASP search. The question of interest is now: to what extent 
can this internal flexibility be displayed without cell parameter variation? That is, can the 
internal flexibility enable local variations of the pore and void geometry without 
macroscopic alterations of the structure? 
 
We investigate this question using a combination of GASP features. In particular, GASP can 
take a "structure" input (a CIF file, defining the starting atomic geometry), a "new structure" 
input (another CIF file, defining cell parameters and fractional coordinates to which the 
atoms are moved before the simulation starts), and also a "new cell" input (a set of cell 
parameters which are imposed on the simulation cell before the simulation starts).  
 
It is therefore possible to provide GASP with the crystal structure of a ZIF, thus defining the 
bonding geometry to be maintained; then to provide, as a "new structure", one of the "edge" 
structures generated during the flexibility window search; and also to provide, as a "new 
cell" the cell parameters of the original crystal. A geometric simulation then begins with the 
cell parameters and template bonding geometry of the crystal structure, but with fractional 
coordinates representing rotations of the nodes and ligands. Geometric relaxation then re-




This strategy lends itself to automation in a two-stage process. In the first stage, GASP runs 
a window search on a ZIF to generate a suite of variant structures with different cell 
parameters. In the second stage, using shell scripting, we loop over the variant structures, 
carrying out GASP relaxations using the "structure/new structure/new cell" approach 
described above. 
 
When applied to our ZIFs, this strategy is successful in producing variant structures which 
have the cell parameters and bonding geometry of the crystal structure while displaying 
different pore profiles and void geometry through collective, cooperative rigid-body motion 
of the ligands and nodes. This immediately suggests that guest molecules entering and 
passing through a ZIF structure may encounter a range of pore profiles and void geometries, 
and thus a range of diffusion energy barriers and binding-site energies, differing from those 
seen in the static crystal structure. 
 
Section S3. MOF properties 
 
Table S2. Structural properties of the MOFs calculated using PoreBlazer [14] used in this 
work. Where available, values from literature are provided for comparison. 







UiO-66 1405739 [15] 0.58 3.7 8.3 (11.0 [16]) 
UiO-66(NH2) 1405739 
[15] 0.55 3.0 7.3 
ZIF-8 602542 [17] 0.60 (0.66  [17]) 2.9 * (2.9 [18]) 11.3 (11.6 [17]) 
ZIF-11 602545 [17] 0.57 (0.58 [17]) 2.0 ** (3.0 [19]) 14.4 (14.6 [17]) 
ZIF-68 671075 [20] 0.59 7.6 (7.5  [20]) 10.4 (10.3 [20]) 
ZIF-70 671078 [20] 0.69 12.9 (13.1 [20]) 14.8 (15.9 [20]) 
ZIF-78 704995 [20] 0.53 3.7 (3.8 [20]) 8.2 (7.1 [20]) 
ZIF-79 704997 [20] 0.55 4.4 (4.0 [20]) 7.9 (7.5 [20]) 
ZIF-82 705002 [20] 0.64 10.4 (8.1 [20]) 12.9 (12.3 [20]) 








Section S4. Potential energy maps and energy as a function of pressure in ZIFs 68-82 
 
(a)  (b)   
(c)  (d)   
(e)    












Figure S3. UAVE as a function of pressure in ZIF-68, ZIF-70, ZIF-78, ZIF-79, and ZIF-82 
 
Section S5. Testing the flexibility window of ZIFs 8, 11, and 78 
 
We used GASP [13] to generate a series of structures within the flexibility windows of ZIF-
8, ZIF-11, and ZIF-78, and performed ab-initio static energy calculations on the output to 
determine the relative potential energies of each structure compared to their lowest energy 
variant (i.e. the bonded contribution to the total energy barrier). We then compared the 
results to the PLD obtained during SMD simulations to determine whether or not the 
forcefield used (UFF [21]) allows for too much flexibility of the pore window, therefore 
allowing us to determine whether or not cisplatin really can move through the pore windows.  
Figure S4 shows the bonded energy barriers and PLD for each GASP variant and the SMD 
configurations during pore-hopping. For ZIFs-8/78, the PLD at the time of pore-hopping is 
within the flexibility window. For ZIF-11, the pore-hop PLD is slightly larger than those 
achieved using GASP. By uniformly expanding the unit cell, it is therefore not possible to 





























(a)  (b)  
(c)   
Figure S4. Potential energy barrier as a function of PLD in the GASP variants and the SMD 
configuration during pore-hopping. Points with zero energy barrier are the PLD of the lowest 




1. Hutter, J., et al., cp2k: atomistic simulations of condensed matter systems. Wiley 
interdisciplinary reviews. Computational molecular science, 2014. 4: p. 25. 
2. VandeVondele, J., et al., Quickstep: Fast and accurate density functional 
calculations using a mixed Gaussian and plane waves approach. Computer Physics 
Communications, 2005. 167(2): p. 103-128. 
3. Borštnik, U., et al., Sparse matrix multiplication: The distributed block-compressed 




































































































4. Frigo, M. and S.G. Johnson, The Design and Implementation of FFTW3. Proceedings 
of the IEEE, 2005. 93(2): p. 216-231. 
5. VandeVondele, J. and J. Hutter, An efficient orbital transformation method for 
electronic structure calculations. The Journal of Chemical Physics, 2003. 118(10): 
p. 4365-4369. 
6. Lippert, B.G., J.H. Parrinello, and Michele, A hybrid Gaussian and plane wave 
density functional scheme. Molecular Physics, 1997. 92(3): p. 477-488. 
7. VandeVondele, J. and J. Hutter, Gaussian basis sets for accurate calculations on 
molecular systems in gas and condensed phases. The Journal of Chemical Physics, 
2007. 127(11): p. 114105. 
8. Perdew, J.P., K. Burke, and M. Ernzerhof, Generalized Gradient Approximation 
Made Simple. Physical Review Letters, 1996. 77(18): p. 3865-3868. 
9. Grimme, S., S. Ehrlich, and L. Goerigk, Effect of the damping function in dispersion 
corrected density functional theory. J Comput Chem, 2011. 32(7): p. 1456-65. 
10. Grimme, S., et al., A consistent and accurate ab initio parametrization of density 
functional dispersion correction (DFT-D) for the 94 elements H-Pu. The Journal of 
Chemical Physics, 2010. 132(15): p. 154104. 
11. Hartwigsen, C., S. Goedecker, and J. Hutter, Relativistic separable dual-space 
Gaussian pseudopotentials from H to Rn. Physical Review B, 1998. 58(7): p. 3641-
3662. 
12. Goedecker, S., M. Teter, and J. Hutter, Separable dual-space Gaussian 
pseudopotentials. Physical Review B, 1996. 54(3): p. 1703-1710. 
13. Wells, S.A. and A. Sartbaeva, GASP: software for geometric simulations of flexibility 
in polyhedral and molecular framework structures. Molecular Simulation, 2015. 
41(16-17): p. 1409-1421. 
14. Sarkisov, L. and A. Harrison, Computational structure characterisation tools in 
application to ordered and disordered porous materials. Molecular Simulation, 
2011. 37(15): p. 1248-1257. 
15. Trickett, C.A., et al., Definitive Molecular Level Characterization of Defects in UiO-
66 Crystals. Angewandte Chemie International Edition, 2015. 54(38): p. 11162-
11167. 
16. Zhu, X., et al., Inherent anchorages in UiO-66 nanoparticles for efficient capture of 




17. Park, K.S., et al., Exceptional chemical and thermal stability of zeolitic imidazolate 
frameworks. Proceedings of the National Academy of Sciences, 2006. 103(27): p. 
10186-10191. 
18. Hobday, C.L., et al., Understanding the adsorption process in ZIF-8 using high 
pressure crystallography and computational modelling. Nature Communications, 
2018. 9(1): p. 1429. 
19. He, M., et al., Toluene-assisted synthesis of RHO-type zeolitic imidazolate 
frameworks: synthesis and formation mechanism of ZIF-11 and ZIF-12. Dalton 
Transactions, 2013. 42(47): p. 16608-16613. 
20. Banerjee, R., et al., Control of Pore Size and Functionality in Isoreticular Zeolitic 
Imidazolate Frameworks and their Carbon Dioxide Selective Capture Properties. 
Journal of the American Chemical Society, 2009. 131(11): p. 3875-3877. 
21. Rappe, A.K., et al., UFF, a full periodic table force field for molecular mechanics 
and molecular dynamics simulations. Journal of the American Chemical Society, 










CHAPTER 7. CONCLUSIONS 
 
MOF nanoparticles are promising drug delivery carriers and molecular simulations provide 
a useful tool for screening frameworks for this application. Typically, MOFs are modelled 
as infinite periodic crystals, yet surprisingly few studies have addressed the influence of 
particle size on the crystal’s performance. Size-dependent N2 adsorption and induced 
flexibility in DUT-8(Ni) was modelled in Chapter 3, which focussed on the influence of the 
external surface. Adsorption energies on the external surface are significantly reduced where 
the typical ligands are replaced by smaller modulators. This effect is short-ranged however, 
and all pores in the crystal (regardless of their distance from the external surface) will exhibit 
the same adsorption sites so long as the pores remain intact. For Chapters 4-6, it was 
therefore concluded that the bulk crystal was sufficient for modelling drug uptake and release 
rates in MOF nanoparticles. Modulators on the external surface influence dispersion 
interactions within the framework, allowing us to manipulate the internal energy and hence 
the gate-opening/closing behaviour. Larger modulators enhance dispersion interactions 
which favour the closed pore structure, and this principle is generally applicable. This 
demonstrates for the first time that modulators can be systematically used to control the gate 
opening / closing pressure. 
 
In Chapter 4, a variety of simulation methods were assessed against experimental results for 
their ability to model cisplatin uptake and release in biocompatible MOFs, UiO-66 and UiO-
66(NH2). Pure-component GCMC simulations are usually used to model drug molecule 
uptake, and when applied they accurately capture the maximum cisplatin loading achieved 
using conjugation. However, this loading substantially exceeds that achieved using 
encapsulation due to favourable energies associated with cisplatin’s solvation shell which 
drives the polar guest molecules out of the pores too small to accommodate the shell (as 
shown by BAR simulations with water). Interaction energies (from pure-component GCMC 
or ab-initio simulations) or energy landscapes (from biased MD simulations) can be used as 
a semi-quantitative way of comparing release rates in different MOFs, however solvated MD 
simulations show that such models are slightly naive due to the formation of the solvation 
shell which displaces cisplatin from the favourable adsorption sites. In the case of polar 
cisplatin molecules, polar functional groups in UiO-66(NH2) form hydrogen bonds with 
water which in turn anchors cisplatin. This shows the crucial role of water in the uptake and 
release of polar guest molecules from solution, and though we can infer a system’s behaviour 
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using pure-component simulations, it is essential to understand the limitations associated 
with doing so. 
 
A MOF’s drug loading capacity is predominantly governed by its accessible pore volume, 
which can be systematically increased by adding defects or using different building units. In 
Chapter 5, UiO-66 (which is prone to missing ligand defects) was compared against its 
isoreticular variants UiO-67 and UiO-68 (which are comparatively defect-free) for their 
ability to retain cisplatin. Non-solvated MD simulations in defective UiO-66 predictably 
showed that cisplatin diffusivity decreases with the pore-window size and polarity of 
modulators. Unexpectedly, the exact positions of defects significantly influenced cisplatin 
diffusivity, indicating the lack of control defects impose. MOF – cisplatin interaction 
energies in UiO-67 and UiO-68 resulted in similar diffusivities compared to defective UiO-
66. When water was added, the same comparison could be made for UiO-67(NH2) and UiO-
68(NH2), showing that the larger pores of functionalised frameworks can offer the same level 
of cisplatin retention as defective UiO-66. It was hence recommended that manipulating 
MOF – drug interaction energies in wider pore frameworks using functional groups is a 
superior means of retaining drug cargo compared to using the narrow pore-window 
diameters as the diffusion bottleneck. This conclusion is important due to the additional 
benefit that more accessible pores with stronger MOF – drug interaction energies will also 
enhance the rate of uptake from solution. 
 
In Chapter 6, a variety of pH sensitive ZIFs were screened for their ability to uptake and 
retain cisplatin. Pure-component GCMC simulations show that the maximum loading is 
proportional to the accessible pore volume, and biased MD simulations show that the energy 
barriers associated with interpore movement can be enhanced with smaller pore-window 
diameters or by incorporating strong, discretised adsorption sites. Out of the ZIFs screened, 
non-polar ZIFs 8 and 11 were excluded because of their small pore window diameter which 
hinder encapsulation. Polar groups on the other hand enhance encapsulation and anchor polar 
cisplatin molecules, yet this effect is forfeit if the polar sites are in close proximity as they 
can form channels with low energy barriers for cisplatin to freely move along as is the case 
e.g. in ZIF-78. The most promising frameworks have a large variation in interaction energies 
as for example in ZIF-82 where the alternation of polar/non-polar regions which creates large 
energy barriers. Ultimately, an ideal drug delivery carrier will have dispersed polar and non-
polar functional groups in large channels with interconnecting windows that are wider than 




Overall, the future selection of drug delivery carriers needs to be carried out with 
consideration of all stages of the process, from uptake into the framework (which relies on 
accessibility, thermodynamic equilibrium, and kinetic factors), to release in the vicinity of 
the tumour (which further relies on the stability of the MOF). This work has shown that 
although a framework might appear promising for one of these stages, it could be ineffective 
as a drug delivery carrier because of shortcomings in another stage (e.g. UiO-66 shows good 
retention properties, however as this is due to kinetic hinderance the initial uptake is also 
hindered). It has also shown that due to the sensitivity of drug molecule movement and 
adsorption with respect to precise details of the framework (such as the precise positions of 
functional groups and defects), we should focus on promising materials with which we have 
good control of the structure experimentally. In the case of cisplatin, it is recommended to 
focus on using structures in which the bulk material is defect-free, with inherent, dispersed 
functionality controlling the adsorption and release rates as-opposed to kinetic hinderance 
controlled by pore window size. 
 
When screening MOFs for the general delivery of chemotherapeutics, it is proposed that pH 
sensitive frameworks (in which either only the MOF-drug bonds hydrolyse, or the 
framework fully degrades when exposed to acidic environments) are considered at the first 
stage of screening. This work emphasises that molecular simulations are a useful tool in 
secondary screening stages, as they provide vast amounts of thermodynamic insight into 
drug uptake and delivery. It also shows that we cannot rely on conclusions drawn from 
molecular simulations alone unless we are fully aware and forthcoming on the entirety of 
the limitations. As an example, it would be easy to claim that cisplatin is retained in amine 
functionalised variants of MOFs because of enhanced MOF-cisplatin interaction energies 
yet adapting the model to include water invalidates this conclusion due to the solvation shell. 
It is crucial to understand the pros and cons of different simulation techniques, and the 
artefacts that can arise from over-simplistic methods and models. For example, assuming 
specific defect configurations or neglecting water can have substantial impacts on the 
calculated cisplatin diffusion rates. Finally, this work accentuates the future need for 
combined simulation – experimental collaboration, to determine what happens in real-life 
MOF-drug delivery systems, and to gain thermodynamic insights into why this happens, so 
that future carriers can be systematically improved. Suggestions for future work specific to 




CHAPTER 8. FUTURE WORK 
 
8.1. Shortcomings of the presented work and proposed solutions 
 
One of the main shortcomings of the presented work is that the forcefields are not 
specifically derived for cisplatin in solvated MOFs. Therefore, the results could loosely 
represent the real-life system (highlighting the need for experimental contributions). Though 
the results obtained in this work were qualitatively validated against ab-initio simulations, 
to obtain meaningful quantitative results the forcefield should ideally be derived for 
cisplatin/water adsorption. For example, MOF-cisplatin forcefields can be developed using 
DFT simulations: First, initial forcefield parameters can be used to generate random 
configurations of cisplatin in the MOF. Single-point static energy calculations can then be 
used to calculate the system energy. By comparing the DFT energy to the potential energy 
function, the forcefield parameters can be updated and used to regenerate configurations in 
an iterative loop until the parameters no longer need updating [1]. Alternatively, forcefields 
can be derived experimentally, however this top-down approach is mainly used for fluids 
(for example based on vapour-liquid equilibria [2]) and it is a challenging to produce an 
accurate forcefield for chemically diverse solids like MOFs [3]. Instead, to avoid the need 
for forcefield development, systems can be modelled using ab-initio methods. However, this 
is computationally demanding. For screening purposes, it may be futile to create system-
specific forcefields, because the main reason they would be used is to reduce computational 
cost, however individual forcefields would need to be derived for each framework, which 
(in itself) would be computationally demanding. It is therefore proposed that ab-initio 
methods should be used as a next screening step, focussing on the MOFs already screened 
from a wider range using universal classical forcefields (e.g. ZIF-82, ZIF-8 or UiO-68(NH2), 
as recommended in Chapters 5/6). 
 
Simulations in Chapters 5 and 6 show that slight variations in the framework (e.g. the exact 
position of functional groups, defects, or slight motion of the framework atoms) can 
significantly impact cisplatin diffusivity and uptake. Therefore, results that rely on marginal 
differences in the MOF structure are at best predictions. The motion of atoms in the 
framework have been captured to an extent in this thesis using simulation techniques such 
as GASP [4] and keeping the framework unrestrained during MD simulations (however 
atomic displacements in this work are determined using the Universal Forcefield which is 
parameterised for alike chemical environments [5], not for specific MOFs). Alternatively, 
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extreme case scenarios based on the root-mean-square displacement of atoms often reported 
with structures derived from X-Ray diffraction could be used to obtain a prediction for the 
accuracy of results. The precise position of functional groups and defects in the structure 
cannot be easily confirmed, yet experimental techniques are being developed to improve 
controllability of such uncertainties. For instance, techniques such as sequential linker 
installation (a multi-stage synthesis method where ligands are sequentially added to a pre-
made MOF, and the positions are controlled based on the ligand/pre-made MOF connectivity 
and compatibility [6]) are progressing, giving researchers better control over precise 
functionalisation. Defects are also becoming better understood and easier to controlled, for 
instance they can be reduced in UiO-66 using enhanced synthesis temperatures or more 
acidic modulators which increase correction rates (of defects) during crystallisation [7, 8]. 
These synthesis techniques could be used to create promising drug-delivery carriers with 
more control, which could then be compared to theoretical models that better represent the 
real system.  
 
Finally, this work has highlighted how changing the model to account for water influences 
diffusivity and adsorption. In reality, plasma contains ~90 % water, and the remaining 10 % 
consists of coagulants, proteins, electrolytes, and immunoglobulins [9]. Most of the 
components (besides water and electrolytes) cannot enter the pores of microporous MOFs, 
therefore including the additional components in simulations is unlikely to change the 
results. However, the initial selection of pH sensitive MOFs (that are stable in water) in 
Chapter 6 needs to be further tested to check their stability in plasma. For example, it is 
known from PXRD experiments that UiO-66 shows no degradation when immersed in water 
for over 24 hours [10], but in phosphate buffer saline (a solution containing salts that is 
isotonic like blood) uncoated UiO-66 nanoparticles degrade by 85 % after six hours [11]. 
 
8.2. Simulation perspectives on future work 
 
From a computational perspective, it is now known what bulk properties of a MOF to aim 
for to achieve an ideal cisplatin drug delivery carrier. Simulations are useful for 
understanding fundamental property – performance relationships, screening drug delivery 
carriers and running what-if scenarios (e.g. what-if certain functional groups are present in 
the framework, how will this influence the drug delivery efficiency). Future computational 
contributions should revolve around functionalising the external surface to prevent 
premature release (e.g. conjugating polymers onto the surface to block pores and/or prevent 
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hydrolysis of metal – ligand bonds by repelling water [12]), prevent nanoparticle 
agglomeration (e.g. via the impregnation of polymers into the framework to create steric 
hinderance against agglomeration [13]), or to target the tumour (e.g. conjugating targeting 
molecules onto the external surface such as folic acid [14]). 
 
For example, Chapter 3 revealed that dispersion interactions between modulators on the 
external surface of DUT-8 can be used as a tool to manipulate gate-opening and gate-closing 
[15]. Using biocompatible breathing MOFs (e.g. iron (III) carboxylate MOFs such as MIL-
53(Fe) [16]), it is worth applying OFAST [17] to determine the most energetically 
favourable structure of the framework upon the adsorption of drug + water molecules (based 
on experimental characterisation of MIL-53(Fe)@[water + lutidine] and MIL-
53(Fe)@[water + pyridine], the favourable pore size will depend on guest – host interaction 
energies [18]). The most energetically favourable structure will further depend upon what 
biomolecules are used to cap the external surface (as shown in Chapter 3, this will depend 
on how they influence the internal energy of the structure [15]). For instance, folate or 
hyaluronic acid could be used to prevent premature release and target tumours [14], and 
these groups are substantially larger than those used in this thesis, hence should enhance 
dispersion interactions potentially favouring a closed pore structure. Normal and biased 
classical MD simulations could then be used to quantify release rates in the presence of water 
for each of the optimised structures. Alternatively (depending on the availability of 
computational resources), ab-initio simulations could be carried out to accurately model 
diffusion in completely flexible structures which are not imposed with the typical constraints 
used in classical simulations (the simulations would not depend on the starting structures 
used to build the MD topology). A hypothetical smart delivery device could consist of pH 
sensitive conjugation bonds between targeting biomolecules such as folate and the external 
surface of the framework. As mentioned, large biomolecules will (likely) favour a closed 
pore structure, yet if hydrolysed an open pore variant may be more optimal (to accommodate 
more water molecules and enhance the host-guest interaction energies). Therefore, it could 
be possible to get enhanced release only upon a change in pH in the microenvironment of 
the tumour, since (as shown by simulations in Chapters 5 and 6) drug molecule diffusion is 
easier in larger open pore structures.  
 
Other useful research directions would be to engineer the nanoparticle’s shell (external 
surface) to: (i) enable tumour recognition, (ii) enable pH sensitive drug release, (iii) block 
pores at the external surface, (iv) not interfere with pores in the bulk crystal, and (v) avoid 
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nanoparticle agglomeration [19]. While (i) and (ii) can be achieved by careful selection of 
the MOF – capping biomolecule combination, (iii) and (iv) can be tested using DFT and MD 
simulations to investigate the binding energy associated with incorporating (via 
impregnation or conjugation) different capping biomolecules onto the external surface to 
study the most likely interfacial properties (e.g. similar to the work of Semino et al [20]). 
Nanoparticle agglomeration (v) can potentially be quantified using bias MD simulations 
such as umbrella sampling. 
 
8.3. Experimental perspectives on future work 
 
One of the main conclusions drawn from this thesis is that large interconnecting windows 
between functionalised pores are a better means of controlling drug molecule diffusion 
compared to using the pore-window diameter as a bottleneck (because the former will likely 
enhance encapsulation). It would be beneficial to test the MOFs recommended from this 
conclusion, by determination of cisplatin loading by encapsulation, in vitro release rates 
(initially), and cell viability studies [21]. In particular, the high diffusion energy barriers 
associated with channels interconnected by large pore windows rely on segregated 
adsorption sites. It is worth clarifying whether (or not) this conclusion is valid at higher 
loadings of cisplatin (since some of the molecules could feasibly bypass the discretised 
favourable sites). 
 
Other information that would be useful from a screening perspective is ideal release rates for 
a specific cancer type. For instance, if experiments show that release rates are too fast to 
retain cisplatin in the large, interconnected pores of recommended MOFs ZIF-82 or UiO-
68(NH2), then they could be reduced further by enhancing the MOF – cisplatin interaction 
energies (e.g. via conjugation). Alternatively, (as mentioned) target specific biomolecules 
(e.g. pH sensitive conjugated biomolecules) could be used on the surface to block pores and 
prevent premature release. However, at what point should the release rate be declared too 
fast or too slow? Potentially this could preliminary be answered by comparing release rates 
and testing the cell viability in vitro using samples of cancer cells and normal cells. However 
in vitro samples will not correctly represent the variation in pH usually targeted during 
chemotherapy due to the buffers used to maintain a cell culture and the lack of physiological 
structure of the tumour’s microenvironment. For this reason, in vivo studies would be more 
representative to trial potential frameworks and it could provide useful targets to aim for in 




One of the key issues in chemotherapy is that tumours can develop drug resistance. As well 
as increasing the initial dose using drug delivery carriers, an alternate drug with different 
attack mechanism could be used. Cisplatin mainly forms intrastrand crosslinks with DNA 
[22], however an isomer of cisplatin, transplatin, forms interstrand crosslinks [23] which are 
more effective at disrupting critical cell processes [24]. To date, transplatin is ineffective as 
a chemotherapeutic because it is highly reactive and deactivates in the circulatory system 
[25]. If transplatin is protected from degradation however, for instance using a pH activated 
prodrug or nanocarrier, it could be a highly effective anti-cancer drug [26]. Should an ideal 
MOF for targeted drug delivery be discovered and thoroughly tested in future, it may be 
beneficial to use a more potent chemotherapeutic such as transplatin.  
 
8.4. Chapter 8 References 
 
1. Demir, H., et al., DFT-based force field development for noble gas adsorption in 
metal organic frameworks. Journal of Materials Chemistry A, 2015. 3(46): p. 23539-
23548. 
2. Eggimann, B.L., et al., An online parameter and property database for the TraPPE 
force field. Molecular Simulation, 2014. 40(1-3): p. 101-105. 
3. Heinen, J. and D. Dubbeldam, On flexible force fields for metal–organic frameworks: 
Recent developments and future prospects. WIREs Computational Molecular 
Science, 2018. 8(4): p. e1363. 
4. Wells, S.A. and A. Sartbaeva, GASP: software for geometric simulations of flexibility 
in polyhedral and molecular framework structures. Molecular Simulation, 2015. 
41(16-17): p. 1409-1421. 
5. Rappe, A.K., et al., UFF, a full periodic table force field for molecular mechanics 
and molecular dynamics simulations. Journal of the American Chemical Society, 
1992. 114(25): p. 10024-10035. 
6. Yuan, S., et al., Sequential Linker Installation: Precise Placement of Functional 
Groups in Multivariate Metal–Organic Frameworks. Journal of the American 
Chemical Society, 2015. 137(9): p. 3177-3180. 
7. Morris, W., et al., Role of Modulators in Controlling the Colloidal Stability and 
Polydispersity of the UiO-66 Metal–Organic Framework. ACS Applied Materials & 
Interfaces, 2017. 9(39): p. 33413-33418. 
225 
 
8. DeStefano, M.R., et al., Room-Temperature Synthesis of UiO-66 and Thermal 
Modulation of Densities of Defect Sites. Chemistry of Materials, 2017. 29(3): p. 
1357-1361. 
9. Mathew, J., P. Sankar, and M. Varacallo, Physiology, Blood Plasma. 2020: 
StatPearls. 
10. Cavka, J.H., et al., A New Zirconium Inorganic Building Brick Forming Metal 
Organic Frameworks with Exceptional Stability. Journal of the American Chemical 
Society, 2008. 130(42): p. 13850-13851. 
11. Abánades Lázaro, I., et al., Selective Surface PEGylation of UiO-66 Nanoparticles 
for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Delivery. Chem, 
2017. 2(4): p. 561-578. 
12. Zhong, J., et al., Recent Advances in Polymeric Nanocomposites of Metal-Organic 
Frameworks (MOFs). Polymers, 2019. 11(10): p. 1627. 
13. Horcajada, P., et al., Porous metal–organic-framework nanoscale carriers as a 
potential platform for drug delivery and imaging. Nature Materials, 2010. 9(2): p. 
172-178. 
14. Gao, X., et al., Controllable synthesis of smart multifunctional nanoscal metal-
organic framework for magnetic resonance/optical imaging and targeted drug 
delivery. ACS applied materials & interfaces, 2017. 9. 
15. Thompson, M., et al., Size-dependent adsorption and framework flexibility in DUT-
8(Ni). 2020, University of Bath. 
16. Baati, T., et al., In depth analysis of the in vivo toxicity of nanoparticles of porous 
iron(iii) metal–organic frameworks. Chemical Science, 2013. 4(4): p. 1597-1607. 
17. Coudert, F.-X., The osmotic framework adsorbed solution theory: predicting mixture 
coadsorption in flexible nanoporous materials. Physical Chemistry Chemical 
Physics, 2010. 12(36): p. 10904-10913. 
18. Millange, F., et al., Selective Sorption of Organic Molecules by the Flexible Porous 
Hybrid Metal−Organic Framework MIL-53(Fe) Controlled by Various Host−Guest 
Interactions. Chemistry of Materials, 2010. 22(14): p. 4237-4245. 
19. Ploetz, E., et al., The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, 
and COF Materials. Advanced Functional Materials. n/a(n/a): p. 1909062. 
20. Semino, R., et al., Microscopic Model of the Metal–Organic Framework/Polymer 
Interface: A First Step toward Understanding the Compatibility in Mixed Matrix 
Membranes. ACS Applied Materials & Interfaces, 2016. 8(1): p. 809-819. 
226 
 
21. Mocniak, K.A., et al., Incorporation of cisplatin into the metal–organic frameworks 
UiO66-NH2 and UiO66 – encapsulation vs. conjugation. Royal Society Chemistry 
Advances, 2015. 5(102): p. 83648-83656. 
22. Eastman, A., The formation, isolation and characterization of DNA adducts 
produced by anticancer platinum complexes. Pharmacology & Therapeutics, 1987. 
34(2): p. 155-166. 
23. Brabec, V. and M. Leng, DNA interstrand cross-links of trans-
diamminedichloroplatinum(II) are preferentially formed between guanine and 
complementary cytosine residues. Proceedings of the National Academy of Sciences, 
1993. 90(11): p. 5345-5349. 
24. Enoiu, M., J. Jiricny, and O.D. Schärer, Repair of cisplatin-induced DNA interstrand 
crosslinks by a replication-independent pathway involving transcription-coupled 
repair and translesion synthesis. Nucleic Acids Research, 2012. 40(18): p. 8953-
8964. 
25. Jung, Y. and S.J. Lippard, Direct Cellular Responses to Platinum-Induced DNA 
Damage. Chemical Reviews, 2007. 107(5): p. 1387-1407. 
26. Li, W., et al., Turning Ineffective Transplatin into a Highly Potent Anticancer Drug 
via a Prodrug Strategy for Drug Delivery and Inhibiting Cisplatin Drug Resistance. 
Bioconjugate Chemistry, 2016. 27(8): p. 1802-1806. 
 
